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Abstract 
Control of pathogens by means of plant-derived plant protection products (PPPs) can be an 
effective, sustainable and environmentally friendly method of crop protection in organic 
agriculture. Larix decidua (European larch) bark is a by-product of the wood processing 
industry and provides a readily available, low cost and sustainable raw material. It was 
therefore planned to commercialise Larix extracts, containing two highly active 
diterpenoids (larixyl acetate and larixol) into a marketable PPP, Larixyne®, to combat 
grapevine downy mildew (Plasmopara viticola) in organic farming. 
 
This thesis outlines the processes and knowledge developed in order to facilitate the 
commercialisation of Larixyne®: 
(i) Analytical protocols using high-performance liquid chromatography (HPLC) and 
gas chromatography (GC-FID) techniques to quantify larixyl acetate, larixol and 
epimanool (the primary impurity) in Larix extracts were developed.  
(ii) Methods for large scale extraction and purification of active compounds from Larix 
were optimised in line with EU specifications for products with organic 
agricultural use. Through extraction with 2-amino-2-methyl-1-propanol (AMP), 
Larix bark contained extract compositions of up to 30.53% larixyl acetate and 
8.45% larixol. Larixyl acetate and larixol extracts were isolated in sufficient 
quantity (8.0 kg) for large scale field trials. 
(iii) High-yield sources of larixyl acetate and larixol were evaluated and identified 
through screening a range of plant samples from central and northern Europe. Larix 
samples were found to vary in content of larixyl acetate (median 0.017% w/w, 
range 0.000 – 4.544% w/w), larixol (median 0.003% w/w, range 0.000 – 0.578% 
w/w), and epimanool (median 0.009% w/w, range 0.000 –0.752% w/w). 
(iv) The activity of larixyl acetate, larixol, epimanool and formulated products of Larix 
extracts against P. viticola on Vitis vinifera were demonstrated. Larixyl acetate and 
larixol exhibited excellent activity in vitro (mean MIC100 of 7 and 16 μg/mL) and 
in planta (EC50 0.2 – 0.7 mg/mL). 
 
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For teaching me to love learning.  
Pam, this one is for you. 
 
 
 v 
 
Acknowledgements 
I would firstly like to thank my supervisor Professor Dulcie Mulholland for the 
opportunity to undertake my PhD in her group and for her guidance throughout. She has 
given me many opportunities to grow and develop and for this I am truly grateful. 
 
The Natural Products Research Group has been a great comfort to me through the years; I 
am grateful to have such a supportive research group. Thank you to Dr. Moses Langat for 
his continuous advice and knowledge and to Dr. Sianne Schwikkard for her support during 
my first year. Thank you particularly to Praveen Jayarajah, who spent his industrial 
placement year working with me and Dr. Yan Sun for her analytical support. Thanks go to 
each other member that I have crossed paths with – Alice, Allah, Areej, Beth, Dorota, Jazz, 
Mina and Watcharee. To my travel buddies and PhD partners in crime, Lorraine and 
Hannah. I look forward to our future travels together as doctors! Special thanks to Lorraine 
for keeping me motivated during my write up with our morning catch up calls. 
 
Thank you to the other chemistry PhD researchers for taking this journey with me (Adam, 
Balqeez, Ben, Catia, Dan, Ed, Emily, Haz, Janella, Jo, Laura, Mahado, Mai, Max, MJ, 
Narwaal, Terry and Thom). Despite our arguments over which area of chemistry is the 
best, we would always come together at lunch time - to argue over board games.  
 
To other members of staff at the University of Surrey. Thank you to Neil Ward, for 
pushing my analytical knowledge and making me a better academic writer. To Alfred 
Thumser, for his statistical knowledge and assistance on how to spot rare African birds. 
Thanks also go to Judith Peters, Qinmin Zhang and Dr. Dan Driscoll for their technical 
support. Thank you to Dr. Alan Farnby for providing me with the magic column. 
 
I would also like to thank my ProLarix project partners for their contributions to my 
research. Thank you to Barbara for hosting me at FiBL. I thank my funding providers at 
the European Research Council and the University of Surrey for facilitating me to do this 
research. 
 
To my family, thank you for bringing me endless cups of tea and for your support, even 
though you still don’t understand what I really do. Finally, thank you to Charles, for taking 
care of me and keeping my feet on the ground. 
 vi 
 
List of Contents 
 
Declaration of originality....................................................................................................... ii 
Abstract ................................................................................................................................ iii 
Dedication ............................................................................................................................. iv 
Acknowledgements ............................................................................................................... v 
List of Contents .................................................................................................................... vi 
List of Figures ....................................................................................................................... ix 
List of Tables ....................................................................................................................... xii 
List of Equations .................................................................................................................. xv 
Abbreviations ..................................................................................................................... xvi 
Chapter 1: Introduction .................................................................................................. 2 
1.1 Grapevine downy mildew (Plasmopara viticola) ........................................................ 2 
1.2 Treatment of grapevine downy mildew in organic viticulture ..................................... 3 
1.3 Development of an organic botanical plant protection product to treat grapevine 
downy mildew .............................................................................................................. 5 
1.3.1 Activity of larixyl acetate and larixol against grapevine downy mildew 6 
1.3.2 Larix composition and quantification 9 
1.3.3 Extraction of larixyl acetate and larixol from Larix 11 
1.0 Thesis outline, aims and objectives ............................................................................ 12 
Chapter 2: Quantification and analysis of larixyl acetate, larixol and epimanool in 
Larix ............................................................................................................ 16 
2.1 Introduction ................................................................................................................ 16 
2.2 Gas chromatography – Flame ionisation detector (GC-FID) ..................................... 21 
2.3 High performance liquid chromatography (HPLC) ................................................... 23 
2.3.1 Development of HPLC separation techniques 24 
2.4 Analytical quantification parameters ......................................................................... 30 
2.4.1 HPLC quantification method 30 
2.4.2 GC-FID quantification method 30 
2.4.3 Preparation of larixyl acetate, larixol and epimanool standards 31 
2.4.4 Preparation of samples 31 
2.4.5 Limits of detection and quantification 32 
2.4.6 Linear dynamic range 33 
2.4.7 Precision 33 
2.4.8 Spike recoveries 34 
2.5 Conclusions ................................................................................................................ 35 
 vii 
 
Chapter 3: Extraction of larixyl acetate and larixol from Larix ............................... 38 
3.1 Introduction ................................................................................................................ 38 
3.2 Experimental .............................................................................................................. 40 
3.2.1 Raw materials 40 
3.2.2 Primary Soxhlet extraction of Larix bark 41 
3.2.3 Development of a large-scale Larix bark extraction method 43 
3.2.4 Purification of Larix oleoresin with sodium hydroxide (NaOH) 44 
3.2.5 Purification of Larix bark extracts and oleoresin with 2-amino-2-methyl-1-
propanol (2-amino-2-methyl-1-propanol) 44 
3.2.6 Analytical methods 46 
3.3 Results and discussion ............................................................................................... 47 
3.3.1 Primary Soxhlet extraction of Larix bark 47 
3.3.2 Preliminary investigation of solvents to extract larixyl acetate and larixol from 
Larix bark 51 
3.3.3 Investigation of economically feasible and industrially safe extraction solvents 
to extract larixyl acetate and larixol from Larix bark 61 
3.3.4 Purification of Larix oleoresin with sodium hydroxide (NaOH) 64 
3.3.5 Purification of Larix bark extracts and oleoresin with amine salt (2-amino-2-
methyl-1-propanol) 68 
3.3.6 Formulation composition 71 
3.4 Conclusions ................................................................................................................ 72 
Chapter 4: High yield sources of larixyl acetate and larixol from Larix .................. 75 
4.1 Introduction ................................................................................................................ 75 
4.2 Experimental .............................................................................................................. 76 
4.2.1 Larix milling 77 
4.2.2 Bench extraction 77 
4.2.3 Soxhlet extraction 78 
4.2.4 Analysis of extracts 79 
4.3 Results and discussion ............................................................................................... 80 
4.3.1 Levels of larixyl acetate, larixol and epimanool in Larix samples 80 
4.3.2 Total content analysis of larixyl acetate, larixol and epimanool in Larix 97 
4.3.3 Statistical evaluations of the Larix samples 101 
4.4 Conclusions .............................................................................................................. 109 
Chapter 5: Activity of larixyl acetate and larixol against Plasmopara viticola ...... 113 
5.1 Introduction .............................................................................................................. 113 
5.2 Experimental ............................................................................................................ 114 
5.2.1 Plant material 114 
5.2.2 Preparation of stock solutions and inoculum 115 
5.2.3 In vitro bioassays 116 
5.2.4 Indoor in planta bioassays 117 
 viii 
 
5.2.5 In vitro activity testing 120 
5.3 Results and discussion ............................................................................................. 121 
5.3.1 In vitro activity of larixol, larixyl acetate and Larix oleoresin formulations 
against Plasmopara viticola 121 
5.3.2 Indoor in planta activity of larixol, larixyl acetate and Larix oleoresin 
formulations against Plasmopara viticola 124 
5.3.3 In vitro activity of larixyl acetate, larixol and epimanool 132 
5.4 Conclusions .............................................................................................................. 134 
Chapter 6: General experimental techniques ........................................................... 139 
6.1 Separation techniques............................................................................................... 139 
6.1.1 Thin layer chromatography 139 
6.1.2 Column chromatography 139 
6.1.3 Flash chromatography 140 
6.2 Identification techniques .......................................................................................... 140 
6.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 140 
6.2.2 Gas-Chromatography Mass-Spectroscopy (GC-MS) 141 
6.2.3 Ultraviolet-visible (UV-Vis) spectroscopy 142 
6.3 Statistical analyses of analytical results ................................................................... 142 
6.3.1 Mean 142 
6.3.2 Median 142 
6.3.3 Standard deviation 143 
6.3.4 Relative standard deviation 143 
6.3.5 Kolmogorov-Smirnov goodness-of-fit test 143 
6.3.6 Pearson correlation coefficient 144 
6.3.7 Spearman rank correlation coefficient 144 
6.3.8 Mann-Whitney U-test 145 
6.3.9 Kruskal-Wallis test 146 
6.3.10 One-way ANOVA, Tukey HSD and Dunnett tests 146 
Chapter 7: Conclusions ............................................................................................... 148 
 
References ......................................................................................................................... 151 
 
 ix 
 
List of Figures 
 
Figure 1.1: Symptoms of grapevine downy mildew infection. Visible sporangiophores 
and sporangia on the underside of leaves (left and centre) and pale yellow 
oil spots (right) causing leaf necrosis. Taken by the author at FiBL. ................. 2 
Figure 1.2: Compounds isolated from plants that have shown activity against 
Plasmopara viticola. ........................................................................................... 6 
Figure 1.3: Epimanool, larixyl acetate and larixol. The functional group at C-6 
(circled) is different for each compound. ........................................................... 8 
Figure 1.4: Pimaric and abietic type resin acids.42,59 .......................................................... 10 
Figure 1.5: Visual outline of this thesis. Chapters are connected by dotted arrows 
where the results or outcomes (specified by text) of a chapter (origin of 
arrow) are used in another chapter (arrowhead). .............................................. 13 
Figure 2.1: Analyte peaks annotated with some commonly used chromatographic 
terms.. ............................................................................................................... 18 
Figure 2.2: The Agilent Technologies 6890N GC-FID instrument at the University of 
Surrey. ............................................................................................................... 22 
Figure 2.3: The HPLC instrument at the University of Surrey (left) and illustration of 
the instrument taken from the Varian Galaxie™ Chromatography 
software92 (right). .............................................................................................. 24 
Figure 2.4: The Pentafluorophenyl phase of an Ascentis® Express reverse phase F5 
column. Adapted from Michel.95 ...................................................................... 27 
Figure 2.5: HPLC chromatograms of a 8.9 mg/mL purified Larix decidua oleoresin 
extract with different acetonitrile mobile phase compositions. ........................ 29 
Figure 3.1: Stem bark of Larix decidua Mill. ..................................................................... 40 
Figure 3.2: Larix oleoresin from L. Cornelissen & Son (left) and C.E. Roeper GmbH 
(center and right)............................................................................................... 41 
Figure 3.3: Large-scale Soxhlet extraction apparatus, with the capacity to hold 800 g 
(left) or 500 g (right) of Larix bark. .................................................................. 42 
Figure 3.4: GC-MS chromatogram of the MeOH Soxhlet extract of Larix bark 
(conditions as reported in section 6.2.2.1) ........................................................ 49 
 x 
 
Figure 3.5: GC-MS chromatogram of the CH2Cl2 extract of Larix bark (conditions as 
reported in section 6.2.2.1). .............................................................................. 50 
Figure 3.6: 1H NMR spectrum of larixyl acetate labelled with assigned common 
identifying peaks. .............................................................................................. 56 
Figure 3.7: The secondary PE extract compositions of primary Larix bark extracts ......... 57 
Figure 3.8: GC-MS chromatogram of Larix oleoresin (C.E. Roeper GmbH). GC-MS 
conditions as reported in section 6.2.2.2........................................................... 66 
Figure 3.9: Extraction of Larix oleoresin with hexane. ...................................................... 67 
Figure 3.10: Mechanism for the formation of a resin acid-amine salt from a resin acid 
and 2-amino-2-methyl-1-propanol (AMP) ....................................................... 68 
Figure 3.11: Large-scale Larix oleoresin extraction process photographs. Resin acid 
precipitate from reaction of Larix oleoresin with AMP (left) and final 
oleoresin extract after reaction with AMP, ready to send for formulation 
into Larixyne® (right). ..................................................................................... 70 
Figure 4.1: Left: Larix samples weighed out into conical flasks before addition of 
ethanol (EtOH). Centre: Larix samples after addition of EtOH on the 
Labcon platform shaker. Right: Dry EtOH extracts after filtration. ................. 77 
Figure 4.2: Left: Larix samples after secondary extraction with petroleum ether, just 
before filtering. Centre: Petroleum ether extracts after filtering. Right: Dry 
petroleum ether extracts. ................................................................................... 78 
Figure 4.3: Soxhlet extractions of Larix samples run in series. ......................................... 79 
Figure 4.4: The concentration (% w/w of Larix) of larixyl acetate (circles), larixol 
(squares), epimanool (triangles) and combined larixyl acetate and larixol 
content (diamonds) in Larix samples. The bars represent the median and 
interquartile range of each dataset. ................................................................... 84 
Figure 4.5: Plot distribution and simplified chorology map for Larix decidua, adapted 
from Da Ronch et al.51 The frequency of Larix decidua occurrences within 
the field observations as reported by the National Forest Inventories and 
the chorology of native spatial range for L. decidua is derived after 
Wagner et al,117 both interpreted by Da Ronch et al. ....................................... 91 
Figure 4.6: The geographical location of Larix samples represented by green circles. 
Divisions of circles represent how many samples were sourced from that 
location. ............................................................................................................ 92 
Figure 4.7: Glen Creston cross-beater mill jammed with a Larix sample. ......................... 96 
 xi 
 
Figure 4.8: Comparison of Soxhlet and bench-scale extraction of the top five Larix 
samples in terms of the total combined larixyl acetate and larixol content. ... 100 
Figure 5.1: Vitis vinifera var. Chasselas plants ready for experiments. .......................... 115 
Figure 5.2: Application of products and inoculum using an air-assisted hand sprayer 
(left) and automatic spray cabinet (right). ...................................................... 118 
Figure 5.3: Impure larixyl acetate (left) and larixol (right) isolated during ForestSpeCs 
and used by FiBL for activity testing. ............................................................ 121 
Figure 5.4: Dose-response curves of larixyl acetate (LA), larixol (L) and a 6:1 
combination of larixyl acetate and larixol (LA:L) on Vitis vinifera var. 
Chasselas seedlings against Plasmopara viticola. ......................................... 126 
Figure 5.5: Efficacy of formulated Larix oleoresin extract LAR-016 and Cu2+ 
reference on grapevine seedlings against Plasmopara viticola. ..................... 128 
Figure 5.6: Efficacy of formulated Larix oleoresin extract LAR-042 and Cu2+ 
reference on grapevine seedlings against Plasmopara viticola. ..................... 130 
Figure 5.7: Inhibition of P. viticola zoospores using larixyl acetate (63 μg/mL), as 
seen in the video of larixyl acetate activity (Appendix A5.9 Larixyl 
acetate). ........................................................................................................... 133 
Figure 5.8: Inhibition of P. viticola zoospores using epimanool (63 μg/mL), as seen in 
the video of epimanool activity (Appendix A5.9 Epimanool). ...................... 134 
 xii 
 
List of Tables 
 
Table 2.1: HPLC-UV and GC-FID limits of detection and quantification for larixyl 
acetate, larixol and epimanool ........................................................................ 33 
Table 2.2: Evaluation of GC-FID precision ....................................................................... 34 
Table 2.3: Evaluation of HPLC precision........................................................................... 34 
Table 2.4: Spike recoveries of larixyl acetate, larixol and epimanool in Larix bark and 
Larix oleoresin ................................................................................................ 35 
Table 3.1: Yield and chemical composition of extracts obtained after extracting bark 
of Larix decidua with different solvents using Soxhlet extraction. ............... 47 
Table 3.2: GC-MS identification of compounds in the MeOH extract of Larix bark 
(Figure 3.4) using the NIST library.35 ............................................................ 49 
Table 3.3: GC-MS identification of compounds in the CH2Cl2 extract of Larix bark 
(Figure 3.5) using the NIST library.35 ............................................................ 50 
Table 3.4: Yield and chemical composition of extracts obtained by agitating milled 
10 mm bark of Larix decidua for five days with different solvents at 
room temperature (RT). .................................................................................. 52 
Table 3.5: Yield and chemical composition of extracts gained by re-extracting 
different Larix decidua bark extracts with petroleum ether. .......................... 59 
Table 3.6: Yield and chemical composition of extracts obtained by agitating milled 
bark of Larix decidua for eight hours with different solvents at room 
temperature (RT) or at 100 °C........................................................................ 62 
Table 3.7: Yield and chemical composition of extracts gained by re-extracting 
different Larix decidua bark extracts with petroleum ether. .......................... 63 
Table 3.8: GC-MS identification of compounds in Larix oleoresin (Figure 3.7) using 
the NIST library.35 .......................................................................................... 66 
Table 3.9: Yield and chemical composition of extracts obtained by precipitating 
diterpene acids with 2-amino-2-methyl-1-propanol (AMP) from two 
Larix decidua bark extracts of different particle size. .................................... 69 
Table 3.10: Composition of larch turpentine before and after removal of diterpene 
acids by reaction with 2-amino-2-methyl-1-propanol (AMP). ...................... 70 
Table 3.11: Composition of Larix formulations ................................................................. 71 
 xiii 
 
Table 4.1: Levels of precision for larixyl acetate, larixol and epimanool concentrations 
in Larix samples. ............................................................................................ 81 
Table 4.2: Median and range of ethanol (EtOH) and petroleum ether (PE) extract 
yields in Larix samples. Number of samples = 50. ........................................ 83 
Table 4.3: Median and range of larixyl acetate, larixol and epimanool concentrations 
in the petroleum ether extract of Larix samples. Number of samples = 50. .. 83 
Table 4.4: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples. Number of samples = 50. ................................................... 85 
Table 4.5a: The extract (primary EtOH and secondary PE) yields and concentrations 
(% w/w of Larix samples and PE extract) for the 10 Larix samples with 
the highest yields of larixyl acetate and larixol. Samples are organised 
from highest to lowest total concentration of larixyl acetate and larixol 
combined in the Larix samples (final column - highlighted). ........................ 87 
Table 4.6: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by species. ............................................................. 90 
Table 4.7: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by country of origin. ............................................. 94 
Table 4.8: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by elevation. ......................................................... 95 
Table 4.9: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by tree part. ........................................................... 96 
Table 4.10: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by colour. .............................................................. 97 
Table 4.11: Soxhlet extraction data of the top fivea Larix samples: total extract yields 
and concentrations of larixyl acetate, larixol and epimanool in extracts. 
The total concentration of larixyl acetate and larixol combined in the 
plant material is shown for direct comparison with bench extraction in 
Table 4.12. ...................................................................................................... 98 
Table 4.12: Comparison of the Soxhlet and bench-scale extraction of the top fivea 
Larix samples in terms of the yield of combined larixyl acetate and 
larixol extracted. ........................................................................................... 100 
Table 4.13: Spearman rank correlation coefficients (rS) for the relationship between 
the percentage mass of larixyl acetate, larixol and epimanool in the Larix 
samples. ........................................................................................................ 102 
 xiv 
 
Table 4.14: Spearman rank correlation coefficients (rS) for the relationship between 
compound percentage mass in the Larix samples and the latitude, 
longitude and elevation the samples originated from. .................................. 103 
Table 4.15: Median larixyl acetate, larixol and epimanool levels in the Larix samples 
for each elevation group and the Kruskal-Wallis statistical test for the 
significant difference. ................................................................................... 103 
Table 4.16: Mann-Whitney U test (one tailed) for Elevation. .......................................... 103 
Table 4.17: Standardised Mann-Whitney U test (one tailed) for Elevation ..................... 104 
Table 4.18: Median larixyl acetate, larixol and epimanool levels in the Larix samples 
for each country group and the Kruskal-Wallis statistical test for the 
significant difference. ................................................................................... 105 
Table 4.19: Mann-Whitney U test (one tailed) for Country. ............................................ 105 
Table 4.20: Median larixyl acetate, larixol and epimanool levels in the Larix samples 
for each tree part and the Kruskal-Wallis statistical test for the significant 
difference. ..................................................................................................... 106 
Table 4.21: Mann-Whitney U test (one tailed) for tree part. ............................................ 107 
Table 4.22: Standardised Mann-Whitney U test (one tailed) for tree part. ...................... 107 
Table 4.23: Median larixyl acetate, larixol and epimanool levels in the Larix samples 
for each colour and the Kruskal-Wallis statistical test for the significant 
difference. ..................................................................................................... 107 
Table 4.24: Mann-Whitney U test (one tailed) for colour. ............................................... 108 
Table 4.25: Standardised Mann-Whitney U test (one tailed) for colour. ......................... 108 
Table 5.1: Minimal inhibitory concentrations (MIC100) of a series of different 
treatments against Plasmopara viticola in in vitro experiments. The 
MIC100 values of LAR-016 and LAR-042 indicate the plant extract 
concentrations contained in the formulations. .............................................. 122 
Table 6.1: The solvent system used to separate crude extracts using a Reveleris® X2 
Flash Chromatography System .................................................................... 140 
 xv 
 
List of Equations 
 
Equation 2.1: Peak resolution ............................................................................................ 19 
Equation 2.2: Purnell equation ........................................................................................... 19 
Equation 2.3:  Martin and Synge plate model .................................................................... 20 
Equation 2.4:  The Van Deemter equation ......................................................................... 20 
Equation 2.5:  The Golay equation .................................................................................... 21 
Equation 5.1: 95% Confidence interval ........................................................................... 117 
Equation 5.2: Efficacy ..................................................................................................... 119 
Equation 5.3: EC50 ........................................................................................................... 120 
Equation 5.4: Arcsin-transformation................................................................................ 120 
Equation 6.1: Mean .......................................................................................................... 142 
Equation 6.2: Standard deviation of a population ............................................................ 143 
Equation 6.3: Standard deviation of a sample.................................................................. 143 
Equation 6.4: Relative standard deviation ....................................................................... 143 
Equation 6.5: Kolmogorov-Smirnov goodness-of-fit ...................................................... 143 
Equation 6.6: Pearson correlation coefficient .................................................................. 144 
Equation 6.7:  Spearman correlation coefficient (no tied-ranks) ..................................... 144 
Equation 6.8: Spearman correlation coefficient (tied-rank)............................................. 144 
Equation 6.9: Mann-Whitney U-test ................................................................................ 145 
Equation 6.10: Standardised Mann-Whitney U-test ........................................................ 145 
Equation 6.11: Kruskal-Wallis test .................................................................................. 146 
 xvi 
 
Abbreviations 
°C degrees centigrade 
13C NMR carbon 13-nuclear magnetic 
resonance 
1D one dimension 
1H NMR proton nuclear magnetic 
resonance 
Ac acetyl 
AMP amino-2-methyl-1-propanol 
A.S.L Above sea level 
CI Confidence interval 
Conc. concentrated 
d doublet 
dd double doublet 
DMSO dimethyl sulfoxide 
EC European Commission 
EC50 The half maximal effective 
concentration  
Et ethyl 
EU European Union 
FiBL Forschungsinstitute fur 
Biologischenlandbau 
Stiftung (the Research 
Institute of Organic 
Agriculture) 
GAB GAB Consulting GmbH 
GC gas chromatography 
GC-FID gas chromatography–flame 
ionisation detector 
GC-MS gas chromatography–mass 
spectroscopy 
HPLC High performance liquid 
chromatography 
I.D Internal diameter 
J coupling constant 
LC Liquid chromatography 
LOD Limit of detection 
LOQ Limit of quantification 
mAU milli arbitrary units 
Me methyl 
MIC Minimum inhibitory 
concentration 
MS  mass Spectrometry 
n.s. not significant 
NMR nuclear magnetic resonance 
spectroscopy 
NP Normal phase 
chromatography 
ns not significantly different  
PE Petroleum ether 
PPP plant protection product 
ppm Parts per million 
q quartet 
RP Reverse phase 
chromatography 
RSD Relative standard deviation 
s singlet 
SURR University of Surrey 
t triplet 
TM Trifolio-M GmbH 
UHEL University of Helsinki 
UK United Kingdom 
  
 
  
 
 
 
 
 
 
 
 
Chapter 1 
 
Introduction 
 
Chapter 1: Introduction 
 
 
2 
Chapter 1: Introduction  
1.1 Grapevine downy mildew (Plasmopara viticola) 
Grapevine downy mildew, caused by Plasmopara viticola (Berk. & M.A. Curtis) Berl. & 
De Toni, is an oomycete that has caused widespread problems in European vineyards since 
the early 20th century.1  
 
P. viticola oospores are produced in dry conditions, when sporulation is less favourable.1 
Mature oospores germinate in response to water, to form sporangia (a structure in which 
spores are formed). The disease is propagated through vineyards by movement of oospores 
and sporangia in water droplets through rain splash.2 These water droplets land on leaves 
and cause the release of self-propelling zoospores from the sporangia. Zoospores swim 
towards and settle inside or in the proximity of the stomata, where they germinate and 
penetrate the leaf to cause infection.3 Although P. viticola primarily infects through the 
stomata, zoospores can also encyst through grape berry legions.4  
   
Figure 1.1: Symptoms of grapevine downy mildew infection. Visible sporangiophores and 
sporangia on the underside of leaves (left and centre) and pale yellow oil 
spots (right) causing leaf necrosis. Taken by the author at FiBL. 
Sporangiophores and sporangia observable on the underside of the leaves and pale yellow 
oil spots are classic grapevine downy mildew symptoms (Figure 1.1).1,5 Both symptoms 
lead to leaf necrosis. Infestation of P. viticola can also cause damage and dehydration to 
the grapes,5 which means they can no longer be used to produce commercial consumable 
products. Grapevine downy mildew can therefore cause huge loss of grape yield (up to 
100%) due to its effects on berries and leaves.1,5 
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1.2 Treatment of grapevine downy mildew in organic 
viticulture 
The Soil Association Organic Market Report 2014 states that consumers are becoming 
more conscious of the benefits of purchasing organic produce, with the reduction in the 
amount of pesticides used and health benefits cited as the top motivators for buying.6 At 
the end of 2012, FiBL noted that Europe contained the largest portion (30%) of the world’s 
organic land, with a total of 11.2 million hectares of organic land being managed by more 
than 320,000 farms.7 As the organic food market is growing in popularity, creating an 
organic agrochemical solution to treat grapevine downy mildew and provide the organic 
market with a predictable supply of grapevine products would greatly increase grape 
producer’s market potential.8 
 
The Council of the European Union recommends the use of natural processes for all 
aspects of organic viticulture, including in plant nutrition, the soil and disease control 
(Regulation (EC) No. 834/2007).9–11 Plant protection products may only be applied in 
organic agriculture after preventative cultivation methods have been exploited. Some Vitis 
vinifera cultivars have resistance to grapevine downy mildew; however organic wine 
consumers still demand wine made from disease-susceptible cultivars and in some 
traditional wine-growing regions, the planting of more robust cultivars is illegal.8  
 
Necessary direct control has been permitted where cultivation techniques do not offer 
sufficient crop protection.8 Grapevine downy mildew is a high-risk disease and so 
prevention of its infestation must be managed through the use of agrochemicals. Where 
natural products are not available in sufficient quantities or qualities and there are no other 
effective alternatives to control a harmful organism, substances from other sources (such 
as copper-based products) may be authorised by the European Union for use in organic 
agriculture.10 Copper-based fungicides are so far the only highly effective means available 
to control P. viticola in organic viticulture.12 
 
The first commercial formulation of a copper fungicide used in vineyards was the 
‘Bordeaux mixture’, which contains a mixture of copper sulfate and copper hydroxide.1 
Cuproxat® (copper sulfate)13, Bentoram® (copper hydroxide)13 and Kocide 2000® 
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(copper hydroxide)14 are common copper-containing fungicides currently available on the 
market to prevent the spread of grapevine downy mildew. 
 
However, although very effective, copper-based agrochemicals are a cause for 
environmental and toxicological concern.15 Agrochemical wash-off from treated vineyards 
can enter aquatic systems through soil leaching, leading to bioaccumulation and 
biotoxicity.15,16 Plants and soil-based-ecosystems are also adversely affected by the 
accumulation of copper in soil.17  
 
Copper is essential for the structure and catalytic function of a variety of biological 
enzymes, including cytochrome c oxidase.18 However, when Cu2+ is reduced to Cu+ it can 
catalyse the formation of highly reactive hydroxyl radicals from hydrogen peroxide, which 
can then initiate the formation of protein and lipid radicals.19 One particular concern is that 
hydroxide radicals are destructive to deoxyribonucleic acid (DNA) through the cleavage of 
phosphoester bonds between nucleotides, or oxidation of bases.20 The human adult body 
typically contains less than 100 mg of copper,21 the highest concentrations residing in the 
liver and the brain. Damage to the regulation of copper in the body has been linked to 
oxidative stress in many neurodegenerative disorders such as Alzheimer’s, Prion and 
Parkinson’s diseases.22 
 
Furthermore, excessive copper concentrations in fungicide residues may also affect the 
fermentation and sensory quality of wine.23,24 The European Commission has therefore set 
maximum residue levels for grapes used in wine and other consumption, which vary (0.2 –
5.0 mg/kg) depending on the fungicide used.25 
 
There is also a restriction on the amount of copper allowed to be applied to both organic 
and non-organic soil in the UK and Europe due to its impact on human health and the 
environment. European Council Regulations (EC) No. 834/2007 and No. 889/2008 on 
organic production and labelling of organic products define the maximum use of copper 
fungicide (in the form of copper hydroxide, oxychloride (tribasic), sulfate, oxide or 
octanoate) as 6 kg copper per hectare per year10,26. Organic grapes used in the production 
of organic wine must be sourced from vineyards grown using organic farming methods 
defined in these regulations, without the use of synthetic fertilisers, agrochemicals or plant 
treatments.  
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Farmers can implement warning models to reduce the amount of copper applied to at-risk 
crops.27 These systems require the daily input of easily collected data, such as temperature, 
rainfall and plant growth (since last fungicide application), to predict the optimum time 
and rate of copper treatment. Although the use of warning models reduces copper 
application, they do not eliminate the presence of copper in the environment or prevent 
long-term consequences caused by the accumulation of copper in soil. Reducing and 
ultimately eradicating the use of copper in agrochemicals is therefore a priority and 
presents high business potential to the farming and environmentally-conscious market. 
 
1.3 Development of an organic botanical plant protection 
product to treat grapevine downy mildew 
Some plant-based alternatives to copper treatment have offered promising activity against 
P. viticola, such as extracts of Rheum rhabarbarum (rhubarb),12 Juncus effusus (common 
rush),28 Salvia officinalis (sage),29 Glycyrrhiza glabra (liquorice) leaf,30 Vitis vinifera 
(grapevine) canes,31 Inula viscosa (false yellowhead),32 and essential tea tree and clove 
oils.13 The structures of some of the active compounds identified in these species can be 
seen in Figure 1.2. 
 
However, many of the potential replacements have high levels of phytotoxicity, 
inconsistent activities, high costs, low availability or low rainfastness (due to their 
solubility in water), which are large disadvantages for a marketable plant protection 
product. Therefore, there is a gap in the market to provide an effective, non-phytotoxic and 
rainfast plant protection product (PPP) that has low raw material costs and high 
extractability, to treat grapevine downy mildew without using copper. 
 
About 50 Mm3 of waste bark material is produced annually by the European forestry 
industry34 and it is mainly used as an energy source. However, this readily available, cheap 
and renewable by-product of the forestry industry has great potential to become a raw 
material for conversion into a high value-added product. 
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Figure 1.2: Compounds isolated from plants that have shown activity against Plasmopara 
viticola. †Dehydroeffusol from Juncus effusus (common rush).28 ‡E-vitisin B, 
the most toxic out of six active compounds isolated from Vitis vinifera 
(grapevine) canes.31 §Licoflavone, §pinocembrin and §glabranin, potentially 
active compounds from Glycyrrhiza glabra (liquorice) leaf.30,33 ◊Tomentosin, 
◊inuvisculid and ◊costic acid from Inula viscosa (false yellowhead).32  
1.3.1 Activity of larixyl acetate and larixol against grapevine downy mildew 
In the EU research project, ForestSpeCs, the bark from five tree species from the Pinaceae 
(pine) family was identified as containing constituents with good to excellent activity 
against P. viticola under greenhouse conditions (Appendix A1.1).35 Three of these species 
were from the Larix genus (Larix decidua Mill., Larix gmelinii (Rupr.) Kuzen., and Larix 
sibirica Ledeb.). A range of active Larix compounds were characterised, including the 
diterpenoids larixyl acetate and larixol), and the lignans lariciresinol and lariciresinol 
acetate.36  
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The work described in this thesis was carried out within the framework of a European 
Commission’s 7th Framework Programme for Research and Technological Development 
project, known as ProLarix (EC Grant agreement number 613600).37–39 The ProLarix 
collaboration consisted of researchers from the University of Surrey, University of 
Helsinki, Forschungsinstitute fur Biologischenlandbau Stiftung (FiBL) and Trifolio-M 
GmbH. Completing the team were consultants in registering a plant protection product 
from GAB Consulting GmbH. The overall objective of the ProLarix project was to 
‘facilitate the market introduction of an innovative plant protection product made from by-
products of the European forest industry’. This plant protection product is Larixyne®.  
 
There are 11 species of the Larix genus. Larix decidua is the only native species in 
Europe,40 which is why it is commonly referred to as the European larch. It has been 
widely reported that L. decidua and L. gmelinii contain large amounts of the labdane-type 
diterpenoids larixol and larixyl acetate41–44. The oleoresin from L. decidua is found to 
differ from other Pinaceae resins by containing higher amounts of larixyl acetate, larixol 
and epimanool,45 which are used as characteristic markers to identify larch oleoresin.46 
Due to the large abundance of L. decidua in Europe and its high larixyl acetate and larixol 
content, the work in this thesis and the ProLarix project focused on L. decidua as a source 
of raw material (both bark and oleoresin) and larixyl acetate and larixol as the active 
constituents. Larixyne® is therefore the plant protection product produced from the Larix 
extract of larixyl acetate and larixol, after final formulation. 
 
To bring Larixyne® to the European organic farming market, the demonstration of 
predictable and consistent disease control was required.12 However, the activity of 
Larixyne® against P. viticola had not yet been evaluated under field conditions, due to 
limitations in extracting enough of the active constituents from Larix for field trials during 
the ForestSpeCs project.38 Therefore, it was essential to identify high-yield sources and 
optimise the extraction process to produce a large amount purified Larix extract, which 
contained a high amount of larixyl acetate and larixol so that field trials could be 
undertaken. The up-scale extraction process would also be required for production of 
Larixyne®. 
 
For registration of Larixyne® as a plant protection product, it must contain a high 
concentration of active constituents (larixyl acetate and larixol), a low concentration or 
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absence of constituents of concern, and an acceptable variation of constituents of no 
interest.38,47 The development of analytical tools was thus needed to quantify larixyl 
acetate and larixol in Larix extracts for the purposes of registration, production and quality 
control. Furthermore, knowledge of the activity (minimum inhibitory concentrations and 
effective concentration values) of these compounds was also required to determine their 
formulation composition. Due to the similarity in structure of epimanool to larixyl acetate 
and larixol (Figure 1.3), epimanool was found to be a primary impurity of Larix extracts. 
The epimanool content of L. decidua therefore needed to be investigated, alongside the 
larixyl acetate and larixol content, for the purposes of Larixyne® registration. 
 
 Anti-fungal activity of larixyl acetate, larixol or L. decidua bark extracts have not been 
reported in the literature nor protected by patents prior to the ForestSpeCs or ProLarix 
projects. Therefore, there was an opportunity for prior ForestSpeCs and current ProLarix 
partners to protect the intellectual property of using Larix-based extracts, larixyl acetate 
and larixol as antifungal agents in plant protection (primarily against the pathogen 
Plasmopara viticola), alongside their registration as the PPP, Larixyne®. 
 
 
Figure 1.3: Epimanool, larixyl acetate and larixol. The functional group at C-6 (circled) is 
different for each compound. 
Epimanool Larixyl 
acetate 
Larixol 
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Additionally, as antifungal activity has not been reported, the physical mode of action 
(observable effects of a fungicide on the host-pathogen interaction) of larixyl acetate and 
larixol against P. viticola was also unknown. Understanding their mode of action could 
help to optimise the product application time as part of disease warning models, to 
improve efficacy against disease.48 Therefore, knowledge of the mode of action would be 
beneficial for future optimisation of larixyl acetate and larixol as plant protection 
products.49  
1.3.2 Larix composition and quantification 
L. decidua is a deciduous coniferous tree native to the high mountainous regions of Europe 
(Alps, Carpathians and Sudetes)40 and can grow at high latitudes and high altitudes, 
between 600 and 2500 m above sea level (a.s.l.).40,50 Trees range in average height of 40 –
55 m, but can grow up to 100 m tall.50 There are three common varieties of Larix decidua 
Mill. recognised (Var. decidua, Var. carpatica and Var. polonica), which differ in their 
distribution and seed cone size.50 
 
The wood from L. decidua is an economically and traditionally important timber and has 
been harvested for centuries by European foresters. Its fast-growth, durability and water 
resistance makes it highly suitable for use in construction and shipbuilding.40,50 L. decidua 
timber has been traditionally used to construct fences, wooden houses, furniture and 
railway sleepers.51 It is also used to make pulpwood for the paper industry.50 Sawdust that 
is produced during the processing of the wood is mainly used in the production of pellet 
fuels,52,53 but has also been used medically to treat inflammation.54 
 
L. decidua produces a transparent, sticky yellow oleoresin known either as Venetian or 
larch turpentine, which is commercially obtained by the live tapping of trees.45 Oleoresin is 
produced both naturally, and induced through stressful events, such as mechanical damage, 
nutrient deficiency and extreme changes in temperature.55 Conifer oleoresins, including 
those of the Pinaceae family (Larix, Picea, Abies and Pinus), are thought to be natural 
protectants against insects and their associated pathogens.56 Larix oleoresin inhibits fungal 
growth on trees and is highly toxic to bark-beetle eggs and larvae.57  
 
Oleoresin and the outer layers of tree bark are non-living parts of the tree that can store 
highly active compounds for use as a chemical defence against pathogens, herbivores and 
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other competitive plant species.55 Bioactive diterpenoids are a large contributor to the 
defence mechanisms of plants.55 Diterpenoids (C20) are made up from the head to tail 
combination of four isoprene units. Diterpene acids of the isopimarane and abietane type 
are present in most Pinaceae oleoresins, where isopimaric, sandaracopimaric, palustric, 
abietic, neoabietic and dehydroabietic acids are abundant.58 Pimaric type resin acids have 
methyl and vinyl substituents at C-13, whereas abietic type resin acids have an isopropyl 
side chain at C-13 (Figure 1.4). 
 
Figure 1.4: Pimaric and abietic type resin acids.42,59 
Other Larix chemical constituents (flavonoids, tannins, fatty acids and phenols) have been 
found to vary within and between species, with the time of year, with age, geographical 
origin (including growth elevation), trunk height and also radial distance from the pith to 
the heart-wood-sapwood boundary.52,60–64 
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In contrast, the quantitative composition of larixyl acetate, larixol and epimanool in Larix 
from different geographical sources and with differing physical characteristics has been 
given little attention in the literature. One paper determined the epimanool and larixol 
acetate heartwood content at different heights,65 however the method of quantitation was 
questionable due to poor chromatogram resolution. In the method used, larixol also eluted 
together with dehydroabietic acid, so it was impossible to determine its exact 
concentrations.65 Seki et al. reported a gas chromatography quantification method to 
determine that larixyl acetate, larixol and epimanool were present in higher concentrations 
in the secondary phloem (living inner bark) compared to the rhytidome (outer bark).66 
However the method used involved derivitisation of the diterpenoids into their 
corresponding methyl esters, which introduced a source of error for accurate 
quantification. 
 
These methods highlight the need for a reliable quantification method to determine simply 
larixyl acetate, larixol and epimanool concentrations in plant extracts. This would open up 
the opportunity to investigate Larix sources with the highest concentrations of active 
compounds, to optimise extraction yields for commercial viability of a plant protection 
product containing these compounds. 
1.3.3 Extraction of larixyl acetate and larixol from Larix 
The European Union Council Regulation (EC) No 834/2007 on organic production and 
labelling of organic products states that all plant production techniques used shall prevent 
or minimise any contribution to the contamination of the environment.10 Furthermore, 
organic production requires the use of naturally-derived substances (no synthetic 
derivatives).10  
 
Chlorinated solvents, once released into the environment, are subject to natural microbial 
degradation that gives rise to highly persistent, toxic and mobile carcinogens.67 Therefore, 
chlorinated solvents that are commonly used in natural products extraction (e.g. 
dichloromethane, chloroform) may not be used in the extraction of an organic plant 
protection product.  
 
Successful extraction of terpenoids from plants has however been achieved using polar 
solvents, such as ethanol, followed by re-extraction with less-polar solvents, such as 
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hexane.68 Pferschy-Wenzig et al. extracted larixol (0.0028%) and larixyl acetate 
(1.1385%) from an n-heptane extract of Larix decidua sawdust (0.5% primary extract 
yield) using a series of chromatographic columns.69 Other researchers have been 
successful in isolating either larixyl acetate, larixol or epimanool from Larix using 
dichloromethane on a small-scale.70 Diethyl ether66 and petroleum ether71 have also been 
used to extract the compounds, showing that it is possible to extract larixyl acetate and 
larixol from plants without using chlorinated solvents or chemically altering the molecules, 
hence using methods acceptable for the organic farming community. Large-scale methods 
of larixyl acetate or larixol extraction from Larix (suitable for organic farming or 
otherwise) have not been reported in the literature. Thus, for the advancement of 
Larixyne® as a plant protection product, there is a need to develop an innovative large-
scale extraction method of larixyl acetate and larixol from Larix that meets the 
requirements for organic production. 
1.0 Thesis outline, aims and objectives 
The overall aim of this work was to provide the tools needed to commercialise an organic 
botanical plant protection product from Larix by-products, which could be used to treat 
Plasmopara viticola. The specific aims of this research to achieve the overall project aim 
were to: determine the concentration of larixyl acetate, larixol and epimanool in Larix 
extracts (Chapter 2); produce an organic, industrially-scalable method of extracting larixyl 
acetate and larixol from Larix by-products (Chapter 3); identify where Larix could be 
sourced for high-yield, up-scale extraction of larixyl acetate and epimanool (Chapter 4); 
and determine the activity and mode of action of larixyl acetate, larixol and epimanool 
against Plasmopara viticola (Chapter 5). General experimental techniques are presented in 
Chapter 6 and thesis conclusions are discussed in Chapter 7. 
 
A visual outline of this thesis is illustrated in Figure 1.5, which shows that some of the 
chapters are connected by the results or outcomes of one chapter being used in another. 
The quantification method developed in Chapter 2 was used in Chapters 3 and 4, the 
extraction method developed in Chapter 3 was used in Chapter 4, and some of the extracts 
extracted in Chapter 3 were used in Chapters 2 and 5. 
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Figure 1.5: Visual outline of this thesis. Chapters are connected by dotted arrows where 
the results or outcomes (specified by text) of a chapter (origin of arrow) are 
used in another chapter (arrowhead). 
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The detailed objectives of this research were: 
Objective 1: 
 
To produce a validated method of quantification for larixyl acetate, larixol 
and epimanool in Larix extracts using high-performance liquid-
chromatography (HPLC) and gas chromatography (GC). (Discussed in 
Chapter 2.) 
Objective 2: 
 
To develop a method to extract high-yields of larixyl acetate and larixol 
from Larix bark that was suitable for organic farming, which can be scaled 
to pilot-plant level. (Discussed in Chapter 3.) 
Objective 3: 
 
To determine a high-recovery extraction method of larixyl acetate and 
larixol from Larix decidua oleoresin using methods acceptable for organic 
farming and to evaluate if this alternative botanical material had a higher 
recovery-yield than L. decidua stem bark. (Discussed in Chapter 3.) 
Objective 4: 
 
To quantify experimentally the larixyl acetate, larixol and epimanool content 
in 50 samples of Larix raw material from different sources in central and 
northern Europe. (Discussed in Chapter 4.) 
Objective 5: 
 
To compare the concentrations of larixyl acetate and larixol in Larix 
samples, to identify the highest-yielding sources of larixyl acetate and 
larixol. (Discussed in Chapter 4.) 
Objective 6: 
 
To evaluate statistically whether the species, geographical (country of 
growth, elevation) or physical (tree part, colour) properties of the Larix 
samples affect their larixyl acetate, larixol or epimanool concentration.  
(Discussed in Chapter 4.) 
Objective 7: 
 
To determine the in vitro and in vivo activity of larixyl acetate, larixol and 
epimanool against Plasmopara viticola and to investigate their mode of 
action. (Discussed in Chapter 5.) 
 
  
 
Chapter 2 
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Chapter 2: Quantification and analysis of larixyl acetate, larixol 
and epimanool in Larix  
2.1 Introduction 
The primary aim of the work described in this chapter was to quantify the content of 
larixyl acetate, larixol and epimanool in extracts of Larix. This work discusses the results 
from objective 2 of this thesis, which was to produce a validated method of quantification 
for larixyl acetate, larixol and epimanool in Larix extracts using high-performance liquid-
chromatography (HPLC) and gas chromatography (GC). 
 
Extracts produced during the extraction method development process (Chapter 3) needed 
to be quantified for larixyl acetate and larixol (the two active compounds) and epimanool 
(the primary impurity) content. This information was necessary to assess the quality of 
extracts produced and support progression of the most appropriate extraction method. 
Quantification of the compounds was also necessary to evaluate the Larix sample extracts 
discussed in Chapter 4 to determine the highest-yielding sources. 
 
According to Commission Regulation (EU) No 284/2013, detailed quantitative and 
qualitative information on the composition of active substances in the plant protection 
product was required for registration of Larixyne® within the European Union.72 
Quantitative analytical methods were therefore also required for registration, and 
additionally patenting, of Larixyne® as a plant protection product. 
 
It was anticipated that the quantitative methods would be adapted by future manufacturers 
of Larixyne® for their specific needs during production and quality control. Therefore, the 
quantitative methods developed needed to be simple, to ease transferral and 
implementation of them to ProLarix partners and other external organisations once the 
ProLarix project was complete.  
 
Analysis using gas chromatography was found to be reliable, easy to run with a large 
throughput of samples, easy to maintain and provided an initial good baseline separation 
(resolution) of larixyl acetate, larixol and epimanool using a standard method. 
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Quantification of larixyl acetate, larixol and epimanool using GC with a flame ionisation 
detector (FID) was therefore first developed. 
 
Trifolio-M was a key industrial ProLarix partner, who were required to quantify larixyl 
acetate and larixol content in Larix extracts during up scaling of extraction methods in 
their pilot plant. After visiting their laboratory, it was evident that their gas 
chromatography instrument was not up to the standard needed for quantitative analysis (no 
auto-sampler or digital data analysis capabilities). It was thus necessary to develop a 
second method to quantify the extracts using HPLC, a technique that they were familiar 
with and had suitable equipment with which to perform analysis. HPLC is also widely 
used for the separation and quantification of natural products73–76 and for the analysis of 
non-volatile compounds. 
 
Analysis of the resin acid content of Larix extracts was out of scope of this research study. 
Resin acids in different matrices have been widely studied using various GC65,77–79 and 
HPLC80,81 techniques reported in the literature. However, a reliable quantification method 
specific to larixyl acetate, larixol and epimanool in Larix could not be located in the 
literature and so it was necessary to develop one for the work discussed in this thesis. 
 
Chromatography encompasses a wide range of separation techniques that involve a 
stationary and mobile phase. Separation of compounds is achieved by the difference in 
affinity between the compounds for the two phases. Modifying the phases can create a 
greater separation of molecules by optimising their affinity for either phase. 
 
Quantification uses peak area or height to determine the concentration of a compound in a 
sample. External or internal standards can be used to reliably quantify samples. Peak 
height or peak area responses provide a measurement of detector signal. Peak height 
measurements can be used when peaks have near perfect symmetry. However, as this is 
often rare, peak area was used. External standards were run separately to samples for 
analysis and calibration curves were constructed from these results. Analysed sample 
response was compared to this calibration curve to calculate the concentration of the 
analyte. 
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Peaks to be quantified must be characterized so that standard solutions can be prepared for 
instrument response calibration. For accurate quantitation, peaks must be well resolved and 
maintain a good baseline. Peaks that are well separated can be easily and reproducibly 
integrated because other peaks will not interfere with the height and area of the peak of 
interest. Sloping or noisy baselines can cause irreproducible integration results. Peak 
symmetry is also important for achieving a good quantitative result; peaks with poor 
symmetry or peaks indicating two poorly resolved compounds (with shoulders, tailing or 
fronting) will not be integrated reproducibly and lead to poor quantitative analysis. 
 
Optimisation of the chromatographic method was necessary to result in effective 
quantification of analytes.  Selection of poor chromatographic conditions can result in no 
separation of analytes, poor resolution of peaks and peaks that are difficult to integrate. 
Good chromatographic conditions result in good baseline separation of peaks (peak 
resolution), which are tall, sharp and narrow. Furthermore, effective optimisation can 
speed up separation by resolving more analyte peaks in the same time period, leading to 
shorter analysis timeframes. 
 
Figure 2.1: Analyte peaks annotated with some commonly used chromatographic terms.  
 t0 = dead volume, or the time a baseline disturbance is seen due to 
differences in detector response as the injection solvent passes through the 
detector. tR1 = retention time of peak 1. w1/2= width of the peak at ½ peak 
height. wb1= base width of peak 1. h = peak height. 
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Resolution is the separation ability of the chromatographic system. Peak resolution (𝑅𝑠) is 
calculated using the separation of two peaks in terms of their average base peak width 
(Equation 2.1 and Figure 2.1).82 It is affected by efficiency, selectivity (separation factor) 
and retention (capacity factor), according to the Purnell equation (Equation 2.2).83 
𝑅𝑠 =
(𝑡𝑅2 − 𝑡𝑅1)
(𝑤𝑏1 + 𝑤𝑏2)/2
 
Equation 2.1: 
Peak resolution 
Where 𝑡𝑅= peak retention time and 𝑤𝑏= base peak width 
 
𝑅𝑠 = (
Efficiency
√𝑁
4
) × (
Selectivity
𝛼 − 1
𝛼
) × (
Retention
𝑘
1 + 𝑘
) 
Equation 2.2: 
Purnell equation 
Where 𝑘 = capacity factor, 𝛼 = selectivity factor and 𝑁 = number of theoretical plates: 
𝑘 =  
(𝑡𝑅 − 𝑡0)
𝑡0
     𝛼 =
𝑘2
𝑘1
     𝑁 = 5.54 (
𝑡𝑅
𝑤1
2⁄
)
2
 
Where 𝑡0 = dead time (non-retained compound) and 𝑤1 2⁄ = width of the peak at ½ peak 
height. 
 
Retention indicates how long an analyte has been interacting with the column. The 
retention capacity factor (𝑘) is the ratio between the retention time of an analyte retained 
on the column (𝑡𝑅), compared to a non-retained compound that has no affinity for the 
stationary phase (𝑡0), as expressed in Equation 2.2. Adjusting the retention to improve 
resolution can be achieved easily (for HPLC) by changing the composition of the mobile 
phase, which will therefore change the amount of time an analyte spends interacting with 
the stationary phase. 
 
Selectivity is the separation factor, which is the ability of the chromatographic system to 
distinguish chemically between analytes. Analytes co-elute when α = 1, so α must be 
greater than 1 for good resolution. Selectivity is affected by the chemistry of the analytes, 
mobile phase and stationary phase. Therefore, adjusting the selectivity is often the most 
powerful way to improve resolution.84 
 
Column efficiency is the quantity of analyte partitions between the stationary and mobile 
phase and is measured by the theoretical plate number (𝑁, Equation 2.2). Loss of 
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efficiency (low plate number) causes band (peak) spreading or broadening. Greater 
efficiency (high plate number) results in narrow peaks, which leads to better resolution and 
more chromatographic power.  
 
The distance an analyte travels in the mobile phase when undergoing one theoretical 
partition is called the height equivalent to one theoretical plate (𝐻).82 𝐻 and 𝑁 are related 
to column length (Equation 2.3).85 In HPLC, the Van Deemter equation (Equation 2.4) 
relates 𝐻 to column flow rate (linear velocity).  
 
𝐻 =
𝐿
𝑁
 Equation 2.3:  Martin and Synge plate model 
Where 𝐻 = Height equivalent to one theoretical plate, 𝐿 = column length and 𝑁 = number 
of theoretical plates. 
 
𝐻 = 𝐴 +
𝐵
𝜇
+ 𝐶𝜇 Equation 2.4:  The Van Deemter equation 
Where 𝑯 = Height equivalent to one theoretical plate, 𝑨 = term relating to eddy diffusion, 
𝑩 = term relating to longitudinal diffusion, µ = flow rate and 𝑪 = term relating to mass 
transfer. 
Eddy diffusion, represented by term 𝐴 in the Van Deemter equation, is the flow path of the 
analyte through the column. Peaks broaden due to analytes taking different paths through 
the column, caused by inhomogeneity in column packing and particle size.86 It is 
independent of flow rate. Longitudinal diffusion (𝐵) is the analyte molecular spread within 
the column. A high flow rate prevents peak broadening by reducing longitudinal diffusion. 
Mass transfer (𝐶) relates to analyte migration between mobile and stationary phases and its 
residence time on the stationary phase. A low flow rate and small stationary phase particle 
and pore size is desired, to minimise mass transfer effects on peak broadening. Optimum 
conditions have a high theoretical plate number, therefore minimum values of 𝐻 are 
desired. 
 
The Golay equation (Equation 2.5) has the same principles as the Van Deemter equation 
but applies to capillary gas chromatography columns.87 GC chromatography does not 
involve packed particles in separation, therefore there is no Eddy diffusion and hence no 
term for this in the equation. Denser gases reduce the longitudinal diffusion term (𝐵), 
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hence the lighter hydrogen and helium gases are the optimum choice for capillary GC 
analysis. 
𝐻 =
𝐵
𝜇
+ 𝐶𝜇 Equation 2.5:  The Golay equation 
Accurate and practical analyte quantification results from optimising the balance of 
chromatographic parameters, to achieve the best separation in an acceptable run time.  
 
Analysis of larixyl acetate, larixol and epimanool using gas chromatography with a flame 
ionisation detector is discussed in section 2.2, followed by analysis with HPLC in section 
2.3. The final quantification methods are described in sections 2.4.2 (GC-FID) and 2.4.1 
(HPLC) alongside the preparation of larixyl acetate, larixol and epimanool standards 
(section 2.4.3), preparation of samples (section 2.4.4) and method validation parameters 
(sections 2.4.5 – 2.4.8). A summary of the results in the chapter can be found in section 
2.5. 
2.2 Gas chromatography – Flame ionisation detector (GC-FID) 
When heated, volatile organic compounds become gaseous. Gas chromatography (GC, 
Figure 2.2) can be used to separate volatile organic compounds. Samples are first injected 
into a chamber through a self-sealing septum (ideally using an auto sampler), where they 
are instantly vapourised. An inert carrier gas then carries the analytes through to the 
column (typical length 15 – 30 m)88 that is located inside an oven and then finally to the 
detector. In split injection, the amount of sample carried onto the column can be controlled 
by opening a purge valve. This can reduce column loading and improve resolution.89 
 
Separation of analytes occurs by means of an equilibrium between analytes in the gaseous 
mobile phase and those interacting with the GC column liquid stationary phase, which is 
coated on the inside of a capillary column wall. Separation is affected by the vapour 
pressure, polarity and molecular weight of the analytes. The oven temperature can 
therefore be easily programmed to improve resolution. 
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Flame ionization detection is a general detector used for GC analysis as it is rugged, very 
sensitive and has a good linear response.90 The flame ionization detector passes the carrier 
gas and analytes from the column through a hydrogen-air flame. The hydrogen-air flame 
produces a few ions, but when an organic compound is passed through the flame, it ionizes 
and increases the number of ions produced. A polarising voltage attracts the ions to a 
collector located near the flame. The current produced is proportional to the amount of 
sample being burned. The current is sensed by an electrometer and converted to a digital 
form, which is then sent to an output device. 
 
Qualitative analysis of the two main compounds of interest in this research, larixyl acetate 
and larixol, was previously undertaken using nuclear magnetic resonance (NMR) 
spectroscopy and gas chromatography with a mass spectrophotometer detector (GC-MS). 
However, the standard chromatographic method used for general GC-MS analysis of 
samples at the University of Surrey was poorly designed for the separation of larixyl 
acetate, larixol and epimanool, leading to a long run time (40 min) and poor separation of 
analytes. Therefore, development of a more efficient gas chromatography method was 
required for quantitative analysis of larixyl acetate, larixol and epimanool in Larix 
samples. 
 
 
Figure 2.2: The Agilent Technologies 6890N GC-FID instrument at the University of 
Surrey. 
Chapter 2: Quantification and analysis of larixyl acetate, larixol and epimanool in Larix 
 
 23 
Simple optimisation of the GC temperature program (to affect mass transfer), injection 
split ratio and reduction in injection volume (to reduce longitudinal diffusion) lead to a 
reduced runtime of 15 minutes, with good resolution of analyte peaks for quantitative 
purposes. The optimised GC-FID quantification method is presented in section 2.4.2. The 
three compounds of interest eluted from the GC in order of increasing mass: epimanool 
first, then larixol and finally, larixyl acetate. 
2.3 High performance liquid chromatography (HPLC) 
A second method of quantification was required. This was due to equipment limitations of 
ProLarix partners who would need to use the method for future quantification. 
Furthermore, analysis of formulated products could not be undertaken using gas 
chromatography, due to the low volatility of additives (such as large polymers). Therefore, 
a quantitative high performance liquid chromatography (HPLC) method was also 
developed. 
 
HPLC (Figure 2.3) is a method of separation that uses a liquid mobile phase that flows 
through a solid packed stationary phase column. The mobile phase is stored in a reservoir 
and a high-pressure pump is used to pump the mobile phase at a particular flow rate 
through the system: through the column, the UV-detector and either to waste or collection. 
Samples are injected into a rotary injection valve, where they fill a sample loop. The valve 
is then rotated and the sample loop is introduced to the column with the mobile phase 
eluent. This allows for a constant flow of the mobile phase and increased accuracy and 
precision of sample introduction.91  
 
HPLC columns have two primary separation modes that use polarity to resolve 
compounds: normal phase (polar stationary phase) and reversed-phase (non-polar 
stationary phase). The mobile phase usually has a different polarity to the stationary phase 
and can be modified to improve analyte resolution. The aqueous and organic components 
of the mobile phase must be miscible, stable and non-reactive. Reversed-phase 
chromatography is commonly used to separate small molecules that are moderately polar 
to non-polar. Normal phase chromatography is commonly used to separate polar to 
moderately non-polar compounds.93 
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Figure 2.3: The HPLC instrument at the University of Surrey (left) and illustration of the 
instrument taken from the Varian Galaxie™ Chromatography software92 
(right). 
The polarity increases from epimanool, to larixyl acetate and larixol. The difference in 
polarity of the compounds is due to their differing functionality at C-6. Epimanool is the 
least polar of the three compounds, with a non-polar hydrocarbon C–H bond at C-6. 
Larixyl acetate has a moderately polar acetate (methyl ester) group at C-6. The double 
bond oxygen in this functional group can accept hydrogen bonds and form a partially 
charged dipole, which contributes to weak intermolecular dipole-dipole forces and overall 
moderate polarity. The hydroxyl group at C-6 on larixol is polar due to the electronegative 
nature of the oxygen in the O–H bond, which can lead to hydrogen bonding. As these 
compounds had overall non-polar to moderately polar qualities, reverse-phase HPLC was 
most suitable for their separation. 
2.3.1 Development of HPLC separation techniques 
Larixyl acetate, larixol and epimanool were difficult to resolve under standard C-18 
reverse phase column conditions previously reported for the separation of diterpenoids 
isolated from Larix decidua, mostly due to epimanool not being detected using these 
methods. Therefore, a standard C-18 method was initially run with isolated standards of 
larixyl acetate, larixol and epimanool, to identify a starting point for optimisation of the 
chromatographic method. The method parameters were as follows: 
 
The preliminary HPLC method used a Varian 920-LC system (Agilent Technologies, 
Santa Clara, United States), equipped with an Agilent Eclipse XDB-C18 reverse-phase 
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column (15cm, 4.6 mm I.D., 5 µm particle size, Sigma Aldrich, St. Louis, Missouri, 
United States), integrated dual-wavelength ultra-violet detector and Varian Galaxie™ 
Chromatography software. The detection wavelength was set at 211 nm. Gradient elution 
of water and acetonitrile (Sigma Aldrich, H2O:MeCN) was programmed for a total runtime 
of 10 minutes: 95:05% to 05:95% over 0 – 5 min; held at 05:95% for 2 min; 7.1 – 10 min 
95:05%. The sustained flow rate was 1.5 mL/min and column temperature was 35 °C. The 
injection volume of each sample was 20 µL. 
 
Under these conditions, larixol acetate had a retention time of 7.16 min, epimanool 
6.42 min and larixol also 6.42 min (Appendix A2.1). Larixol and epimanool peaks were 
particularly challenging to resolve. This was thought to be due to the similarity of the 
molecules, with their structures only differing in the functional group situated at C-6 (a 
proton for epimanool, hydroxyl for larixol and acetyloxy group for larixyl acetate). 
Separation of these compounds was integral to be able to quantify the compounds in 
samples for analysis. Furthermore, these conditions lead to chromatograms with noisy 
baselines, which would also make accurate quantification difficult. Therefore, optimisation 
of the method was undertaken to identify parameter conditions that would result in an 
appropriate resolution for quantitation of the analytes for the purposes required in the work 
described in this thesis. 
 
The detection wavelength for larixyl acetate, larixol and epimanool in samples was 
determined by analysing the ultraviolet-visible spectra of the compounds and samples 
containing the compounds (method in section 6.2.3). The spectra (Appendix A6.12 – 
A6.14) indicated absorbance peaks present at similar wavelengths for larixyl acetate 
(212 nm), larixol (210 nm) and epimanool (212 nm). Furthermore, absorbance peaks were 
also present at similar wavelengths for samples containing these three compounds 
(Appendix A6.15 – A6.17), including for a standard solution of larixyl acetate, larixol and 
epimanool combined (210 nm), Larix_REF (212 nm) and Larix oleoresin (215 nm). 
Therefore, a wavelength of 211 nm was initially chosen as the detection wavelength. 
However, a lower detection wavelength of 203 nm was found to reduce additional baseline 
noise present in the HPLC-UV spectra of samples analysed in this thesis.  
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The temperature of the system was increased from 35 ºC to 40 ºC to account for 
fluctuations in poorly-regulated laboratory temperature during analysis in summer months. 
Using a higher temperature would also reduce the viscosity of the mobile phase, leading to 
lower column pressure and improved mass transfer. 
 
The HPLC method was originally developed using a column diameter of 4.6 mm. By 
decreasing the internal diameter of the column to 2.1 mm, the sensitivity of the 
chromatographic system could be increased. Reduction in internal column diameter also 
increased column efficiency (compared to an F5 column of 4.6 mm internal diameter), as a 
lower flow rate was needed to achieve the same linear velocity. This also meant that it was 
more environmentally friendly and cost efficient to use a smaller diameter column, as it 
resulted in a reduction in the amount of mobile phase solvent volume needed per analysis, 
without affecting the runtime. The injection volume was also reduced from 20 µL to 4 µL 
to prevent overloading of the column. 
 
Using an alkyl C18 phase is generally a good starting point for a wide range of analyte 
separations. However, changing the stationary phase can give a better separation by 
affecting the selectivity of the chromatographic system. A variety of different stationary 
phases and columns were tested during method development, however a Ascentis® 
Express reverse phase column (10 cm, 2.1mm I.D., 2.7 µm particle size, Sigma Aldrich, 
St. Louis, Missouri, United States) with a pentafluorophenyl (F5) phase was found the 
most suitable for the separation of larixyl acetate, larixol and epimanool. 
 
Typical alkyl phases can only separate compounds based on their polarity. The rigidity of 
the bonded F5 phase (Figure 2.4) causes it to have an enhanced selectivity for analytes that 
differ in size and shape.94 This means that compounds closely related in polarity, such as 
larixyl acetate, larixol and epimanool, can be easily separated by their differing shape 
using an F5 column.  
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Figure 2.4: The Pentafluorophenyl phase of an Ascentis® Express reverse phase F5 
column. Adapted from Michel.95  
The F5 phase is a strong Lewis acid due to the electron withdrawing effect of the five 
fluorine groups, which causes electron deficiency of the pentafluorophenyl ring. This 
means that π – π interactions can occur between the ring and electron-rich analytes. The 
electronegativity of the fluorine atoms also means that dipole – dipole, dispersive and 
charge-transfer interactions can also occur.94 Therefore polar compounds can be retained 
and interact with the column to cause separation. 
 
The Ascentis® Express column was packed with fused core particles (2.7 µm diameter). 
These particles had a dense solid silica core, with a thin (0.5 µm thick) porous silica shell. 
Compared to a completely porous particle, the solid core of a fused core particle would 
have reduced the diffusion path (Eddy diffusion) in the Van Deemter equation (Equation 
2.4), leading to increased column efficiency. Reducing the particle size from 5 µm to 
2.7 µm would have also reduced Eddy diffusion and additionally mass transfer effects, to 
contribute to greater chromatographic efficiency. 
 
In reversed-phase chromatography, hydrophobic compounds are retained on the stationary 
phase for longer than hydrophilic compounds, which elute quicker with the hydrophilic 
(aqueous) mobile phase. Larixyl acetate, larixol and epimanool are hydrophobic. 
Therefore, reversed-phase chromatography was most suitable for their separation as they 
would interact with the hydrophobic stationary phase. The standard mobile phase for 
reversed-phase chromatography is a combination of acetonitrile (MeCN) and water. 
 
The F5 column can perform in both reversed-phase and HILIC (Hydrophilic Interaction 
Liquid Chromatography)96 retention modes, due to having polar and non-polar character. 
The choice of mobile phase can affect its mode of separation, with a low acetonitrile 
Chapter 2: Quantification and analysis of larixyl acetate, larixol and epimanool in Larix 
 
 28 
content favouring reversed-phase retention and a high acetonitrile content favouring 
HILIC retention.97 Reversed-phase retention was favoured for the separation of larixyl 
acetate, larixol and epimanool, so the content of mobile phase was chosen accordingly. 
 
Retention, and therefore resolution, is affected by mobile phase composition. Furthermore, 
an isocratic mobile phase is desired over gradient elution, where the chromatographic 
conditions can be kept constant throughout the analysis.73 Therefore a range of isocratic 
mobile phase compositions were investigated for their suitability. As illustrated in Figure 
2.5, retention of hydrophobic compounds (larixyl acetate, larixol and epimanool) was 
decreased by increasing the acetonitrile composition of the mobile phase. At 90% 
acetonitrile concentration there was no retention of any component of the purified Larix 
oleoresin extract, as indicated by the one broad peak at t0 (dead volume).  
 
Improved resolution of larixyl acetate, larixol and epimanool peaks was seen when the 
acetonitrile concentration dropped to 55%, however at this composition the larixyl acetate 
and larixol peaks were co-eluting with other constituents in the sample. At a lower 
concentration of 39% acetonitrile, selectivity for larixyl acetate was increased, however 
larixol co-elution with a different constituent of the sample was seen. Loss of efficiency 
for epimanool was also seen in the form of broad peak fronting, which was most likely 
caused by the increased retention time. The optimum concentration of acetonitrile mobile 
phase was concluded to be 48%, where good resolution of the three compounds was 
ascertained. 
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Figure 2.5: HPLC chromatograms of a 8.9 mg/mL purified Larix decidua oleoresin extract 
with different acetonitrile mobile phase compositions.  
 
Optimisation of the preliminary HPLC qualitative method lead to an improved method 
with good resolution of analyte peaks suitable for quantitative analysis of larixyl acetate, 
larixol and epimanool. The optimised HPLC quantification method is presented in section 
2.4.1. 
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2.4 Analytical quantification parameters 
This section describes the analytical parameters of the definitive quantification methods 
used to determine the quantity of larixyl acetate, larixol and epimanool in Larix extracts 
and other samples analysed in this thesis. These methods are a direct outcome of the 
development work discussed in sections 2.2 and 2.3. 
2.4.1 HPLC quantification method 
Samples were analysed using HPLC with a Varian 920-LC system (Agilent Technologies, 
Santa Clara, United States) equipped with Ascentis® Express reverse phase F5 column 
(10 cm, 2.1 mm I.D., 2.7 µm particle size, Sigma Aldrich, St. Louis, Missouri, United 
States), integrated duel-wavelength ultraviolet-visible detector and Varian Galaxie™ 
Chromatography software. An isocratic mix (48:52 v/v) of acetonitrile (MeCN, Sigma 
Aldrich) and H2O (deionized, prepared using a Millipore Milli-Q water purification 
system, Molsheim, France) was used as the mobile phase, with a 14-minute runtime. The 
flow rate was maintained at 0.3 mL/min and the column temperature at 40 °C. The 
detection wavelength was set at 203 nm. The injection volume of each sample was 3 μl. 
 
Sample data was exported from the instrument as a .csv file and then transferred to 
GraphPad Prism (version 7.0c for Mac OS X, GraphPad Software, La Jolla, United States), 
for construction of calibration curves and quantitative analysis of the sample data. 
Retention times of standards were recorded as 3.04 min for larixyl acetate, 6.10 min for 
larixol and 11.66 min for epimanool (chromatogram in Appendix A2.2). 
2.4.2 GC-FID quantification method 
Samples were analysed quantitatively in triplicate using a capillary gas chromatograph 
with a flame ionization detector (GC-FID) using an Agilent Technologies 6890N GC 
instrument (Agilent Technologies, Santa Clara, California). The capillary column used was 
a Rt®-γDEXsa (fused silica), 30 m × 0.32 (i.d.) mm, 0.25 µm (film thickness) (Restek, 
Bellefonte, Pennsylvania). The injector and detector temperatures were maintained at 
250 and 260 °C respectively. The injection volume was 4 μl, with a split ratio of 1:25. 
Hydrogen was used as carrier gas (1 mL/min) and detector gas (15 mL/min) with air 
(280 mL/min). Nitrogen was used as make-up gas (15 mL/min). The oven temperature was 
programmed from 200 to 350 °C as follows: 200 °C held for 3 minutes, 200 to 300 °C at 
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20 °C/min, held at 300 °C for 4 minutes, 300 to 350 °C at 25 °C/min and held at 350 °C 
for 1 minute.  
 
Sample data was exported from the instrument as a .csv file and then transferred to 
GraphPad Prism (version 7.0c for Mac OS X, GraphPad Software, La Jolla, United States), 
for construction of calibration curves and quantitative analysis of the sample data. 
Retention times of standards were recorded as 11.73 min (larixyl acetate), 10.91 min 
(larixol) and 9.28 min (epimanool) (chromatogram in Appendix A2.3). 
2.4.3 Preparation of larixyl acetate, larixol and epimanool standards 
Standards of larixol, larixyl acetate and epimanool were isolated using flash column 
chromatography (method in section 6.1.3) followed by column chromatography (method 
in section 6.1.2). The purity of the isolated standard compounds was determined as > 95% 
by comparison against a reference standard of larixyl acetate (Sigma-Aldrich, St. Louis, 
MO, USA) using HPLC (section 2.4.1). Larixyl acetate and larixol were recrystallized 
with MeOH (epimanool was an oil at room temperature) and all were dried to constant 
weight before use. 
 
A standard stock solution of the three compounds of interest was prepared by dissolving 
100 mg of each compound in MeOH (100 mL volumetric flask). This yielded a stock 
solution with a concentration of 1 mg/mL for each analyte (larixyl acetate, larixol and 
epimanool). This stock solution was used to prepare external calibration standards (section 
2.4.6).  
2.4.4 Preparation of samples 
Complex sample matrices can contain many different components that can interfere with 
chromatographic separation, by masking or co-eluting with peaks of interest. Large 
particles in the sample matrix can also reduce column or equipment lifetime by causing 
blockages in columns. Therefore, sample preparation was required to enhance analyte 
concentration and remove the sample matrix. Sample preparation was also needed to make 
sure the sample was in the required state for analysis. For example, solid milled Larix bark 
needed to be dissolved in solvent before introduction to either HPLC or GC techniques. 
 
Some preliminary sample preparation, for the purposes of concentrating the analytes of 
interest, was undertaken in the extraction process (i.e. yielding a primary extract from 
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Soxhlet extraction). Samples for analysis using HPLC or GC were prepared according to 
the following method.  
 
Samples were weighed into a 1.5 mL Eppendorf® tube or vial of appropriate size and 
diluted to an approximate concentration of 30 mg/mL (Larix bark or similar sample 
matrix) or 1 mg/mL (Larix oleoresin or similar concentrated extract) using a micropipette 
(100 – 1000 µL Discovery Comfort, PZ HTL S.A, Warsaw, Poland) with HPLC grade 
MeOH (Sigma Aldrich, St. Louis, Missouri, United States). Two-step dilution was 
necessary for oleoresin analysis due to the sticky nature of the material. Solutions were 
sonicated for 15 minutes to ensure full dissolution of analytes of interest and then left to 
stand for 15 minutes. They were then filtered through a Merck Millipore Ltd. (Cork, 
Ireland) Sterile Millex® Filter Unit with a pore size of 0.45 µm and MF-Millipore™ 
(mixed cellulose esters) membrane into a 0.3 mL or 1 mL sample vial (Supelco, 
Pennsylvania, USA). Solutions found to be at concentrations above the quantified 
calibration range for larixyl acetate, larixol or epimanool were further diluted to within the 
range. 
2.4.5 Limits of detection and quantification 
The described HPLC-UV and GC-FID analytical methods were validated according to the 
ICH guidelines.98 The following validation characteristics were evaluated: limits of 
detection and quantification, accuracy, precision and linearity. The limit of detection 
(LOD) is defined by IUPAC as the smallest amount or concentration of analyte in the test 
sample that can be reliably distinguished from zero.99 The limit of quantification (LOQ) is 
defined by IUPAC as the concentration or amount below which the analytical method 
cannot operate with an acceptable precision.99 
 
To determine the limit of detection (LOD) and limit of quantitation (LOQ) a 1 mg/mL 
standard solution of larixyl acetate, larixol and epimanool was diluted with HPLC-grade 
methanol in a series of two-fold dilutions. The HPLC-UV and GC-FID limits of detection 
and quantification were calculated from replicate analyses of the dilution series. The 
dilution with a signal-to-noise ratio (peak height vs. baseline noise) of at least 3:1 and 10:1 
respectively determined the limits of detection and quantification.98 Table 2.1 indicates the 
HPLC-UV and GC-FID calculated limits of detection and quantification for each 
compound.  
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Table 2.1: HPLC-UV and GC-FID limits of detection and quantification for larixyl 
acetate, larixol and epimanool 
Compound 
HPLC-UV  GC-FID 
Limit of 
detection 
(mg/mL) 
Limit of 
quantification 
(mg/mL) 
 
Limit of 
detection 
(mg/mL) 
Limit of 
quantification 
(mg/mL) 
Larixyl acetate 0.010 0.020  0.0020 0.0101 
Larixol 0.005 0.015  0.0020 0.0040 
Epimanool 0.010 0.030  0.0010 0.0020 
2.4.6 Linear dynamic range 
For the quantitative analysis of samples, ten-point calibration curves were prepared from 
calibration standards, which were analysed in triplicate at the start or end of each set of 
samples. Calibration curves were constructed as concentration against UV response area 
(mAU*min) for HPLC analysis and concentration against FID response peak area (pA*s) 
for GC-FID analysis. All calibration curves had R2 values of at least 0.998 for HPLC 
analysis and 0.995 for GC-FID analysis. The selected concentration ranges for calibration 
(10 – 1000 µg/mL for GC-FID analysis and 20 – 1000 µg/mL for HPLC analysis) were 
made within the limits of the initial small quantity of isolated and purified larixyl acetate, 
larixol and epimanool available. Fortunately, these concentrations were within the linear 
dynamic range (where the detector response is linearly dependant on sample 
concentration) for both HPLC and GC-FID instrumental analysis.  
2.4.7 Precision 
Reproducibility (interday precision) was assessed by analysis of either a 0.93 mg/mL Larix 
oleoresin solution in MeOH (GC-FID, n = 18) or a 0.10 mg/mL standard solution of 
larixyl acetate, larixol and epimanool in MeOH (HPLC) over a number of runs on different 
days (n = 8). Repeatability (intraday precision) for GC-FID and HPLC methods were 
assessed by analysis of a 0.93 mg/mL Larix oleoresin solution (in MeOH) over one run 
(n = 5 HPLC, n = 8 GC-FID). Precision was then evaluated by calculation of the relative 
standard deviation% (section 6.3.3) of the repeated measurements. 
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Table 2.2: Evaluation of GC-FID precision 
Compound 
Mean ± Standard 
deviationa  
(n = 5) (mg/mL) 
Relative Standard deviation (%) 
Reproducibility 
(n = 18) 
Repeatability 
(n = 8) 
Larixyl acetate 0.33 ± 0.004 1.3 5.6 
Larixol 0.05 ± 0.001 0.9 4.7 
Epimanool 0.11 ± 0.001  0.9 5.1 
aMean and standard deviation calculated from reproducibility data. 
 
Table 2.3: Evaluation of HPLC precision 
Compound 
Mean ± Standard 
deviationa  
(n = 8) (mg/mL) 
Relative Standard deviation (%) 
Reproducibility 
(n = 8) 
Repeatability 
(n = 5) 
Larixyl acetate 0.10 ± 0.005 4.7 6.6 
Larixol 0.10 ± 0.004 4.3 3.7 
Epimanool 0.10 ± 0.004 4.0 3.4 
aMean and standard deviation calculated from reproducibility data. 
 
GC-FID RSD values of 0.9 – 1.3% indicate a very high level of reproducibility for the 
repeated measurement of the Larix oleoresin solution over a period of one month (n = 18). 
Measurements over the period of one day (n = 8) also had good repeatability, with RSD 
values of 4.7 – 5.6%. Precision of the HPLC method was also good, with RSD values of 
4.0 – 4.7% for reproducibility and 3.4 – 6.6% for repeatability. Therefore, based on repeat 
measurements of a Larix oleoresin standard solution and larixyl acetate, larixol and 
epimanool standard solution, analysis using GC-FID and HPLC methods were concluded 
to be precise. 
2.4.8 Spike recoveries 
Spike recoveries of larixyl acetate, larixol and epimanool were undertaken in different 
sample matrices to provide an estimate of the accuracy for the analysis of the compounds 
in these materials. The recovery from Larix bark and turpentine matrixes was determined 
by spiking samples with a stock mix of larixyl acetate, larixol and epimanool at three 
different concentrations. The appropriate volume of the standard mixed stock solution (in 
MeOH) was added to a small glass vial (three replicates for each concentration) and the 
solvent evaporated under atmosphere for 48 hours. The final concentration of each 
compound in each vial was 0.05 (n = 3), 0.10 (n = 3), and 0.50 mg/mL (n = 3). A blank 
was also analysed in triplicate using the same procedure with MeOH in place of the stock 
solution. The matrix solution of interest (either 800 μl of 2.5 mg/mL Larix bark MeOH 
extract in MeOH or 800 μl of 0.928 mg/mL Larix oleoresin in MeOH) was then added to 
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each vial. The vials were sonicated for 15 minutes and mixed on a Whirl mixer for 1 
minute to ensure thorough dissolution and mixing of the compounds in the sample matrix 
before analysis. The spiked samples were finally analysed by the standard GC-FID method 
(section 2.4.2). The percentage recovery results are presented in Table 2.4. 
Table 2.4: Spike recoveries of larixyl acetate, larixol and epimanool in Larix bark and 
Larix oleoresin 
Compound Spike concentration (mg/mL) 
Percentage recovery (%) n=3 
Larix bark Larix oleoresin 
Larixyl acetate 
0.05 56 – 70 102 – 109 
0.1 57 – 60 107 – 113 
0.5 53 – 58 109 – 115 
Larixol 
0.05 43 – 46 100 – 106 
0.1 43 – 45 99 – 105 
0.5 47 – 64 103 – 109 
Epimanool 
0.05 38 – 48 97 – 103 
0.1 51 – 54 99 – 104 
0.5 68 – 97 104 – 110 
 
Larixyl acetate, larixol and epimanool were all found to be within an acceptable spike 
recovery range (80 – 120%) when analysed in the Larix oleoresin matrix. However, the 
percentage recovery for compounds in the Larix bark matrix was much lower than the 
acceptable range. Therefore, this must be considered when comparing literature 
concentrations with sample concentrations (that have matrix similar to Larix bark) 
determined by this analytical method. Nevertheless, the recoveries for larixyl acetate (53 – 
70%) and larixol (43 – 64%) in the Larix bark matrix were fairly consistent and so for 
comparisons between Larix bark extracts, the low recoveries should not influence 
statistical data. Epimanool had a much broader range of recoveries in the Larix bark matrix 
(38 – 97%) and so comparison of epimanool concentration between Larix bark samples 
must be undertaken with caution.  
2.5 Conclusions 
The results of the method development in this chapter provided suitable high-performance 
liquid chromatography (HPLC) and gas chromatography (GC-FID) quantification methods 
for larixyl acetate, larixol and epimanool in Larix samples and therefore met the criteria for 
achieving objective 2 of this thesis. These methods were used to analyse the content of 
these compounds in Larix oleoresin and Larix bark and oleoresin extracts studied in the 
next chapters of this thesis. 
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The techniques were validated in terms of their limits of detection and quantification, 
precision, and linearity. As no certified reference material was available for larixyl acetate, 
larixol and epimanool analysis in complex natural product matrices, spike recoveries were 
undertaken to provide an estimate of the accuracy of the quantitative GC-FID method used 
to analyse the samples investigated in this thesis. Quantitation of larixyl acetate, larixol 
and epimanool was found to have acceptable accuracy when analysed in the Larix 
oleoresin matrix.  However, there were found to be limitations in the quantitative analysis 
of samples with a Larix bark matrix. As a result of this limitation, comparison between 
epimanool concentrations in samples with a Larix bark matrix and comparison of all 
compounds with literature values should be undertaken with caution. 
 
These quantitative HPLC and GC-FID methods were used to quantify the composition of 
active substances (larixyl acetate and larixol) and the primary impurity (epimanool) in the 
plant protection product Larixyne®, which were required for the purpose of patenting and 
registration according to Commission Regulation (EU) No 284/2013.72 Additionally, these 
chromatographic quantitative methods can be used and adapted by ProLarix partners and 
future manufacturers of Larixyne®, for their specific needs during production and quality 
control. 
 
This work contributes to the literature by offering two chromatographic (HPLC and GC-
FID) separation methods suitable for the qualitative and quantitative analysis of larixyl 
acetate, larixol and epimanool in Larix samples. Simultaneous quantitative analysis of 
these three compounds has not been reported previously in the literature, as much of the 
literature focused on qualitative identification of larixyl acetate and larixol as Larix 
oleoresin markers.42,46,100 
 
As a result of this method development, further research could be conducted into 
improving the sample preparation, increasing the speed of quantitative analysis using 
UHPLC (ultra-high performance liquid chromatography) and transferring the HPLC 
method to a preparative column. Preliminary tests (not reported) indicated promising 
separation of larixyl acetate, larixol and epimanool on a semi-preparative scale. This, 
alongside the extraction methods developed in the following chapter, could be further 
explored to produce high purity standards of larixyl acetate, larixol and epimanool.
 
 
 
 
Chapter 3 
 
Extraction of larixyl acetate and 
larixol from Larix 
 
 
 
 
Chapter 3: Extraction of larixyl acetate and larixol from Larix 
38 
 
Chapter 3: Extraction of larixyl acetate and larixol from Larix 
3.1 Introduction 
The overall aim of the work described in this chapter was to determine an industrially 
scalable method of extracting larixyl acetate and larixol from Larix by-products, using 
processes suitable for organic agriculture. This chapter discusses the results from 
objectives 2 and 3 of this thesis. Objective 2 was to develop a method to extract high-
yields of larixyl acetate and larixol from Larix bark that was suitable for organic farming, 
which can be scaled up to pilot-plant level. Objective 3 was to determine a high-recovery 
extraction method of larixyl acetate and larixol from Larix decidua oleoresin using 
methods acceptable for organic farming and to evaluate if this alternative botanical 
material had a higher recovery-yield than Larix bark. 
 
The word ‘Larix’ in this chapter refers either to Larix bark (of Larix decidua origin) or 
Larix oleoresin (also of Larix decidua origin). In registration terminology, an active 
substance extracted from a plant source is referred to as a ‘technical grade’.101 Therefore, 
an extract of larixyl acetate and larixol from Larix is referred to as a ‘technical’ or 
‘technical grade’ extract in this chapter. The plant protection product produced from this 
technical grade extract (after final formulation) is called Larixyne®. 
 
During these investigations, production of a large quantity of technical grade extract of 
Larix was required for field-testing of the efficacy of the active constituents. Sufficient 
quantities of technical grade extract produced by the refined extraction procedure also 
needed to be produced for further field and registration-related testing. Therefore, the 
extraction process needed to have scalability to pilot-plant stage (for the production of 
technical grade extract for field trials) and industrial-scale (for the production of 
Larixyne® to meet future market demands). 
 
Producing a technical grade extract of Larix on a commercial scale required optimisation 
of the extraction and purification process. For registration purposes, the process needed to 
yield a technical grade extract with a high concentration of larixyl acetate and larixol and 
an acceptable variation of epimanool.38  
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ProLarix partner Trifolio-M GmBH will use the extraction process developed in this 
chapter and adapt it to their facilities for the industrial-scale extraction of Larix, to produce 
Larixyne®. Therefore, the pre-existing technology and infrastructure available at Trifolio-
M was taken into consideration during development of the extraction process. Extraction 
of a plant extract to product a plant protection product therefore required the use of 
standard equipment and cost-efficient and safe solvents and processes. 
 
Chapter 1 provides the background literature review of extraction and purification methods 
discussed in this chapter. Chapter 2 describes the quantitative methods used in this chapter 
to quantify the concentration of larixyl acetate, larixol and epimanool in the extracts. 
Chapter 4 uses one of the extraction methods developed in this chapter to determine the 
sources of Larix with the highest content of larixyl acetate and larixol. Finally, Chapter 5 
determines the activity of larixyl acetate, larixol and Larixyne® extracts produced in this 
chapter against Plasmopara viticola. 
 
Extraction of larixyl acetate and larixol from Larix bark was investigated first with Soxhlet 
extraction (section 3.3). After initial Soxhlet extractions, a large-scale Larix bark 
extraction method was explored by looking at suitable solvents to extract larixyl acetate 
and larixol (section 3.3.2) and then further refining these solvents to optimise other 
parameters (section 3.3.3). Purification of Larix oleoresin was then studied by using 
sodium hydroxide (section 3.3.4) and 2-amino-2-methyl-1-propanol (section 3.3.5) to 
remove the impurities. The experimental conditions for each extraction are described in 
section 3.2 and a summary of the results presented in this chapter can be found in section 
3.4. 
 
Additionally, the technical grade Larix extracts produced in this chapter were prepared into 
different formulations for field trials and activity testing (discussed in Chapter 5); the 
composition of the formulations are presented in section (3.3.6). 
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3.2 Experimental 
The following experimental procedures were undertaken to produce the results described 
in this chapter. 
3.2.1 Raw materials 
Two forms of Larix decidua were investigated: Larix bark and Larix oleoresin. 
3.2.1.1 Larix decidua bark 
Stem bark of Larix decidua Mill. (Figure 3.1) was collected in December 2013 from 
Bergün in Switzerland (N 46.3748, E 9.450 at 1370 m above sea level) by FibL. It was 
also used in Chapter 4 as a reference material (Larix_REF) to identify European Larix 
sources with the highest recovery yield of larixyl acetate and larixol. 
 
Figure 3.1: Stem bark of Larix decidua Mill. 
Larix decidua bark was received as 10 mm ground chips (Figure 3.1). It was air-dried and 
milled to a smaller 4 mm particle size using a Glen Creston cross-beater mill (Glen 
Creston Limited, London, UK). 
3.2.1.2 Larix decidua oleoresin 
Larch turpentine is the oleoresin produced from L. decidua. The terms ‘turpentine’ and 
‘oleoresin’ are used interchangeably in this thesis. 
 
Preliminary studies of L. decidua oleoresin (not discussed in this thesis) were conducted 
on readily available artist’s turpentine from L. Cornelissen & Son, which was sourced 
from Austrian larch. The safety data sheet identified that this source contained abietic acid 
(25 – 35%), α-pinene (7 – 16%), β-pinene (max. 1.5%) and limonene (max. 1%), with a 
Chapter 3: Extraction of larixyl acetate and larixol from Larix 
41 
 
total essential oil content of 10 – 20%.102 It also stated that the turpentine was insoluble in 
water but resulted in a clear to slightly opalescent solution when dissolved 1:2 in 80% 
ethanol (EtOH) (v/v). 
 
Further studies were conducted with L. decidua oleoresin (Type 109.327), purchased from 
C.E. Roeper GmbH (Hamburg, Germany) from a UK distributor: Thew Arnott & Co Ltd 
(Wallington, UK). The oleoresin was originally sourced from Italian and Austrian larch 
(South and East Tyrol). 
 
The oleoresin from both sources was received as a dark orange, transparent, highly 
viscous, sticky liquid (Figure 3.2).   
3.2.2 Primary Soxhlet extraction of Larix bark 
Soxhlet extraction of the Larix bark was explored initially. All Soxhlet extractions 
contained anti-bumping granules added to the round bottom flask. 
3.2.2.1 Separate Soxhlet extraction of Larix bark  
Milled L. decidua bark (100 g, 4 mm particle size) was extracted using a Soxhlet apparatus 
for two hours, with 500 mL of either dichloromethane (CH2Cl2), methanol (MeOH) or 
ethyl acetate (EtOAc) as the extraction solvent. Fresh bark was used for each experiment. 
After two hours, the extracts were allowed to stand until they reached room temperature 
and then were filtered and solvent was removed under vacuum to obtain crude, primary 
extracts. 
 
Figure 3.2: Larix oleoresin from L. Cornelissen & Son (left) and C.E. Roeper GmbH 
(center and right). 
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3.2.2.2 Successive Soxhlet extraction of Larix bark 
Soxhlet extraction of milled (4 mm particle size) L. decidua bark (100 g) was performed 
for two hours with CH2Cl2 (500 mL). The solvent was then removed and the sample was 
extracted for a further two hours with MeOH (500 mL). After extraction, the solvent 
extracts were allowed to stand until they reached room temperature and then filtered. The 
solvent was removed under vacuum to obtain the crude, primary extracts. 
3.2.2.3 Large-scale extraction of Larix bark for 2014 field trials 
A technical grade extract of L. decidua bark was prepared, which was sent to FiBL, Frick 
for preliminary field trials in 2014. Praveen Jayarajah, a placement student working within 
the natural products research group, assisted with this work. L. decidua bark (18.5 kg) was 
extracted with MeOH using two sets of Soxhlet apparatus. The apparatus had capacity to 
hold either 800 g or 500 g of plant material and required 8 L or 4 L of solvent, 
respectively. The L. decidua bark was extracted during working hours (approximately 8 – 
10 hours per day) over 35 days. Bark was replaced when the solvent in the side arm of the 
Soxhlet apparatus ran clear (indicating that all soluble constituents had been extracted). To 
reduce the environmental impact of waste disposal, the huge volume of MeOH required 
for the extraction was recovered (through distillation of the extract) and recycled back into 
the extraction process. The remaining extract was filtered and concentrated under reduced 
pressure to obtain a combined crude extract of 1.3 kg (7.0%). 
 
Figure 3.3: Large-scale Soxhlet extraction apparatus, with the capacity to hold 800 g (left) 
or 500 g (right) of Larix bark. 
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3.2.3 Development of a large-scale Larix bark extraction method  
Identifying appropriate solvents was the main focus in the development of a large-scale 
Larix bark extraction method. 
3.2.3.1 Preliminary solvent investigation 
Several common solvents were investigated to determine their suitability as large scale 
extraction solvents for isolation of larixyl acetate and larixol from Larix bark. These were: 
acetone (Sigma Aldrich, St. Louis, Missouri, United States), methanol (MeOH, Sigma 
Aldrich), ethanol (EtOH, Fisher Scientific, Loughborough, UK), petroleum ether (PE, 
Sigma Aldrich), ethyl acetate (EtOAc, Sigma Aldrich), tap and distilled water (H2O), 
dichloromethane (CH2Cl2, Sigma Aldrich), diethyl ether (Sigma Aldrich), hexane (Fisher 
Scientific), a 1:1 EtOH-H2O (distilled) mixture and a commercially available ‘Green 
CH2Cl2’ solvent (premixed ethyl acetate/EtOH 3:1 (v/v) solution, Sigma Aldrich). 
 
For each solvent investigated, approximately 80 g of L. decidua bark (10 mm particle size) 
was weighed into a 500 mL conical flask and 400 mL of solvent was added to the flask. 
All of the solvents were investigated in a batch run. The flasks were covered in foil and 
left to stand for 5.5 days with intermittent agitation through shaking. The extracts were 
then filtered through filter paper and the bark was washed with 120 mL of the same 
extraction solvent. Extracts were then left in large beakers (500 mL) for the solvent to 
evaporate, to obtain one crude extract of each solvent (except for 1:1 EtOH-H2O, which 
was repeated three times as a control).  
 
Crude extracts were then re-extracted with PE (40-60°C fraction, Fisher Scientific) in the 
same beaker. PE (300 mL) was added to each beaker and then they were each covered in 
foil. Beakers were sonicated until the visible residue had dissolved (up to 15 minutes) and 
then left to stand for 24 hours. Extracts were filtered through filter paper (Whatman®, GE 
Healthcare, Amersham, UK) and solvent was removed under vacuum to obtain secondary 
extracts. 
3.2.3.2 Economically feasible and industrially safe extraction solvents 
A range of solvents were selected for further investigation as economically feasible and 
industrially safe large-scale extraction solvents: acetone (Sigma Aldrich, St. Louis, 
Missouri, United States), MeOH (Sigma Aldrich), PE (Sigma Aldrich), EtOH (Fisher 
Scientific, Loughborough, UK), distilled water (H2O), and a 1:1 EtOH-H2O (distilled) 
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mixture. H2O and EtOH-H2O mixtures were investigated at both 100˚C and room 
temperature (RT). L. decidua bark (100 g) of either 4 mm or 10 mm particle size was 
transferred into a 1 L conical flask with 500 mL solvent and covered with foil. The conical 
flasks were left on an automated shaker at room temperature (RT) or in a heated water bath 
(100˚C) for 8 hours. The extracts were then filtered through cotton wool and concentrated 
under reduced pressure to obtain crude extracts. 
 
Crude extracts were then re-extracted with PE (40-60°C fraction, Fisher Scientific). 
Extracts (1.00 g) were transferred to conical flasks and dissolved in 100 mL PE. Conical 
flasks were covered with foil and left on an automated shaker to extract at room 
temperature for two hours. The extracts were then filtered through filter paper and 
concentrated under vacuum to obtain secondary, oily extracts. 
3.2.4 Purification of Larix oleoresin with sodium hydroxide (NaOH) 
Larix oleoresin (20.0 g) was first dissolved in hexane (300 mL) in a beaker. The solution 
was then transferred to a separating funnel (500 mL) and was extracted with three volumes 
of 3M sodium hydroxide (3 x 180 mL). Extraction of Larix oleoresin with PE was 
undertaken using the same methodology, but with 1.7 g oleoresin dissolved in 15 mL PE, 
which was extracted with 3 x 25 mL 3 M sodium hydroxide. The organic layers were 
filtered to remove any residual precipitate, combined and dried over magnesium sulfate. 
The extracts were concentrated further by dissolution in a small amount of CH2Cl2 and 
subsequent removal of this solvent was conducted under vacuum.  
3.2.5 Purification of Larix bark extracts and oleoresin with 2-amino-2-methyl-1-
propanol (2-amino-2-methyl-1-propanol) 
The Larix bark extracts and Larix oleoresin were purified using 2-amino-2-methyl-1-
propanol to form an amine salt with the resin acids, which could then be easily removed 
from the extract by filtration. 
3.2.5.1 Purification of selected Larix bark extracts with 2-amino-2-methyl-1-
propanol 
The EtOH:H2O (1:1, RT, 4 mm and 10 mm particle size) crude extracts obtained as 
described in section 3.2.3.2 were selected for secondary extraction with 2-amino-2-methyl-
1-propanol (AMP). 1.00 g of each extract was weighed out and transferred into separate 
500 mL three-neck round bottom flasks, with 100 mL PE (40-60°C fraction, Fisher 
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Scientific, Loughborough, UK) and anti-bumping granules. The flasks were fitted with a 
condenser, thermometer and a dropping funnel containing 2 mL 2-amino-2-methyl-1-
propanol (AMP) (Sigma Aldrich, St. Louis, Missouri, United States, 95%, H2O 5%).  
 
The solutions were refluxed initially at 60 °C, for 30 min, to allow for complete 
dissolution of the extract. AMP was then added drop wise over a further reflux period of 
30 minutes. The mixtures were refluxed for one hour and then left to cool to room 
temperature, for approximately two hours.  
 
The precipitate resulting from each reaction was then removed from the mixture by 
filtering it through cotton wool by gravity filtration. The precipitates were washed three 
times with PE (50 mL per wash) to recover any larixyl acetate, larixol and epimanool 
entrapped in the precipitate. The filtrates were then concentrated under vacuum to yield an 
oily product. 
3.2.5.2 Purification of Larix oleoresin with 2-amino-2-methyl-1-propanol 
 
 Larix oleoresin (1 kg, C.E. Roeper GmbH, Hamburg, Germany) and 2.5 L n-hexane 
(Sigma Aldrich, St. Louis, Missouri, United States) were transferred into a 5 L round-
bottomed flask containing anti-bumping granules. The flask was equipped with a refluxing 
condenser and dropping funnel containing 150 mL 2-amino-2-methyl-1-propanol (AMP) 
(Sigma-Aldrich, St. Louis, Missouri, United States, 95%, H2O 5%). The mixture was 
gently heated to reflux (approximately 70 °C) and swirled regularly until the oleoresin had 
fully dissolved in the solvent. 
 
The AMP was then added slowly (the reaction was exothermic), as the refluxing solution 
was swirled. A large amount of resin acid – amine salt precipitated immediately as a thick 
white solid. Once the addition of AMP was complete, the batch was cooled to room 
temperature and the precipitate (resin acid – amine salt) was removed through filtration 
under vacuum or gravity, using cotton wool. The precipitate was washed three times with 
hexane (2.5 L in total) to recover any entrapped larixyl acetate and larixol from the 
precipitate.  
 
The filtrates were then combined and concentrated by removing most of the solvent 
through distillation. Distillation also allowed for the removal of other volatile impurities 
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(mainly monoterpenes and hydrocarbons) from the product. The recovered solvent from 
the distillation process was re-used in the next batch extraction.  
 
The resulting products (filtrates) from each batch were then weighed and combined into a 
bottle suitable for the transport of viscous liquids. This method was used to produce 
approximately 2.0 kg (2014) and 6.0 kg (2015) of a Larix oleoresin extract that was used 
in field experiments in 2014 (Frick, Switzerland) and 2015 (Frick, Switzerland; San 
Michele, Italy; and Veria, Greece). 
3.2.6 Analytical methods 
Extracts were analysed for larixyl acetate, larixol and epimanool content using gas 
chromatography coupled to a flame ionisation detector (GC-FID, see section 2.4.2 for 
methodology), gas chromatography coupled to a mass spectrometer (GC-MS, 
methodology in section 6.2.2.2) and 1H nuclear magnetic resonance (NMR) spectroscopy 
(methodology in section 6.2.1).  
 
Samples for analysis using gas chromatography were prepared according to the following 
method. A solution of each extract (approximately 4 mg/mL for primary bark extracts or 
1 mg/mL for secondary PE and oleoresin extracts) was prepared by transferring the extract 
into a 1.5 mL Eppendorf® tube and adding 1 mL MeOH (HPLC grade, Sigma Aldrich, St. 
Louis, Missouri, United States) using a micropipette (100 – 1000 µL Discovery Comfort, 
PZ HTL S.A, Warsaw, Poland). Extracts were sonicated for 15 min and then left to stand 
for a further 15 min to ensure that they were fully dissolved. After dissolution, the solution 
was filtered through a Sterile Millex® Filter Unit (Merck Millipore Ltd., Cork, Ireland), 
with a pore size of 0.45 µm and MF-Millipore™ (mixed cellulose esters) membrane, into 
an appropriately sized (1.5 mL or 0.3 mL) sample vial (Supelco, Pennsylvania, USA). 
Solutions found to be at concentrations above the quantified calibration range for larixyl 
acetate, larixol or epimanool were further diluted to within the range. 
 
Samples for qualitative 1H NMR analyses were dissolved directly from the extract beaker 
using deuterated chloroform (Cambridge Isotope Laboratories Inc., Andover, 
Massachusetts, United States). 
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3.3 Results and discussion 
3.3.1 Primary Soxhlet extraction of Larix bark 
Soxhlet extraction was explored first to optimise the extraction of larixyl acetate, larixol 
and epimanool from Larix decidua bark. Previous studies, as part of the ForestSpeCs 
project, had determined that CH2Cl2 and MeOH were suitable for extraction of larixyl 
acetate and larixol compounds from Larix gmelinii and Larix decidua bark.36 However, 
quantitative methods had not been developed until now (Chapter 2). To determine 
quantitatively the extraction capabilities of the solvents CH2Cl2, MeOH and EtOAc, small 
scale Soxhlet extractions were undertaken (methodology in section 3.2.2). 
In separate small-scale extractions, CH2Cl2 and MeOH both extracted larixyl acetate and 
larixol from Larix bark (Table 3.1). The CH2Cl2 extract (2.12% extraction yield) contained 
4.37% larixyl acetate and 0.31% larixol. The MeOH extract (6.03% extraction yield) 
contained 0.63% larixyl acetate and 0.19% larixol. EtOAc gave a very low extraction yield 
(0.002%) and so was not further analysed.  
 
Both CH2Cl2 and MeOH Larix decidua bark extracts were brown and sticky substances. 
On further evaporation of the solvent, both extracts could be dried and ground into a fine 
Table 3.1: Yield and chemical composition of extracts obtained after extracting bark of 
Larix decidua with different solvents using Soxhlet extraction. 
Method of 
extraction Solvent 
Extract 
yield 
from 
bark 
(% w/w) 
 Content in extract 
(%) 
 Yield from bark (% w/w) 
 Larixyl 
acetate Larixol 
 Larixyl 
acetate Larixol 
Combined 
actives 
Separate 
Small scale † 
CH2Cl2 2.12  4.37 0.31  0.093 0.007 0.099 
MeOH 6.03  0.63 0.19  0.038 0.011 0.049 
EtOAc 0.002 §  - -  - - - 
Total         0.15 
Successive 
Small scale † 
CH2Cl2 2.12  4.37 0.31  0.093 0.007 0.099 
MeOH 
after 
CH2Cl2 
1.32 
 
2.43 0.70 
 
0.032 0.009 0.041 
Total  3.44     0.125 0.016 0.14 Separate 
Large scale ‡ MeOH 7.02 
 0.58 0.14  0.041 0.010 0.051 
† 100 g bark; ‡ 18.5 kg bark to produce extract for field season 2014; § Low yield, not 
further analysed. Compound content in extracts were analysed using GC-FID 
(methodology in section 2.4.2). 
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powder (ready for further analysis or extraction). Both extracts were soluble in a variety of 
solvents: MeOH, CH2Cl2, hexane, PE and CHCl3.  
 
MeOH gave the largest extract yield from the bark, but the extract contained a lower 
content of larixyl acetate and larixol when compared to CH2Cl2. Using MeOH as the 
extraction solvent yielded 0.038% larixyl acetate and 0.011% larixol, whereas CH2Cl2 
yielded 0.093% larixyl acetate and 0.007% larixol. The percentage of combined active 
compounds (larixyl acetate plus larixol) extracted from the Larix bark was therefore 
almost twice as much using CH2Cl2 (0.099%) compared to using MeOH (0.049%). This 
shows that MeOH extracts more impurities, alongside the compounds of interest (larixyl 
acetate and larixol), than CH2Cl2. These results imply that CH2Cl2 is more selective for the 
extraction of larixyl acetate and larixol. 
 
Combining the CH2Cl2 and MeOH extraction yields gave a total of 0.15% combined active 
compounds from the Larix bark extracts. If sequential extraction (CH2Cl2 followed by 
MeOH) was used, the total percentage of active compounds was approximately the same, 
at 0.14%.  
 
The separate MeOH and CH2Cl2 Larix bark Soxhlet extracts were analysed using GC-MS 
(method in section 6.2.2.1). Peaks for epimanool, larixyl acetate and larixol were identified 
in the MeOH extract, with retention times of 20.96, 23.63 and 22.86 min respectively 
(Figure 3.4). The presence of epimanool (20.97 min), larixyl acetate (23.67 min) and 
larixol (22.87 min) was also observed for the CH2Cl2 Larix bark extract. 
 
Other constituents in the extracts, identified by the NIST library,103 are displayed in Table 
3.2 (MeOH extract) and Table 3.3 (CH2Cl2 extract). The NIST database also gives a 
percentage probability to compounds it identifies, as an indication of the likelihood that it 
has identified that compound correctly. The CH2Cl2 Larix bark extract appeared to extract 
more volatile substances than the MeOH extract due to the presence of constituents, such 
as pinene (5.95 min) and myrtensaeure (12.97 min), eluting quickly from the GC-MS 
column. It is likely that more constituents were present in the extracts, however 
identification of compounds was limited by the presence of compounds in the NIST 
library.  
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Figure 3.4: GC-MS chromatogram of the MeOH Soxhlet extract of Larix bark (conditions 
as reported in section 6.2.2.1) 
Table 3.2: GC-MS identification of compounds in the MeOH extract of Larix bark (Figure 
3.4) using the NIST library.103  
Retention time (min) Suggested compound by NIST library Probability (%) 
19.92 hexadecanoic acid 69 
20.96 epimanool 77 
21.61 unidentified - 
22.86 larixol 82 
22.58 pimara-7,15,dien-3-one 37 
23.63 larixyl acetate 86 
24.13 unidentified - 
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Figure 3.5: GC-MS chromatogram of the CH2Cl2 extract of Larix bark (conditions as 
reported in section 6.2.2.1). 
Table 3.3: GC-MS identification of compounds in the CH2Cl2 extract of Larix bark 
(Figure 3.5) using the NIST library.103  
Retention time (min) Suggested compound by NIST library Probability (%) 
5.95 pinene 21 
12.97 myrtensaeure 84 
19.93 hexadecanoic acid 72 
20.97 epimanool 75 
21.54 oleic acid 10 
21.57 linoleic acid 31 
22.58 pimara-7,15-dien-3-one 44 
22.87 larixol 87 
23.67 larixyl acetate 86 
24.19 unidentified - 
24.53 dehydroabietic acid 17 
 
After consultation with ProLarix partners, it was concluded that the use of CH2Cl2 had to 
be avoided in the extraction procedure and field trials due to the detrimental health and 
environmental effects of chlorinated solvents.104  
 
Therefore, extraction of Larix bark with MeOH was chosen to produce a technical grade 
extract for initial field-testing in 2014 at Frick, Switzerland. Large-scale extraction 
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(method in section 3.2.2.3) of 18.5 kg Larix using MeOH (Table 3.1) produced 1.3 kg 
extract (7.02% yield). The extract contained larixyl acetate (0.58%) and larixol (0.14%). 
The extraction resulted in a total yield from the bark of 0.041% larixyl acetate and 0.010% 
larixol (0.051% combined actives), which was comparable to small-scale extraction with 
MeOH (0.049% combined actives) as discussed previously. The technical grade extract 
was delivered to Trifolio-M GmBH for formulation (section 3.3.6) before field trials. 
3.3.2 Preliminary investigation of solvents to extract larixyl acetate and larixol from 
Larix bark 
Large-scale Soxhlet extraction is not practical for industrial extraction. Therefore, a more 
suitable extraction method was required for extracting larixyl acetate and larixol from 
Larix on an industrial scale. Optimisation of the extraction method parameters was 
required, including consideration of the simplicity, cost, energy and safety of the 
procedure. As the outcomes of this research would be carried forward by the ProLarix 
partner Trifolio-M GmBH for pilot-plant testing and final production, their particular 
requirements (such as avoidance of certain solvents) also determined the direction of the 
work. 
 
Determining a suitable extraction solvent, with good yields from Larix bark and a high 
affinity for larixyl acetate and larixol, was the main priority for this work. ‘It is considered 
good practice to select solvent(s) for extraction that maximise the botanical substances 
required and minimise harmful components,’ according to the guidelines for submission of 
a plant protection product to the European Commission.101 
3.3.2.1 Primary extraction of Larix bark with a range of solvents 
A suitable solvent to extract larixyl acetate and larixol from Larix bark needed to be 
identified. Previous results (section 3.2.2.1) identified that CH2Cl2 may be more selective 
in extracting larixyl acetate and larixol than MeOH. However, the use of chlorinated 
solvents (such as CH2Cl2) needs to be avoided in agriculture, to prevent its detrimental 
bioaccumulation in groundwater.67,105 Therefore, further investigation was undertaken 
(methodology in section 3.2.3.1) using a range of solvents with varying polarities. CH2Cl2 
and EtOAc, although previously investigated, were included for comparison. Extracts were 
analysed quantitatively using GC-FID for the content of larixyl acetate, larixol and 
epimanool (the primary impurity).  
  
 
 
 
 
Table 3.4: Yield and chemical composition of extracts obtained by agitating milled 10 mm bark of Larix decidua for five days with different 
solvents at room temperature (RT). 
 
Solvent 
Extract yield 
from Larix bark 
(% w/w) 
 Content in extract (%)  Yield from Larix bark (% w/w) 
 Larixyl acetate Larixol Epimanool  Larixyl acetate Larixol Epimanool 
H2O (tap) 0.86  2.99 0.67 5.50  0.026 0.006 0.047 
H2O (distilled) 0.78  1.57 - -  0.012 - - 
EtOH:H2Oa 1:1 3.76 ± 0.16  0.85 ± 0.14 
0.92 ± 
0.11 0.84 ± 0.13  0.032 ± 0.004 0.035 ± 0.004 0.032 ± 0.006 
EtOH 2.57  2.92 1.26 1.89  0.075 0.032 0.049 
MeOH 3.95  1.22 0.83 0.89  0.048 0.033 0.035 
PEb 0.95  10.09 2.69 6.89  0.096 0.026 0.066 
EtOAcc 2.66  3.87 1.38 2.26  0.103 0.037 0.060 
CH2Cl2 1.61  5.43 1.45 2.86  0.088 0.023 0.046 
Acetone 2.40  4.11 1.45 2.32  0.099 0.035 0.056 
Diethyl ether 1.86  4.57 1.55 2.61  0.085 0.029 0.048 
Hexane 0.63  13.67 3.44 8.11  0.087 0.022 0.051 
‘Green CH2Cl2’d 3.29  2.79 1.09 1.78  0.092 0.036 0.059 
 
aDistilled water, n = 3, ± the standard deviation. bPetroleum ether. cEthyl acetate d‘Green CH2Cl2’; a 3:1 (v/v) solution of ethyl 
acetate/EtOH (Sigma-Aldrich)106 Compound content in extracts were analysed using GC-FID (methodology in section 2.4.2).  
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H2O (both tap and distilled) gave some of the lowest extraction yields (Table 3.4) from the 
Larix bark (0.86% and 0.78%, respectively). The tap water extract contained low amounts 
of larixyl acetate (2.99%) and larixol (0.67%) but a high amount of epimanool (5.50%). 
This was also reflected in the total yields of these compounds from the Larix bark (larixyl 
acetate 0.026%, larixol 0.006% and epimanool 0.047%). The distilled water extract 
contained only larixyl acetate at a detectable level (1.57%), resulting in the lowest yield of 
larixyl acetate (0.012%) from the Larix bark out of all of the solvents tested.  
 
Acetone had a high extract yield (2.40%), which contained a moderate amount of larixyl 
acetate (4.11%), larixol (1.45%) and epimanool (2.32%). The diethyl ether extract (1.86% 
yield) contained a similar content of larixyl acetate (4.57%), larixol (1.55%) and 
epimanool (2.61%) to the acetone extract. The resulting yields of larixyl acetate, larixol 
and epimanool from the Larix bark were moderately high for both the acetone (0.099%, 
0.035% and 0.056% respectively) and diethyl ether (0.085%, 0.029% and 0.048% 
respectively) extracts. 
 
EtOH had a high extract yield from Larix bark (2.57%), which had a moderate content of 
larixyl acetate (2.92%), larixol (1.26%) and epimanool (1.89%). This resulted in a total 
yield of 0.075% larixyl acetate, 0.032% larixol and 0.049% epimanool from the Larix 
bark. 
 
A 1:1 ratio of EtOH:H2O (distilled) was also investigated as a suitable solvent. It was 
thought that, if effective, combining EtOH and H2O would reduce the cost of using pure 
EtOH (a common solvent for extracting natural products). Extraction using this solvent 
was repeated three times (n = 3) to assess the repeatability of the method, which was good 
for the purpose of natural product extraction. Using this combination of solvents resulted 
in a much higher extract yield from Larix bark (3.76 ± 0.16%) than EtOH or H2O alone. 
The content of larixyl acetate (0.85 ± 0.14%), larixol (0.92 ± 0.11%) and epimanool 
(0.84 ± 0.13%) in the extract was lower than in the EtOH extract, but higher than in the 
distilled water extract. The total yields of larixyl acetate (0.032 ± 0.004%), larixol 
(0.035 ± 0.004%) and epimanool (0.032 ± 0.006%) were higher using EtOH:H2O 
compared to distilled water. The total yield of larixyl acetate was about half as much using 
EtOH:H2O compared to pure EtOH. While the total yield of epimanool was also lower 
using EtOH:H2O, compared to pure EtOH, larixol was comparable between the two 
solvents. 
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MeOH had the highest extract yield from Larix bark (3.95%), but it contained low 
amounts of larixyl acetate (1.22%), larixol (0.83%) and epimanool (0.89%). Poor total 
yields of larixyl acetate (0.048%), larixol (0.033%) and epimanool (0.035%) therefore 
resulted from the Larix bark. This result was comparable to the Soxhlet extract (which also 
had a high yield from the Larix bark but low total yield of larixyl acetate and larixol). The 
CH2Cl2 extract was also comparable to the results of the Soxhlet extract; it had a low 
extract yield from Larix bark (1.61%) but contained a high amount of larixyl acetate 
(5.43% of the extract and 0.088% total yield from the Larix bark). 
 
‘Green CH2Cl2’ was a commercially available, premade mix of solvents formulated as a 
green alternative to use as a replacement for CH2Cl2. It is comprised of ethyl acetate/EtOH 
3:1 (v/v) solution (Sigma-Aldrich, St. Louis, Missouri, United States), which was 
advertised as being ‘far less hazardous and significantly lower in toxicity to both humans 
and the environment’ than CH2Cl2.106 These results indicate that ‘Green CH2Cl2’ had an 
overall similar, if not better, extraction profile to CH2Cl2. The extract yield from Larix 
bark of ‘Green CH2Cl2’ (3.29%) was higher than CH2Cl2 and it also contained a higher 
total content of larixol acetate (0.092% compared to 0.088%), larixol (0.036% compared to 
0.023%) and epimanool (0.059% compared to 0.046%). 
 
EtOAc was previously used for Soxhlet extraction (section 3.2.2.1) and demonstrated a 
very low extraction yield (0.002%). However, using this methodology, the EtOAc extract 
yield from Larix bark was much higher at 2.66%. This could potentially be due to the 
increased extraction time. Larixyl acetate, larixol and epimanool content in the extract was 
average compared to the other solvents, however the total yields of these compounds from 
the Larix bark was the highest for larixyl acetate (0.103%) and larixol (0.037%). 
 
The extracts resulting from using hexane and PE as solvents were of particular interest. 
Both extracts had low yields from the Larix bark (PE: 0.95%, hexane: 0.63%). However, 
the content of larixyl acetate, larixol and epimanool in the extracts were the highest 
compared to all other solvents tested. The PE extract contained 10.09% larixyl acetate, 
2.69% larixol and 6.89% epimanool, whereas the hexane extract contained a slightly 
higher amount of each compound (13.67% larixyl acetate, 3.44% larixol and 8.11% 
epimanool). The total yields of these compounds extracted from the Larix bark was 
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therefore high for both PE and hexane (despite their low extract yields), due to their high 
selectivity for larixyl acetate, larixol and epimanool. Although high selectivity for the 
primary impurity epimanool may be construed negatively, due to the similar chemistry of 
the three compounds, it was highly unlikely that larixyl acetate and larixol could be 
extracted separately from epimanool at this stage. 
3.3.2.2 Secondary extraction of Larix primary extracts with petroleum ether 
The EtOH (10 mm particle size) extract’s 1H NMR spectrum, in comparison to that of 
larixol, larixyl acetate and epimanool (Appendix A3.2), showed that it contains high 
amounts of resin acids (such as pimaranes and abietanes, structures in Figure 1.4) 
alongside larixyl acetate, larixol and epimanool. A typical double doublet (dd) peak for H-
14 of the ‘AMX’ system (terminal double bond H-14, H-15A and H-15B, Figure 3.6) for 
larixyl acetate, larixol and epimanool can be found at δH 5.88 – 5.90. The resonance peak 
for the H-14 of the ‘AMX’ system of resin acids (where the terminal double bond was 
present) was found to be at a lower chemical shift, between δH 5.75 – 5.84. 
 
On the 1H NMR spectrum of the EtOH (10 mm particle size) extract (Appendix A3.2), the 
peak at δH 5.88 confirmed the presence of larixyl acetate (dd, J = 17.4, 10.8 Hz) and larixol 
(dd, J = 17.4, 10.7 Hz). The similar peak for epimanool was present at δH 5.90 (dd, 
J = 17.3, 10.7 Hz). However, a peak at δH 5.79 (dd, J = 17.4, 10.7 Hz) indicated that resin 
acids were also present at a high concentration. Therefore, further purification of the 
extracts needed to be undertaken. 
 
PE and hexane appeared to be selective for larixyl acetate, larixol and epimanool. 
Although the hexane extract contained a higher amount of larixyl acetate and larixol than 
the PE extract, the use of PE was preferred instead of hexane due to the economic costs of 
purchasing the solvents. Therefore, to purify further the initial extract, the primary Larix 
extracts were re-extracted with PE to produce secondary PE extracts. The composition of 
larixyl acetate, larixol and epimanool in these extracts are illustrated in Figure 3.7.
  
 
 
Figure 3.6: 1H NMR spectrum of larixyl acetate labelled with assigned common identifying peaks.  
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Figure 3.7: The secondary PE extract compositions of primary Larix bark extracts. PE 
extracts are sorted by solvent used for primary extraction of the Larix bark and 
are arranged from the highest to lowest combined larixyl acetate and larixol 
content.  
The PE extract from the primary combination of EtOH:H2O (1:1, distilled) extract clearly 
contained the highest combined percentage of larixyl acetate and larixol (32.04%) 
compared to the other extracts. This was mostly due to the high amount of larixol in the 
extract (16.98 ± 2.68%). The PE extract resulting from the hexane primary extract had the 
second highest percentage of larixyl acetate and larixol (23.51%), but had a higher amount 
of larixyl acetate (18.09%) than the EtOH:H2O PE extract (15.06 ± 2.02%). 
 
The primary PE extract was extracted for a second time with PE for comparative purposes. 
The content of active compounds in the extract increased by undertaking this secondary 
extract, from 10.09 to 15.19% larixyl acetate, from 2.69 to 4.49% larixol and from 6.89 to 
9.60% epimanool. This indicates that more impurities had not been extracted by the 
secondary extraction and were hence left behind in the beaker. The secondary PE extract 
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contained the third highest amount (% in the PE extract) of larixyl acetate and larixol 
combined (19.68%), just lower than the hexane extract. 
 
The primary diethyl ether (18.26%), ‘Green CH2Cl2’ (17.17%) and MeOH (16.83%) 
extracts contained a similar amount of larixyl acetate and larixol, as a percentage of the PE 
extract. Acetone (13.38%), EtOAc (13.22%), EtOH (13.10%) and CH2Cl2 (10.03%) 
extracts contained lower amounts of the two compounds (as a percentage of their PE 
extracts) than the other solvents.  
 
The content of epimanool in the PE extracts followed a similar pattern to the content of 
combined larixyl acetate and larixol content of the extracts. No trace of larixyl acetate, 
larixol or epimanool could be identified in the H2O extracts (tap or distilled). This could be 
because the secondary PE extract yield was extremely low (0.005%). 
 
Alongside the overall composition of larixyl acetate and larixol in the purified extract, the 
overall yield of the PE extract from the Larix bark must be considered. Maximising both 
the extract yield and purity of the extract was important so that the resulting extraction 
method would be suitable for industrial use. The PE secondary extract yields and 
composition figures are displayed in Table 3.5.  
 
The three PE extracts with the highest percentage composition of larixol and larixyl acetate 
(EtOH:H2O 1:1, hexane and PE) unfortunately also had some of the lowest total yields 
from Larix bark (0.05 ± 0.01%, 0.39% and 0.57%, respectively). However, due to their 
affinity for larixyl acetate and larixol, these solvents were good purification solvents and 
so a compromise would be required between the purity and yield of the final extract to use 
these solvents. EtOH:H2O and PE are industrially safe solvents and so were investigated 
further (in the next section). However, as PE and hexane had similar extraction profiles 
and hexane is more expensive to purchase than PE, the use of hexane was not additionally 
explored.
 
 
 
 
 
 
 
 
Table 3.5: Yield and chemical composition of extracts gained by re-extracting different Larix decidua bark extracts with petroleum ether. 
Initial extract  Petroleum ether extract 
Solvent initial 
extract 
Yield from 
Larix bark 
(% w/w) 
 Yield from 
initial extract 
(% w/w) 
Yield from 
bark (% w/w) 
 Content in extract (%)  Yield from Larix bark (% w/w) 
  Larixyl acetate Larixol Epimanool 
 Larixyl 
acetate Larixol Epimanool 
H2O (tap) 0.86  0.58 0.005  - - -  - - - 
H2O (distilled) 0.78  - -  - - -  - - - 
EtOH:H2Oa 1:1 3.76 ± 0.16  1.32 ± 0.38 0.05 ± 0.01  
15.06 ± 
2.02 
16.98 ± 
2.68 
10.88 ± 
0.94 
 0.007 ± 
0.002 
0.008 ± 
0.001 
0.005 ± 
0.002 
EtOH 2.57  43.75 1.13  10.42 2.68 5.99  0.117 0.030 0.068 
MeOH 3.95  23.89 0.94  13.39 3.44 8.07  0.126 0.033 0.076 
PEb 0.95  59.29 0.57  15.19 4.49 9.60  0.086 0.025 0.054 
EtOAcc 2.66  22.16 0.59  10.88 2.34 6.29  0.064 0.014 0.037 
CH2Cl2 1.61  87.72 1.42  8.08 1.95 4.62  0.114 0.028 0.065 
Acetone 2.40  51.00 1.23  10.14 3.24 5.48  0.124 0.040 0.067 
Diethyl ether 1.86  89.67 1.66  14.07 4.19 7.91  0.234 0.070 0.132 
Hexane 0.63  62.13 0.39  18.09 5.42 9.79  0.071 0.021 0.039 
‘Green CH2Cl2’d 3.29  64.87 2.13  13.54 3.63 8.21  0.289 0.077 0.175 
aDistilled water, n = 3, ± the standard deviation. bPetroleum ether. cEthyl acetate d‘Green CH2Cl2’; a 3:1 (v/v) solution of ethyl acetate/EtOH 
(Sigma-Aldrich)106 Compound content in extracts were analysed using GC-FID (methodology in section 2.4.2). 
 
Chapter 3: Extraction of larixyl acetate and larixol from Larix 
 
60 
 
The PE extract from ‘Green CH2Cl2’ resulted in the highest yield from Larix bark (2.13%), 
followed by diethyl ether (1.66%). These two extracts contained a good percentage content 
of larixyl acetate and larixol. The MeOH extract contained a similar content of the two 
compounds, but had a lower yield from the Larix bark (0.94%). ‘Green CH2Cl2’ and 
diethyl ether would make good candidates for industrial extraction of larixyl acetate and 
larixol. However, these solvents were not investigated further due to cost limitations. 
MeOH is widely used as an industrial solvent. However, the ProLarix project partner that 
would use this extraction method for industrial production of Larixyne® did not want to 
use MeOH as an extraction solvent, due to the explosive nature of MeOH vapour/air 
mixtures (the vapour pressure of MeOH at 20°C is 12.3 kPa).107,108 Therefore, MeOH was 
also ruled out as a suitable extraction solvent. 
 
Secondary PE extracts with acetone and CH2Cl2 contained lower amounts of larixyl acetate 
and larixol, but good yields from Larix bark (1.23% and 1.42% respectively). Almost all of 
the CH2Cl2 primary extract was re-extracted with PE, whereas about half of the acetone 
extract was re-extracted with PE. Extraction with CH2Cl2, followed by PE could be a good 
extraction sequence, however CH2Cl2 was ruled out due to the environmental toxicity, as 
previously discussed. The results from extraction of Larix bark with acetone, followed by 
PE were good enough to take forward for further investigation (in the next section). 
 
The secondary PE extract from the EtOAc extract had a low yield of 0.59% from the Larix 
bark. As the content of larixyl acetate and larixol was also lower in the PE extract than in 
other extracts, EtOAc was not considered for further investigation as a suitable extraction 
solvent. Although the EtOH PE extract contained a similar amount of larixyl acetate and 
larixol to EtOAc, its yield from Larix bark was almost double (1.13%). This, combined 
with the fact that it is an authorised solvent to use in organic agriculture (even in the 
preparation of plant ingredients),26 was the reason why it was taken forward as a potential 
solvent for extraction of larixyl acetate and larixol. 
 
The extractions of larixyl acetate and larixol from Larix bark with H2O (tap and distilled) 
using this methodology resulted in extremely poor yields and content of the compounds. 
However, it is a very cheap solvent and so preferred for use in industry. Therefore, to 
consider H2O as an effective extraction solvent for the purpose of extracting larixyl acetate 
and larixol, the method needs to be further improved. Hence, H2O was investigated further. 
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Re-extraction of the primary extracts with PE increased the percentage composition of 
larixyl acetate and larixol in all of the extracts. The 1H NMR spectrum of the EtOH Larix 
bark extract before and after purification with PE (Appendix A3.4) shows a reduction in 
the number of resin acids present (decrease in intensity of resin-acid ‘AMX’ peak at 
δH 5.79 (dd, J = 17.4, 10.7 Hz)). Therefore, it was concluded that extraction with PE 
results in good purification of the initial extracts. 
 
3.3.3 Investigation of economically feasible and industrially safe extraction solvents 
to extract larixyl acetate and larixol from Larix bark  
From the previous findings, it was decided to investigate further the use of H2O, EtOH, 
EtOH:H2O, acetone and PE as primary extraction solvents and PE as a secondary 
extraction solvent. These solvents were considered both environmentally friendly and 
economically feasible for use in an up-scaled industrial extraction method, for the 
production of a plant protection product suitable for the organic agricultural market. 
 
The results from the extraction of Larix bark with these solvents is presented in Table 3.6 
(only the active constituents of interest are presented for clarity, as epimanool followed a 
similar extraction profile to larixyl acetate and larixol). 
 
Extraction of material of two particle sizes, using EtOH and EtOH:H2O, was also 
explored. Particle size did have an impact on the yields of larixyl acetate and larixol from 
the Larix bark. The larger particle size (10 mm) extracts gave higher yields of the 
compounds than smaller (4 mm) particle sizes. EtOH yielded 0.016% (4 mm) and 0.066% 
(10 mm) larixyl acetate and 0.004% (4 mm) and 0.016% (10 mm) larixol. Additionally, 
EtOH:H2O yielded 0.010% (4 mm) and 0.015% (10 mm) larixyl acetate and 0.006% (4 
mm) and 0.008% (10 mm) larixol. It was thought that the increase of extraction yield of 
large particles was due to increased solvent mobility. 
  
 
 
 
 
 
 
Table 3.6: Yield and chemical composition of extracts obtained by agitating milled bark of Larix decidua for eight hours with different 
solvents at room temperature (RT) or at 100 °C. 
Solvent Extraction temperature 
Particle size 
(mm)  
Extract yield from 
bark (% w/w)  
Content in extract (% w/w) 
 
Yield from bark (% w/w) 
Larixyl acetate Larixol Larixyl acetate Larixol 
Acetone RT a 4  2.19  3.00 0.72  0.066 0.016 
PE b RT 4  0.57  13.82 2.99  0.079 0.017 
EtOH 
RT 4  1.58  1.01 0.28  0.016 0.004 
RT 10  2.61  2.51 0.62  0.066 0.016 
H2O c 
RT 4  0.82  - 0.17  - 0.001 
100 °C 4  4.15  - 0.11  - 0.005 
EtOH:H2O 1:1 
RT 4  7.09  0.14 0.09  0.010 0.006 
RT 10  4.22  0.35 0.18  0.015 0.008 
EtOH:H2O 1:1 100 °C 4  7.12  0.42 0.13  0.030 0.009 a Room temperature; b Petroleum ether; c distilled. Compound content in extracts were analysed using GC-FID (methodology in section 
2.4.2).  
  
  
 
 
 
 
 
 
Table 3.7: Yield and chemical composition of extracts gained by re-extracting different Larix decidua bark extracts with petroleum ether. 
Initial extract from Larix bark  Petroleum ether extract 
Solvent initial 
extract 
Extraction 
temperature 
Particle 
size (mm) 
Yield from bark 
(% w/w)  
Yield from initial 
extract (% w/w) 
Yield from bark 
(% w/w) 
 Composition (%) 
 Larixyl acetate Larixol 
Acetone RT a 4 2.19  0.06 0.001  61.97 8.09 
EtOH 
RT 4 1.58  6.70 0.11  3.72 0.86 
RT 10 2.61  16.92 0.44  13.02 2.68 
H2O 
RT 4 0.82  0.05 0.001  2.74 2.59 
100 °C 4 4.15  0.06 0.002  2.49 - 
EtOH:water 1:1 
RT 4 7.09  1.01 0.07  14.56 3.46 
RT 10 4.22  2.70 0.11  17.36 5.50 
100 °C 4 7.12  0.40 0.03  7.83 2.93 
a Room temperature. Compound content in extracts were analysed using GC-FID (methodology in section 2.4.2).  
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H2O and EtOH:H2O were investigated at both room temperature (RT) and hot (100 ºC) to 
try and increase the extraction yield of larixyl acetate and larixol. The H2O extract yield 
increased from 0.82% to 4.15% by increasing the extraction temperature from RT to 
100 ºC, however the percentage content of larixyl acetate and larixol in the extract was not 
improved (the larixyl acetate concentration was under the detection limit). No substantial 
increase in extract yield was seen for extraction using EtOH:H2O (4 mm) at an increased 
temperature, however the percentage content of larixyl acetate in the extract was 
significantly improved from 0.14% at RT to 0.42% at 100 ºC. 
 
Good yields of larixyl acetate (0.066%) and larixol (0.016%) were obtained from 
extraction of Larix bark (10 mm) with EtOH. These yields were comparable to the yields 
of the acetone (0.066% larixyl acetate, 0.016% larixol) or PE (0.079% larixyl acetate, 
0.017% larixol) extracts. H2O gave very poor yields of larixyl acetate (below the detection 
limit) and larixol (0.001 – 0.005%), while EtOH:H2O produced an intermediate amount of 
larixyl acetate (0.010 – 0.030%) and larixol (0.006 – 0.009%). 
 
The extracts were purified further by re-extracting them with PE, to obtain extracts with 
higher concentrations of larixyl acetate and epimanool. This purification was thought to 
remove the resin acids from the extracts, as PE was previously found to be selective for 
larixyl acetate and larixol. The results are presented in Table 3.7. The EtOH (10 mm) PE 
extract had the highest overall yield from the Larix bark (0.44%). In contrast, the acetone 
and H2O extracts had very poor yields of 0.001% and 0.001 – 0.002% respectively. The 
percentage composition of larixyl acetate and larixol was increased in all extracts by re-
extracting them with PE.  
3.3.4 Purification of Larix oleoresin with sodium hydroxide (NaOH) 
It was at this point a second source of Larix decidua, Larix oleoresin (Larch turpentine), 
was introduced for investigation as an alternative source of larixyl acetate and larixol from 
Larix. Plant oils, including pine oil, are authorised (under Regulation (EEC) No 2092/91 
and carried over into Regulation (EC) No 889/2008) for use as a fungicide.26 Therefore it 
was likely that inclusion of Larch turpentine, as a potential source for a plant protection 
product for organic agriculture, would not cause unforeseen difficulties during registration. 
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Initially the Larix oleoresin was analysed using GC-MS (method in section 6.2.2.2) and 
the compounds were identified using the 2008 National Institute of Standards and 
Technology (NIST) GC-MS database. Peaks for epimanool, larixol and larixyl acetate, 
with retention times of 21.50, 23.56 and 24.37 minutes respectively (Table 3.8) were 
observed. A high concentration of larixyl and larixyl acetate in the technical grade extract 
was required for field trials. From the description of the chemical constituents present in 
(Table 3.8), it was clear that a method to remove the monoterpenes and diterpene acids 
was required to produce an enriched extract from Larix oleoresin.  
 
The 1H NMR spectrum of Larix oleoresin was recorded (Appendix A3.3). Characteristic 
proton resonances for larixyl acetate and larixol were present: double bond proton 
resonances of an ‘AMX’ system for H-14, H-15A, H-15B, terminal double bond proton 
resonances for 2H-17, a methine proton resonance for H-6 and an acetoxy methyl group 
proton resonance for 3H-22. Proton resonances for larixol include the double bond proton 
resonances of an AMX system for H-14 and 2H-15, terminal double bond proton 
resonances for 2H-17 and a methine proton resonance for H-6. However, resonances 
typical of resin acids were also present. 
 
Previous research into Larix bark extraction (section 3.3.2) found that hexane and PE 
solvents had superior selectively, compared to other solvents, for the extraction of larixol 
and larixyl acetate. Hence, these non-polar solvents would be expected to dissolve larixyl 
acetate, larixol and epimanool present in the oleoresin, but not the other diterpene acids. It 
was found that the Larix oleoresin dissolved comfortably in hexane and PE in an 
approximate 1 g oleoresin to 15 mL solvent ratio (at room temperature). 
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Figure 3.8: GC-MS chromatogram of Larix oleoresin (C.E. Roeper GmbH). GC-MS 
conditions as reported in section 6.2.2.2. 
Table 3.8: GC-MS identification of compounds in Larix oleoresin (Figure 3.8) using the 
NIST library.103 
Retention time 
(min) 
Suggested compound by NIST 
library % Probability 
6.16 α-pinene 96 
7.06 β-pinene 94 
8.08 D-limonene 95 
15.05 germacrene 96 
16.04 γ-elemene 91 
21.06 rimuen 91 
21.23 unidentified - 
21.36 thunbergol 95 
21.50 epimanool 91 
23.17 unidentified - 
23.56 larixol 91 
23.73 abietic acid 86 
23.98 unidentified - 
24.12 unidentified - 
24.37 larixyl acetate 94 
24.64 1-octadecanethiol 53 
25.13 unidentified - 
25.19 pimaric acid 43 
Chapter 3: Extraction of larixyl acetate and larixol from Larix 
 
67 
Therefore, the Larix oleoresin was dissolved in hexane or PE and the resin acid impurities 
were removed by a simple reaction with sodium hydroxide (Figure 3.9 and experimental 
section 3.2.4). Sodium hydroxide neutralised the resin acids to produce resin acid-salts, 
which then precipitated and were filtered out.  
   
Figure 3.9: Extraction of Larix oleoresin with hexane.  
a: Larix oleoresin dissolved in hexane; b: final organic phase (before drying); 
c: final organic phase (after initial drying); d: final hexane phase (dry). 
The purified organic hexane phase (containing active Larix constituents) was very slow to 
dry under atmospheric conditions and yielded an initial hard, sticky material (Figure 3.9c). 
After some initial attempts to dry the material, dissolution of the product in CH2Cl2 
followed by rotary evaporation was found necessary to dry the product. The resulting 
extract was pale yellow in colour (Figure 3.9d) and almost powdery in appearance, with 
46.7% yield. The PE extract behaved similarly, but produced an extract with 36.14% yield. 
The overlaid 1H NMR spectra of Larix oleoresin extracted with hexane and PE (Appendix 
A3.5) confirm that the extracts from both solvents are comparable. 
 
Appendix A3.6 shows the overlaid 1H NMR spectra for the Larix oleoresin hexane extract 
and the precipitate produced as a result of the reaction between the resin acids and sodium 
hydroxide. The spectra show that the precipitate contains more resin acids than larixyl 
acetate, larixol or epimanool than the hexane extract. Further washing of the precipitate 
could retrieve the minor amounts of larixyl acetate, larixol and epimanool present in the 
precipitate. In addition, the spectra show that the amount of resin acids in the hexane 
extract was low in comparison to the amount of larixyl acetate, larixol and epimanool. 
 
 
a b c d 
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The resin acid-salt precipitate frequently formed a viscous third layer between the aqueous 
and organic layers that was difficult to remove from the separation funnel. (Appendix 
A3.1) Other researchers have found similar problems, with resin acids sticking to the 
inside of glassware.109 Interphases that form in solvent-solvent extractions (such as these) 
can cause problems in industrial processes, by blocking columns and filters. In addition to 
this, a large amount of salt waste would be produced by following this method. This could 
be reduced by regenerating the carboxyl group of the resin acid-salt through simple 
acidification, thereby making the resin acids available for exporting to other industries and 
reducing waste. However, this would incur additional costs in processing and storage and 
the filter-blocking problem would still be an issue. Therefore, another way of purifying the 
Larix extracts and oleoresin was identified.  
3.3.5 Purification of Larix bark extracts and oleoresin with amine salt (2-amino-2-
methyl-1-propanol) 
An alternative way of purifying the Larix bark extracts and Larix oleoresin was using 2-
amino-2-methyl-1-propanol (AMP) to form an amine salt with the resin acids (Figure 
3.10).110,111 The precipitating amine salts were then easily removed from the extract. Using 
AMP to produce resin salts was a much cleaner and more efficient extraction process than 
using NaOH. NaOH purification also required an additional separation step that was often 
difficult to perform. 
 
Figure 3.10: Mechanism for the formation of a resin acid-amine salt from a resin acid and 
2-amino-2-methyl-1-propanol (AMP)   
The efficient 2–amino-2-methyl-1-propanol (AMP) purification method was used to purify 
Larix bark extracts and Larix oleoresin, to determine the source with the highest 
composition of larixyl acetate and larixol, for production of Larixyne®. Two EtOH:H2O 
extracts (discussed in section 3.3.3) were treated with AMP in order to remove the 
diterpenoid acids. The results from this reaction are presented in Table 3.9. 
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Table 3.9: Yield and chemical composition of extracts obtained by precipitating diterpene 
acids with 2-amino-2-methyl-1-propanol (AMP) from two Larix decidua bark extracts of 
different particle size. 
Initial extract  AMP extract 
Solvent 
initial 
extract 
Extraction 
temperature 
Particle 
size 
(mm) 
Yield 
from 
bark 
(% 
w/w) 
 
Yield 
from 
initial 
extract 
(%) 
Yield 
from 
bark 
(%) 
Composition 
(%) 
Yield from 
bark (% w/w) 
 Larixyl acetate Larixol 
Larixyl 
acetate Larixol 
EtOH:H2O 
1:1 
RT a 4 7.09  0.16 0.011 30.53 8.45 0.003 0.001 
RT 10 4.22  1.59 0.067 22.78 4.36 0.015 0.003 
a Room temperature. 
The composition of larixyl acetate and larixol in the extracts after treatment with AMP 
reached 30.53% larixyl acetate and 8.45% larixol for the 4 mm extract (39.0% combined 
active concentration). This is a very large increase from the original Larix bark extract 
composition of  0.14% larixyl acetate and 0.09% larixol (Table 3.6). However, the yield of 
this extract was low, meaning that the overall yield of these compounds from Larix bark 
was also low (0.003% larixyl acetate, 0.001% larixol). The 10 mm EtOH:H2O AMP 
extract had a lower composition of larixyl acetate (22.78%) and larixol (4.36%), with a 
combined active concentration of 27.1%. This was also a large increase from the original 
Larix bark extract composition of 0.35% larixyl acetate and 0.18% larixol (Table 3.6). 
However, when compared to the 4 mm extract, the 10 mm extract had a higher extract 
yield from the Larix bark (0.067%), hence the overall yield of compounds from 10 mm 
Larix bark was higher (0.015% larixyl acetate, 0.003% larixol). 
 
Larix oleoresin, purchased from C.E. Roeper GmbH (Hamburg, Germany), contained 
31.24% larixyl acetate and 5.33% larixol (36.6% combined actives) (Table 3.10). The 
concentrations of larixyl acetate and larixol were increased by removal of the diterpene 
acids using AMP. Larixyl acetate content was increased to 58.77% and larixol content to 
7.67% (66.5% combined actives). Purification of oleoresin with AMP had a 42% extract 
yield. Therefore, by using this method, 420 g of purified extract could be produced per kg 
of Larix oleoresin. This is the highest yield achieved for the extraction of larixyl acetate 
and larixol from Larix in the body of this work. 
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The Larix oleoresin contained mainly larixyl acetate, larixol and epimanool but also minor 
amounts of impurities (such as labdane, abietane and isopimarane acids). 1H NMR analysis 
was undertaken (Appendix A3.7 – A3.9) to confirm that all resin acids had been removed 
in the AMP extracts of both Larix bark and oleoresin. Both 1H NMR spectra showed that 
the presence of resin acids in the extract had decreased by using this purification method. 
 
An important benefit of AMP extraction was the reduction in a large amount of impurities 
in the final Larix extract. Impurities, such as resin acids, could cause issues in using the 
extract as a plant protection product. ProLarix partner FiBL found that Larix oleoresin 
could not be used directly as a plant protection product as it was found to be slightly toxic 
to grapevine seedlings. However, after extraction of the oleoresin with AMP, the resulting 
extract was no longer toxic to seedlings (FiBL 2015, unpublished raw data). 
Table 3.10: Composition of larch turpentine before and after removal of diterpene acids 
by reaction with 2-amino-2-methyl-1-propanol (AMP). 
Turpentine 
Yield from 
oleoresin 
(%) 
Chemical composition (%) 
Larixyl 
acetate Larixol 
Other constituents 
Epimanool Others 
Before reaction with 
AMP - 31.24 5.33 10.87 52.56 
After reaction with AMP 
(oleoresin extract) 42 58.77 7.67 21.66 11.90 
   
Figure 3.11: Large-scale Larix oleoresin extraction process photographs. Resin acid 
precipitate from reaction of Larix oleoresin with AMP (left) and final 
oleoresin extract after reaction with AMP, ready to send for formulation 
into Larixyne® (right). 
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The purification of Larix oleoresin using AMP was used on a large scale (Figure 3.11) to 
produce approximately 2.0 kg (2014) and 6.0 kg (2015) of a Larix oleoresin extract that 
was formulated (LAR-016, LAR-042) for use in field experiments in 2014 (Frick, 
Switzerland) and 2015 (Frick, Switzerland; San Michele, Italy; and Veria, Greece). 
3.3.6 Formulation composition 
The technical grade Larix extracts produced as a result of the work in this chapter were 
prepared into three different formulations by ProLarix partner Trifolio-M GmBH for field 
experiments. The in vitro and in planta activity of LAR-016 and LAR-042 formulations 
were also investigated and are discussed in Chapter 5. 
 
Table 3.11: Composition of Larix formulations 
Formulation 
Extract 
from 
Larix 
 Composition 
 Larix extract 
(%) 
Emulsifier 
(%) 
Adjuvant 
(%) 
Solvent 
(%) 
LAR-016 Oleoresin  25 5 5 65 
LAR-042 Oleoresin  50 5 5 40 
LAR-024 Bark  20 10 20 50 
 
Formulations of Larix extracts were required to optimise their use (shelf life, solubility) 
and agronomical properties (efficacy, UV stability and rain fastness). Formulations 
therefore had varying composition of components (emulsifiers, adjuvants and solvents) 
alongside the active extract (Table 3.11). Emulsifiers were required so that the 
formulations emulsified spontaneously when added to water, to produce a solution suitable 
for spraying. Adjuvants were added to formulations to improve the performance of the 
product. Solvents carried the components of the liquid formulations. The identity of 
components remained confidential to Trifolio-M GmBH. 
 
LAR-016 and LAR-042 were formulated from Larix oleoresin extracts (produced from 
experimental section 3.2.5.2). LAR-016 contained 25% extract and 65% solvent, whereas 
LAR-042 contained twice as much extract (50%) and less solvent (40%). Both 
formulations contained 5% emulsifier and 5% adjuvant. LAR-024 was formulated from a 
Larix bark extract (experimental section 3.2.2.3) and contained 20% extract, 10% 
emulsifier, 20% adjuvant and 50% solvent. 
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3.4 Conclusions 
The results of this chapter provided economically viable and environmentally friendly 
methods for the extraction of larixyl acetate, larixol and epimanool from Larix bark and 
oleoresin (meeting objectives 2 and 3). These methods were successfully used to provide 
enough technical grade extract to be formulated and used in field trials of the plant 
protection product.  
 
EtOH and PE were identified as the best solvent candidates for the industrial extraction of 
larixyl acetate and larixol from Larix bark. This was due to their low cost and the high 
yields obtained in primary EtOH (2.61% w/w) and secondary PE extraction (0.44% w/w), 
combined with the good percentage composition of larixyl acetate (13.02%) and larixol 
(2.68%) in the final extract. The use of EtOH extraction prior to PE extraction could 
increase the primary extraction yield, meaning that more secondary compounds could be 
isolated from the extract for other commercial uses. In addition, it was found that the 
particle size of Larix bark could affect extraction yields; surprisingly the smaller particle 
sizes provided smaller extraction yields. This was possibly due to the reduced mobility of 
the solvent. 
 
Both Larix bark and oleoresin are suitable starting materials for the extraction of a 
technical grade extract of Larixyne®. Larix oleoresin provided superior extraction yields 
of larixyl acetate (58.77% composition) and larixol (7.67% composition) in comparison to 
Larix bark (30.53% composition larixyl acetate and 8.45% composition larixol), through 
extraction with 2-amino-2-methyl-1-propanol (AMP). Although higher yields of larixol 
and larixyl acetate were present in the oleoresin AMP extract, both sources will proceed to 
industrial up-scale. It is predicted to be more cost effective to use oleoresin as a source of 
Larix actives due to the faster, fewer and less energy consuming processing stages. 
However, the raw bark material is considerably cheaper and more widely available than 
the oleoresin. A full analysis of these costs will be undertaken by Trifolio-M GmBH 
during transfer of the up-scale process into their pilot plant. 
 
By-products from the extraction process (such as phytosterols, fatty acids and resin acids) 
could also be marketable and provide additional commercial value to the bark material.38 
Purification with sodium hydroxide forms resin-acid sodium salts. The carboxyl group of 
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the resin acids can be converted back from the sodium salt through simple acidification. 
After purification of Larix extracts with 2-amino-2-methyl-1-propanol, the amine can be 
regenerated by using an ion-exchange resin.112 This process would also free the resin acids, 
meaning that they can be used as another commercial avenue of the extraction process. 
Further work could explore this procedure within the extraction process developed in this 
chapter.  
 
In conclusion, the work described in this chapter has shown that the extraction of larixyl 
acetate and larixol from Larix bark and oleoresin is technically feasible within the 
restraints of producing a commercial plant protection product for use in organic 
agriculture.
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Chapter 4: High yield sources of larixyl acetate and larixol from 
Larix  
4.1 Introduction 
The primary aim of the work described in this chapter was to identify European Larix 
sources with the highest recovery yield of larixyl acetate and larixol using an 
environmentally friendly extraction method. If a correlation between the physical or 
geographical parameters of Larix and level of larixyl acetate or larixol could be identified, 
then the parameters could be used to evaluate high-level sources of larixyl acetate and 
larixol easily, before extraction was undertaken.  
 
This chapter discusses the results from objectives 4, 5 and 6 of this thesis. Objective 4 was 
to quantify experimentally the larixyl acetate, larixol and epimanool content in 50 samples 
of Larix raw material from different sources in central and northern Europe. Objective 5 
was to compare the concentrations of larixyl acetate and larixol in Larix samples, in order 
to identify the highest-yielding sources of larixyl acetate and larixol. Objective 6 was to 
evaluate statistically whether the species, geographical (country of growth, elevation) or 
physical (tree part, colour) properties of the Larix samples affect their larixyl acetate, 
larixol or epimanool concentration.  
 
These results would indicate where sources of Larix should be obtained for the highest 
value large scale commercial extraction. The costs of purchasing and transporting raw 
materials from each location to a singular industrial plant were not considered as part of 
this study, as these variables may change. It was important to first identify which sources 
have the potential to yield the highest quantities of active components, so that this 
information would be available to industrial partners to make financial and logistical 
calculations. As previously discussed in Chapter 1, epimanool is a primary impurity of the 
larixyl acetate and larixol extract. It has no known activity against Plasmopara viticola; 
however, quantification of epimanool was required for registration of the plant protection 
product. 
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Chapter 2 describes the development of the quantitative method used in this chapter to 
quantify the concentration of larixyl acetate, larixol and the primary impurity (epimanool) 
in these samples. In the previous chapter (Chapter 3), the most efficient and sustainable 
techniques for the extraction of larixyl acetate, larixol and epimanool from plant material 
were described. These were used to extract the compounds from the Larix samples in this 
chapter.  
 
Fifty Larix samples were collected by collaborators from the University of Helsinki and 
delivered to the University of Surrey to determine the plant sources with the highest 
concentrations of larixyl acetate and larixol. The plant samples were milled and extracted 
in batches (section 4.2.2). The concentration of larixyl acetate, larixol and epimanool in 
each sample was determined using gas chromatography (see section 4.2.4 for 
methodology). The samples were sorted into different categories based on their 
geographical origins and physical characteristics. The overall levels measured and the 
concentration in each category is outlined in section 4.3. The five samples identified to 
have the highest concentration of larixyl acetate and larixol extracted using bench 
extraction were also analysed for their total content using Soxhlet extraction (section 
4.3.2). Statistical evaluations of the results were finally undertaken to identify if there were 
any correlations between the geographical origin and physical characteristics of the Larix 
samples on the levels of larixyl acetate, larixol and epimanool (section 4.3.3). The results 
from this chapter are summarised in section 4.4. 
4.2 Experimental 
The Larix samples (n = 50) were received by the University of Surrey between 10/06/2014 
and 04/02/2015 from Professor Heikki Hokkanen from the University of Helsinki (UHEL). 
Larix decidua, Larix gmelinii, Larix sibirica and Larix kaempferi samples were received.  
Three shipments of Larix samples were delivered to the University of Surrey, each sample 
weighing between 40 – 500 g and sent in separate brown paper bags labelled with a source 
code from UHEL (Appendix A4.1). Full Larix sample information can be found in 
Appendix A4.2. The following preparation and extraction procedure was undertaken for 
each Larix sample. 
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4.2.1 Larix milling 
The samples received varied in particle size. Milling the Larix samples to a uniform size 
ensured a fair comparison between the samples. Each bark source was ground using a Glen 
Creston cross-beater mill with a mesh size of 4 mm (Glen Creston Limited, London, UK) 
and transferred to a plastic bag to comply with laboratory health and safety regulations. To 
avoid contamination, the cross-beater mill was cleaned using a cardboard cycle, followed 
by brushing and removing of dust using compressed air after each mill. 
4.2.2 Bench extraction 
Two batch runs, of 20 and 30 samples, were prepared for extraction. Primary extraction of 
the Larix samples was limited to 40 g of material due to limitations in equipment and the 
amount of some samples received; approximately 40 g of each Larix sample was weighed 
into a 500 mL glass conical flask. The conical flasks from the batch were loaded onto the 
Labcon platform shaker (Laboratory Consumables, PTY, Durban, South Africa). 250 mL 
of absolute EtOH (Fisher, Loughborough, UK) was added to each conical flask and the 
flask was covered in foil to prevent evaporation of the solvent (Figure 4.1). The flasks 
were shaken for 1 hour at 115 rpm. 
 
 
Figure 4.1: Left: Larix samples weighed out into conical flasks before addition of ethanol 
(EtOH). Centre: Larix samples after addition of EtOH on the Labcon platform 
shaker. Right: Dry EtOH extracts after filtration. 
 
After extraction, the EtOH extracts were filtered through an 18 cm glass funnel plugged 
with cotton wool (to prevent the transfer of bark material) into a 400 mL beaker. Extracts 
were filtered in the same order as the EtOH was added previously to ensure consistency. 
The remaining bark in the funnel was pressed three times to ensure the maximum amount 
of extract was released. The funnel tip was washed with MeOH (Sigma-Aldrich, St. Louis, 
Missouri, United States) and the EtOH extracts were left to dry in a fume cupboard (Figure 
4.1). The extract masses were noted when constant mass was achieved (7-10 days). 
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Figure 4.2: Left: Larix samples after secondary extraction with petroleum ether, just 
before filtering. Centre: Petroleum ether extracts after filtering. Right: Dry 
petroleum ether extracts. 
 
Secondary extraction with petroleum ether (PE) was then undertaken (Figure 4.2). To the 
dry EtOH extracts was added 200 mL PE (40-60 °C fraction, Fisher, Loughborough, UK) 
for the secondary extraction. After addition of the solvent, the sides and bottom of the 
beaker were scraped down evenly using a spatula. The beaker was then covered in foil to 
prevent solvent evaporation. Beakers were left to stand for 100 minutes with agitation 
(stirring) after 50 minutes. The PE extracts were filtered using a 10 cm glass funnel fitted 
with a 150 mm diameter filter paper. The funnel tip was washed with MeOH. PE extracts 
were left in the fume cupboard for solvent to evaporate and the mass noted when constant 
mass was achieved (7-10 days). 
4.2.3 Soxhlet extraction 
Soxhlet extraction was undertaken to assess the total recovery possible of larixol and 
larixyl acetate from plant samples (section 4.3.2). Due to time constraints set by industrial 
partners, it was not possible to extract all 50 Larix samples using a Soxhlet apparatus. To 
assess complete larixyl acetate and larixol extraction, the five Larix samples with the 
highest concentration of larixyl acetate and larixol in the PE extract from the previous 
bench extraction were extracted using a Soxhlet (25 cm height, 200 mL siphoning volume, 
1 L round bottom flask). These five samples were analysed alongside a reference bark 
material (Larix_REF) provided by the Research Institute of Organic Agriculture (FiBL). 
Quantitative analysis of larixol, larixyl acetate and epimanool content was undertaken 
using gas chromatography, as detailed in section 4.2.4.  
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Approximately 70 g of plant material (or as much remaining material as possible left from 
the previous study) was weighed out and transferred to the Soxhlet apparatus. 
Dichloromethane (CH2Cl2, Sigma-Aldrich, St. Louis, Missouri, United States) was added 
(600 mL) and heated until the point of reflux. The material was extracted for 8 hours a day, 
for a total of 24 hours before the solvent was removed from the apparatus and the extract 
left to dry under atmosphere. A new batch of 600 mL CH2Cl2 was then added to the same 
plant material and the 24-hour extraction process was repeated. Three extractions were set 
up in series to reduce waste water (Figure 4.3). 
4.2.4 Analysis of extracts 
The PE extracts were analysed using gas chromatography fitted with a flame ionisation 
detector (GC-FID, see section 2.4.2 for methodology), and 1H nuclear magnetic resonance 
(NMR) spectroscopy. The limits of detection for this GC-FID method were 0.002 mg/mL 
larixyl acetate, 0.002 mg/mL larixol and 0.001 mg/mL epimanool (section 2.4.5). A 
2 mg/mL solution of each PE extract was prepared by weighing out approximately 20 mg 
of the extract into a weighing boat, transferring it into a 10 mL volumetric flask and 
dissolving it in MeOH. After dissolution, any remaining precipitate was filtered out 
through cotton wool during transfer of the sample to the GC-FID sample vial. Samples for 
qualitative 1H NMR analyses were dissolved directly from the petroleum extract beaker 
using deuterated chloroform (Cambridge Isotope Laboratories Inc., Andover, 
Massachusetts, United States). 
 
 
Figure 4.3: Soxhlet extractions of Larix samples run in series. 
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4.3 Results and discussion 
4.3.1 Levels of larixyl acetate, larixol and epimanool in Larix samples 
This section details the levels of larixyl acetate, larixol and epimanool in the Larix 
samples. The overall levels are discussed in section 4.3.1, which includes a discussion of 
the results in terms of the geographical origins of the Larix samples (country, latitude, 
longitude, elevation). in section 4.3.1.3 and in terms of their physical characteristics (tree 
part, colour) in section 4.3.1.4. Concentration results are presented in this chapter in units 
of% w/w, which was a requirement for the reporting of active constituents in a plant 
protection product to the European Commission.72 The% w/w unit represents the 
constituent amount as a mass percentage of total plant (Larix) material.  
 
In this thesis values are reported to the same number of decimal places as two significant 
figures of the reference sample standard deviation, where experimental error allows.113 The 
total mass percentage (% w/w) of compounds with concentrations below the limit of 
detection are displayed in the results tables as ‘-‘. Concentrations above the limit of 
detection but below the acceptable level of significance are displayed as 0, to the 
appropriate order of magnitude. The median values and number of samples above the limit 
of detection are stated for each category, as was suggested by Hornung and Reed,114 to 
represent data containing values close to the limits of detection more accurately. Bias 
estimates of data could otherwise result from reporting the mean and standard deviation in 
this case. Concentrations of compounds below the limit of detection are omitted from 
combined compound total calculations.  
 
Due to limited time and resources, only one extraction per Larix sample was undertaken. 
Therefore, a reference material (Larix_REF) was extracted three times alongside the Larix 
samples for comparison. This Larix decidua Mill. reference sample was collected in 
December 2013 from Bergün in Switzerland (N 46.3748, E 9.450 at 1370 m above sea 
level) by FibL and was previously used in Chapter 3 for the development of extraction 
techniques.  
 
Experimental precision was determined by analysing three reference repeats over two 
batch runs (one sample in the first run and two samples in the second run). This neither 
represented repeatability (analysis over one run in the same period of time) or 
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reproducibility (analysis over multiple runs in the same period of time). Unfortunately, not 
enough repeats were undertaken to determine true repeatability or reproducibility of the 
data due to time and equipment limitations. A high relative standard deviation (RSD) for 
total larixyl acetate (25.3%), larixol (24.7%) and epimanool (24.8%) concentration in 
Larix samples indicates that the results have poor precision (Table 4.1). The level of 
precision was slightly better for the concentration of active compounds in the PE extract 
(larixyl acetate 19.2, larixol 17.6 and epimanool 17.8%). The natural variation of 
compounds within natural products could cause a high RSD, but this cause was thought to 
be mitigated by thorough mixing of samples during milling to achieve a constant sample 
matrix. The most likely reason for a high RSD in this case was variables in the extraction 
method.  
 
Table 4.1:  Levels of precision for larixyl acetate, larixol and epimanool concentrations in 
Larix samples. 
Conc. in Compound Range (% w/w) 
Mean  
(n = 3) 
(% w/w) 
Standard 
deviation 
(% w/w) 
Relative 
standard 
deviation 
(%) 
Larix 
sample 
Larixyl acetate 0.029 – 0.045 0.035 0.009 25.3 
Larixol 0.004 – 0.007 0.005 0.001 24.7 
Epimanool 0.014 – 0.023 0.018 0.004 24.8 
PE 
extract 
Larixyl acetate 5.882 – 8.697 7.357 1.415 19.2 
Larixol 0.849 – 1.177 1.067 0.188 17.6 
Epimanool 2.964 – 4.159 3.720 0.661 17.8 
Conc. = Concentration, PE = Petroleum ether. 
 
Sources of experimental variation include the first filtration stage, as some of bark was 
more absorbent than others and retained solvent and some solvent could also be lost to the 
cotton wool plug or filter paper. This in the future could be overcome by using vacuum 
filtration; gravity filtration was used here as it is the standard practice for liquid products 
and was easier to undertake in the time constraints of the large batch process due to the 
available space and equipment. Equipment margins of error can also contribute to 
experimental error.  
 
While the poor experimental precision of the reference sample must be taken into account 
when analysing the total sample population results, the good level of precision for the 
quantitative analysis (Chapter 2) however remains. There has not been a quantitative study 
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of Larix (particularly L. decidua) samples on this scale reported in the literature before and 
so these results offer a new comparison between a wide range of Larix sources, despite the 
limitations. 
4.3.1.1 The overall levels of larixyl acetate, larixol and epimanool in Larix 
samples  
This section presents the overall results obtained from the analysis of Larix samples. The 
samples were extracted using the method described in section 4.2.2 and the yields of these 
extractions can be seen in Table 4.2. Full results tables for each Larix sample can be found 
in Appendix A4.4 – A4.5 
 
1H Nuclear magnetic resonance (NMR) spectra for the Larix PE extract samples 
(Appendix A4.6) were firstly qualitatively assessed for the presence of larixyl acetate and 
larixol. Typical larixyl acetate resonance peaks can be identified as a singlet at 2.06 ppm 
(H-22) and overlapped resonances (double-doublet for H-17A, double-triplet for H-6) at 
5.07 ppm (see Figure 3.6 in Chapter 3 for an annotated spectrum). A typical larixol 
identifying resonance peak can be found at 3.86 ppm (double-triplet for HC-OH of H-6). 
When assessing the NMR spectra the peaks were either denoted as ‘P’ for the presence of 
a peak or ‘T’ for presence of a peak trace. Trace peaks were assigned when no clear 
identifiable peak was recognised at that resonance.  
 
All peaks assigned as ‘P’ were found to contain a concentration above the analytical limit 
of detection of larixol or larixyl acetate. Both typical larixyl acetate resonances (2.06 ppm 
and 5.07 ppm) were found in most cases (29) where larixyl acetate was present. Larix_32 
was the only exception, where the identifying larixyl acetate peak at 2.06 ppm was found 
to be present (P) but absent (T) at 5.07 ppm. The other 20 samples were assigned as ‘T’ for 
all three resonance peaks. Due to the small concentration of larixol found in the samples, 
only 8 samples were identified as having a peak (P) at 3.86 ppm for larixol. The other 42 
samples were noted as trace peaks (T), even though in some cases the concentration of 
larixol was higher (identified by GC-FID) than in other spectra where a peak was 
identified. This could be due to the unmeasured and so differing concentrations of extracts 
used during NMR spectroscopy analysis. In only one sample (Larix_27), a peak (P) for 
larixol was assigned without a peak for larixyl acetate (T, T). This correlates with 
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Larix_27 being uniquely found to contain a higher quantified larixol concentration 
(0.134% w/w) than larixyl acetate concentration (0.039% w/w). 
 
Primary extraction of the samples with EtOH resulted in an average median extract yield 
of 3.67% (range: 0.54 – 16.75%). These extracts were then extracted with PE, resulting in 
a median extraction yield of 16.12% (range: 1.20 – 81.50%) from the EtOH extract and a 
total extraction yield of median 0.44% (range: 0.07 – 13.65%).  
 
The concentrations of larixyl acetate, larixol and epimanool in the secondary PE extracts 
of Larix samples are illustrated in Table 4.3. Larixyl acetate was found in the highest 
quantity in the PE extract of the Larix samples (median 4.6% w/w, range 0.2 – 33.3% 
w/w), followed by epimanool (median 2.39% w/w, range 0.42 – 10.83% w/w) and then 
larixol (median 0.76% w/w, range 0.05 – 16.57% w/w). The total Larix concentrations 
were calculated from these values, as the concentrations of each compound in the primary 
EtOH extract were too low to calculate directly. 
  
Table 4.2: Median and range of ethanol (EtOH) and petroleum ether (PE) extract yields in 
Larix samples. Number of samples = 50. 
Extract 
Extract yield 
(% w/w from Larix) 
Median Range Interquartile Range 
Primary EtOH 3.67 0.54 – 16.75 2.30 – 5.77 
Secondary PEa 0.44 0.07 – 13.65 0.21 – 0.72 16.12a 1.20 – 81.50a 7.38 – 25.20a 
avalues are% w/w from EtOH extract. 
Table 4.3: Median and range of larixyl acetate, larixol and epimanool concentrations in 
the petroleum ether extract of Larix samples. Number of samples = 50. 
Compound 
Concentration  
(% w/w of Larix sample PEa extract) Number above 
LODb Median Range Interquartile Range 
Larixyl acetate 4.6 0.2 – 33.3 0.7 – 8.2 42 
Larixol 0.76 0.05 – 16.57 0.17 – 1.83  33 
Epimanool 2.39 0.42 – 10.83 0.91 – 3.64 49 
a PE = petroleum ether. b LOD = limit of detection.  
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Figure 4.4: The concentration (% w/w of Larix) of larixyl acetate (circles), larixol 
(squares), epimanool (triangles) and combined larixyl acetate and larixol 
content (diamonds) in Larix samples. The bars represent the median and 
interquartile range of each dataset. 
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An overview of the concentrations of larixyl acetate, larixol, epimanool and (combined 
larixol and larixyl acetate content) in Larix samples are presented in Figure 4.4 and Table 
4.4. Complete datasets for all fifty Larix samples can be found in Appendix A4.4 – A4.5. 
There was great variability in the concentration of larixyl acetate, larixol and epimanool in 
Larix samples. Larixyl acetate (median 0.017% w/w, range 0.000 – 4.544% w/w) was 
found in the highest quantity in the Larix samples, followed by epimanool (median 
0.009% w/w, range 0.000 – 0.752% w/w) and then larixol (median 0.003% w/w, range 
0.000 – 0.578% w/w).  
 
The interquartile range of larixol (0.000 – 0.009% w/w) was close to the lower end of the 
overall range and 17 samples were below the limit of detection for larixol, indicating that 
the general concentration of larixol in Larix was low. Furthermore, in the majority (70%) 
of samples the larixol concentration was found to be the lowest of the three compounds. In 
the other 15 (30%) samples, one (Larix_49) was below the limit of detection for larixyl 
acetate, seven (Larix_07, 15, 16, 24, 25, 34, 41) were below the limit of detection for both 
larixol and larixyl acetate and two (Larix_10 and 29) contained a similar low concentration 
of both larixol and epimanool (0.011, 0.009 and 0.009, 0.008% w/w, respectively). The 
five remaining samples (Larix_ 26, 27, 33 and 46) were found to contain a higher 
concentration of larixol than epimanool and were within the top nine highest combined 
larixyl acetate and larixol concentrations (as shown in Table 4.5a). This is a particularly 
interesting observation, as it is likely that a connection exists between finding a higher 
concentration of larixol than epimanool in Larix and yielding a high combined larixol and 
larixyl acetate content. 
 
Table 4.4: Median and range of larixyl acetate, larixol and epimanool concentrations in 
Larix samples. Number of samples = 50. 
Compound 
Concentration  
(% w/w of Larix sample) Number above 
LODa Median Range Interquartile Range 
Larixyl acetate 0.017 0.001 – 4.544 0.003 – 0.045 42 
Larixol 0.003 0.001 – 0.578 0.000 – 0.009 33 
Epimanool 0.009 0.000 – 0.752 0.005 – 0.023 49 
a LOD = limit of detection. 
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In addition to the previously mentioned samples below the limit of detection above, 
Larix_49 was also below the limit of detection for larixyl acetate. The interquartile range 
for larixyl acetate (0.003 – 0.045% w/w) was reasonably high compared to larixol and 
epimanool. One sample in particular, Larix_30, clearly contained the highest concentration 
of larixyl acetate (4.544% w/w), larixol (0.578% w/w) and epimanool (0.752% w/w), with 
the next highest yielding sample, Larix_48, containing 0.310% w/w larixyl acetate, 
0.227% w/w larixol and 0.203% w/w epimanool. 
 
The median concentration of larixol identified in this study closely matches the findings of 
Pferschy-Wenzig et al., whom isolated larixol (0.003% w/w) and larixyl acetate (1.138% 
w/w) from an n-heptane extract of Larix decidua sawdust, with a 0.5% primary extract 
yield.69 The primary extract yield of their study is also similar to the median secondary PE 
extract yield of the Larix samples (0.44%), which indicates that n-heptane and PE have a 
similar Larix extraction properties. The concentration of larixyl acetate that Pferschy-
Wenzig et al. isolated was higher than the average found in this study (0.017% w/w), but 
within its range.  
 
Epimanool was found in almost all 50 Larix samples, with only one sample (Larix_01) 
having a concentration below the limit of detection. This sample was also below the limit 
of detection for larixol and found to contain a low amount of larixyl acetate (0.002% w/w). 
These results suggest that epimanool is found in nearly all Larix trees, even where larixyl 
acetate or larixol are not present or present in lower concentrations. 
 
The ten Larix samples with the highest combined larixyl acetate and larixol concentrations 
are shown in Table 4.5a and Table 4.5b. The top ten yielding samples (Larix_30, 48, 42, 
27, 33, 18, 26, 28, 46 and 36) were organised from highest to lowest total Larix sample 
concentration (% w/w) of larixyl acetate and larixol combined (Table 4.5a, final column), 
with a range of 0.069 – 5.122% w/w. The concentrations of larixyl acetate, larixol and 
epimanool in the PE extracts (% w/w of PE extract) do not directly match the order of total 
Larix sample concentrations due to the difference in extraction yields between samples. 
Total Larix sample concentration of larixyl acetate and larixol combined was ranked 
instead of PE extract concentration as it represents the overall extractability of the active 
compounds from the Larix samples.  
  
 
 
Table 4.5a: The extract (primary EtOH and secondary PE) yields and concentrations (% w/w of Larix samples and PE extract) for the 10 Larix 
samples with the highest yields of larixyl acetate and larixol. Samples are organised from highest to lowest total concentration of 
larixyl acetate and larixol combined in the Larix samples (final column - highlighted). 
Larix 
sample 
Extract yield  
(% w/w of Larix) Yield of PE 
extract from 
EtOH extract  
(% w/w of 
EtOH extract) 
Concentration in secondary PEa extract  
(% w/w of PE extract) 
Total concentration in Larix sample  
(% w/w of Larix) 
Primary 
EtOH  
Secondary 
PE 
Larixyl 
acetate Larixol Epimanool 
Larixyl 
acetate  
+  
Larixol 
Larixyl 
acetate Larixol Epimanool 
Larixyl 
acetate  
+  
Larixol 
30 16.75 13.65 81.5 33.3 4.23 5.51 37.5 4.544 0.578 0.753 5.122 
48 4.22 1.87 44.4 16.5 12.12 10.83 28.6 0.31 0.227 0.203 0.537 
42 1.89 0.70 36.8 24.8 2.25 5.75 27.1 0.173 0.016 0.04 0.188 
27 4.65 0.81 18.0 4.8 16.57 4.73 21.4 0.039 0.134 0.038 0.172 
33 3.66 0.68 19.1 11.2 0.72 0.72 11.9 0.076 0.005 0.005 0.081 
18 4.58 0.57 12.5 11.3 2.37 5.66 13.7 0.065 0.014 0.032 0.078 
26 5.43 1.12 21.5 3.8 3.03 1.46 6.8 0.042 0.034 0.016 0.076 
28 3.00 0.89 30.6 7.7 0.81 5.69 8.5 0.068 0.007 0.05 0.075 
46 0.67 0.31 45.8 17.8 5.57 4.77 23.4 0.055 0.017 0.015 0.072 
36 3.36 0.60 17.8 9.9 1.55 2.10 11.5 0.059 0.009 0.013 0.069 
EtOH = ethanol. PE = petroleum ether. 
 
 
 
  
 
 
Table 4.5b: The categories (country, latitude, longitude, elevation, tree part, species, primary and secondary level colour) and qualitative 1H 
NMR spectroscopy resonance peaks of the 10 Larix samples with the highest yields of larixyl acetate and larixol combined. 
Larix 
sample Country 
Latitude 
(deg.) 
Longitude 
(deg.) 
Elevation 
a.s.l (m) 
Tree 
part Species Colour  
Other 
observations  
Qualitative 1H NMR Spectroscopy 
Resonance peaksa 
Larixol acetate Larixol 
2.06 (s) ppm 5.07* ppm 3.86 (dt) ppm 
30 Germany 48.35 12.45 470 Wood L. decidua Light Fine chips P P P 
48 Austria 47.12 13.76 1030 Twigs L. decidua Light Fine chips P P P 
42 Austria 47.56 13.99 485 Wood L. decidua Light Large chips P P P 
27 Finland 60.18 24.9 15 Twigs L. gmelinii Mix Green needles T T P 
33 Germany 48.38 12.21 394 Twigs L. decidua Mix Green needles P P T 
18 Germany 48.35 12.13 466 Twigs L. decidua Mix Medium chips P P T 
26 Finland 60.18 24.9 15 Twigs L. gmelinii Mix Green needles T T T 
28 Sweden 59.9 17.6 15 Twigs L. decidua Mix Green needles P P T 
46 Germany 48.35 12.45 470 Wood L. decidua Light Fine chips P P P 
36 Estonia 58.3 26.5 80 Twigs L. decidua Mix Large chips P P T 
 aResonance peaks typical of larixyl acetate and larixol presence. (s) = singlet, * = overlapped resonances (double-doublet for H-17A and double-triplet 
for H-6), (dt) = double triplet. T = peak trace and P = peak.  
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All top ten samples have concentrations of larixyl acetate above 0.050% w/w. The 
concentration of larixol and epimanool however varies between the samples. Larixol 
ranges from 0.005% w/w (epimanool also 0.005% w/w) in Larix_33 (fifth highest 
combined larixyl acetate and larixol content) to 0.578% w/w (epimanool 0.753% w/w) in 
Larix_30, the highest yielding combined larixyl acetate and larixol sample.  
 
It is important to consider the extract yields of the top ten Larix samples, alongside the 
percentage concentration of combined larixyl acetate and larixol, to determine the most 
suitable source of Larix for commercial scale-up. For example, Larix_46 has a reasonable 
combined larixyl acetate and larixol concentration of 0.072% w/w of Larix sample, but a 
very low primary EtOH extraction yield of 0.67% compared to other samples (median 
3.67%). Hence Larix_46 would not make a good source of larixyl acetate and larixol for 
commercialisation because it would require a high amount of starting material for low 
active compound return. In contrast, Larix_30 has a high primary EtOH extract yield of 
16.75% w/w of Larix sample, combined with a high combined larixyl acetate and larixol 
content of 5.122% w/w of Larix sample. A high proportion (81.50%) of the primary EtOH 
extract was extracted into the secondary PE extract, of which 37.522% consisted of 
combined larixyl acetate and larixol. These high extraction yields and active compound 
composition indicate that Larix_30 would be a good source of larixyl acetate and larixol 
for industrial up-scale. Larix_48 contains the next highest total combined larixyl acetate 
and larixol content (0.537% w/w) after Larix_30, with a sufficient 4.22% w/w primary 
EtOH extract yield to be considered for up-scale purposes. The other top ten samples have 
a reasonable range of primary EtOH extract yields (1.89 – 5.43% w/w of Larix sample) 
combined with total larixyl acetate and larixol concentrations (0.069 – 0.189% w/w of 
Larix sample).  
 
The top ten combined larixyl acetate and larixol yielding samples did not give any obvious 
indication of an ideal geographical location source, as they were sampled from several 
countries: Germany (4), Austria (2), Finland (2), Sweden (1) and Estonia (1) (Table 4.5b). 
The elevation of the sample sources also ranged from 15 – 1030 m above sea level, giving 
no initial indication that elevation contributed to a high combined larixyl acetate and 
larixol content. The top ten combined larixyl acetate and larixol yielding sample species 
were found to be L. decidua (8) or L. gmelinii (2).  
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There were no Larix samples categorised as ‘Dark’ or ‘Bark’ identified in the top ten 
highest yielding combined larixyl acetate and larixol sources; the colour of the top ten 
sources were found to be categorised as either ‘Light’ (4) or ‘Mix’ (6). The plant part of 
the top ten samples was found to be categorised as either Wood (3) or Twigs (7).  
 
Explanations of these categories and further analyses of physical and geographical 
attributes of the Larix samples are discussed in sections 4.3.1.3 and 4.3.1.4, respectively. 
Statistical analyses of these attributes can additionally be found in sections 4.3.3.2 and 
4.3.3.3.  
4.3.1.2 The effect of Larix species on concentration  
Four different species of Larix were sampled (Table 4.6): Larix decidua (n = 45), Larix 
gmelinii (n = 3), Larix sibirica (n = 1) and Larix kaempferi (n = 1). The statistical 
differences between species could not be compared to assess the highest yielding species 
in this study due to the low number of samples of species additional to Larix decidua 
received. However, previous studies in the Mulholland research group115 identified Larix 
decidua as one of the highest yielding species of larixyl acetate. This, alongside the ease of 
collecting abundant Larix decidua, was why the majority of the samples received were 
from the Larix decidua species.  
 
Of the three Larix gmelinii samples analysed, only two samples were above the limit of 
detection for larixol (median 0.034% w/w, range 0.034 – 0.134% w/w) and epimanool 
Table 4.6: Median and range of larixyl acetate, larixol and epimanool concentrations 
in Larix samples grouped by species.  
Speciesa n Compound 
Concentration (% w/w of 
Larix) 
Number 
above 
LODb Median Range 
Larix decidua 45 
larixyl acetate 0.014 0.001  – 4.544 38 
larixol 0.002 0.001  – 0.578 30 
Epimanool 0.009 0.000 – 0.753 45 
Larix gmelinii 3 
larixyl acetate 0.039 0.002 – 0.042 3 
larixol 0.034 0.034  – 0.134 2 
Epimanool 0.017 0.017  – 0.038 2 
a Larix kaempferi (n = 1) and Larix sibirica (n = 1) have been omitted from the table 
due to low n values. The concentration of larixyl acetate, larixol and epimanool in the 
samples were 0.018, 0.012, 0.019% and 0.000, 0.000, 0.001%, respectively.  
b LOD = limit of detection. n = number of samples. 
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(median 0.017% w/w, range 0.017 – 0.038% w/w). The sample population was therefore 
too low to make a justifiable comparison with Larix decidua for these compounds. 
However, all three larixyl acetate concentrations were above the limit of detection. The 
median L. gmelinii larixyl acetate concentration of 0.039% w/w (range 0.002 – 0.042% 
w/w) was found to be higher than the median L. decidua concentration of 0.014% w/w 
(range 0.001 – 4.544% w/w, n = 45). Of the forty-five L. decidua samples, all were above 
the limit of detection for epimanool (median 0.009% w/w, range 0.000 – 0.753), compared 
to just 30 for larixol (median 0.002% w/w, range 0.001 – 0.578% w/w) and 38 for larixyl 
acetate. 
4.3.1.3 The effect of geographical distribution of Larix on concentration 
European larch (Larix decidua Mill.) is naturally distributed in the Alps, Sudetes, 
Carpathians and in scattered populations across Poland,116 as illustrated in Figure 4.5. Over 
85% of larch can be found in the Alps, with the other native regions of larch being 
scattered across Eastern Europe.40 
 
Figure 4.5: Plot distribution and simplified chorology map for Larix decidua, adapted 
from Da Ronch et al.51 The frequency of Larix decidua occurrences within 
the field observations as reported by the National Forest Inventories and the 
chorology of native spatial range for L. decidua is derived after Wagner et 
al,117 both interpreted by Da Ronch et al. 
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Sample collection sites were located at saw-mills in regions near Larix forests in Central 
and Northern Europe. Figure 4.6 indicates where Larix was sampled by the University of 
Helsinki. The two clusters of sample sites in Central and Northern Europe represent 
plentiful areas of Larix growth in the native Larix Alpine region around Austria and 
plantations of Larix in southern Finland. The number of divisions in the circles represents 
the number of samples taken from that area.  
 
 
Figure 4.6: The geographical location of Larix samples represented by green circles. 
Divisions of circles represent how many samples were sourced from that 
location. 
 
The sample sites ranged in latitude (median 50.51, range 46.25 – 61.80 deg.) and longitude 
(median 13.99, range 9.40 – 29.31 deg.). The elevation of the sample sites ranged from 10 
– 1175 m above sea level (a.s.l.), with a median of 313 m a.s.l.. The concentrations of 
larixyl acetate, larixol and epimanool found in the samples in relation to latitude and 
longitude are discussed in section 4.3.3.2. 
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The sample sources included six different countries in Europe, with samples from Finland 
(n = 20), Germany (n = 15), Austria (n = 11), Estonia (n = 2), Sweden (n = 1) and Italy 
(n = 1). The results are displayed in Table 4.7. Countries with a number of samples greater 
or equal to two will be discussed here as these sample sizes give a more reliable 
representation of the source. Finland had the lowest overall concentration of larixyl acetate 
(median 0.002% w/w) and larixol (median 0.001% w/w). From the 20 samples originating 
from Finland, only 12 were above the limit of detection for larixyl acetate, 19 for 
epimanool and only 9 for larixol. This is a broad indication that Finnish Larix generally 
does not contain a high amount of larixol or larixyl acetate. Larixol concentration was 
slightly higher in Austria and Germany (0.003% w/w and 0.004% w/w respectively) 
compared to Finland. Estonia contained the highest concentration (median 0.009% w/w), 
although this high value is probably due to the low n-value (n = 2). This reason most likely 
also explains why Estonia has the highest larixyl acetate concentration (median 0.046% 
w/w). However, Germany (n = 15) has the next highest average concentration of larixyl 
acetate, median 0.025% w/w, closely followed by Austria (median 0.020% w/w). This 
observation is consistent with the findings that the highest yielding sample of larixyl 
acetate and larixol, Larix_30, was sourced from Germany and the next highest yielding 
sample, Larix_48 was sourced from Austria. Epimanool concentration was fairly 
consistent across the countries, with Austria containing slightly less (median 0.008% w/w) 
than the others (Estonia median 0.010, Finland median 0.010, Germany median 0.010% 
w/w).  
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Table 4.7: Median and range of larixyl acetate, larixol and epimanool concentrations in 
Larix samples grouped by country of origin. 
Country 
of origina n Compound 
Concentration  
(% w/w of Larix) Number above LODb Median Range 
Austria 11 
Larixyl acetate 0.020 0.004 – 0.310 11 
Larixol 0.003 0.002 – 0.227 9 
Epimanool 0.008 0.001 – 0.203 11 
Estonia 2 
Larixyl acetate 0.046 0.032 – 0.060 2 
Larixol 0.009 0.009 – 0.009 2 
Epimanool 0.010 0.008 – 0.013 2 
Finland 20 
Larixyl acetate 0.002 0.002 – 0.042 12 
Larixol 0.001 0.001 – 0.134 9 
Epimanool 0.010 0.001 – 0.040 19 
Germany 15 
Larixyl acetate 0.025 0.001 – 4.543 15 
Larixol 0.004 0.002 – 0.578 11 
Epimanool 0.010 0.000 – 0.753 15 
aItaly (n = 1) and Sweden (n = 1) have been omitted from the table due to low n values. 
The concentration of larixyl acetate, larixol and epimanool in the samples were 0.022, 
0.004, 0.008% and 0.068, 0.007, 0.051%, respectively. 
b LOD = limit of detection. n = number of samples. 
 
Elevations were assigned into three groups for comparison: low (0 – 300 m a.s.l.), medium 
(301 – 700 m a.s.l.) and high (701 – 1175 m a.s.l.). Table 4.8 illustrates that as the 
elevation in the groups increases, so does the median concentration of larixyl acetate and 
larixol. At low elevation the median concentration of larixyl acetate was found to be 
0.003% w/w, which then increased to 0.023% w/w at medium elevation and 0.029% w/w 
at high elevation. A similar pattern occurs for larixol concentration; at low elevations the 
median concentration of larixol was 0.001% w/w, increasing to 0.005% w/w at medium 
elevation and further rising to 0.007% w/w at high elevation. The concentration of 
epimanool remains constant at low and medium elevations (median 0.009% w/w for both) 
and slightly increases at high elevations (median 0.012% w/w). The significance of these 
results is discussed in section 4.3.3.2. 
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Table 4.8: Median and range of larixyl acetate, larixol and epimanool concentrations in 
Larix samples grouped by elevation. 
Elevation n Compound 
Concentration (% w/w of Larix) Number 
above 
LODa Median Range 
Low  
(0 – 300 m) 25 
Larixyl acetate 0.003 0.002 – 0.061 17 
Larixol 0.001 0.001 – 0.134 13 
Epimanool 0.009 0.001 – 0.040 24 
Medium  
(301 – 700 m) 20 
Larixyl acetate 0.023 0.001 – 4.544 20 
Larixol 0.005 0.002 – 0.578 16 
Epimanool 0.009 0.000 – 0.753 20 
High  
(701 – 1175 m) 5 
Larixyl acetate 0.029 0.004 – 0.310 5 
Larixol 0.007 0.002 – 0.227 4 
Epimanool 0.012 0.001 – 0.203 5 
a LOD = limit of detection. n = number of samples. 
4.3.1.4 The effect of physical appearance of Larix on concentration 
The Larix samples were categorised by their physical appearance or attributes into groups 
based on the tree part they were sampled from and their colour. The results from these 
categories are discussed in this section. 
 
Samples varied in tree part and were categorized by the University of Helsinki (UHEL) 
into three groups (as shown in Table 4.9): twigs (n = 22), wood (n = 11) and bark (n = 17). 
The specific criteria for classification were unknown. Twigs were found to contain the 
highest concentration of larixyl acetate (median 0.041% w/w), larixol (median 0.007% 
w/w) and epimanool (median 0.014% w/w) compared to bark and wood. Bark was 
identified as the lowest yielding group, containing a median of 0.011% w/w larixyl acetate, 
0.001% w/w larixol and 0.006% w/w epimanool. Wood contained a moderate amount of 
larixyl acetate (median 0.018% w/w), larixol (median 0.003% w/w) and epimanool 
(0.007% w/w). 
 
The range of concentrations for each compound were also found to be lower in bark 
(0.001 – 0.025% w/w larixyl acetate, 0.001 – 0.011% w/w larixol and 0.000 – 0.040% w/w 
epimanool) than in twigs (0.013 – 0.310% w/w larixyl acetate, 0.002 – 0.227% w/w larixol 
and 0.001 – 0.203% w/w epimanool) and wood (0.002 – 4.544% w/w larixyl acetate, 
0.001 – 0.578% w/w larixol and 0.001 – 0.753% w/w epimanool), suggesting that there 
were no outstanding high concentrations of active compounds in bark samples. 
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Table 4.9: Median and range of larixyl acetate, larixol and epimanool concentrations in 
Larix samples grouped by tree part. 
Tree 
part n Compound 
Concentration  
(% w/w of Larix) Number above LODa Median Range 
Bark 17 
Larixyl acetate 0.011 0.001 – 0.025 16 
Larixol 0.001 0.001 – 0.011 8 
Epimanool 0.006 0.000 – 0.040 17 
Twigs 22 
Larixyl acetate 0.041 0.013 – 0.310 18 
Larixol 0.007 0.002 – 0.227 17 
Epimanool 0.014 0.001 – 0.203 21 
Wood 11 
Larixyl acetate 0.018 0.002 – 4.544 8 
Larixol 0.003 0.001 – 0.578 8 
Epimanool 0.007 0.001 – 0.753 11 
a LOD = limit of detection. n = number of samples. 
 
The presence of oleoresin was thought to cause difficulties in the milling of some of the 
lighter coloured Larix samples, which stuck to the beater and jammed the mill (Figure 4.7). 
It was thought that some of the lighter coloured Larix samples could contain higher 
quantities of active compounds than other samples and that the colour of the Larix sample 
is an indicator of the concentration of larixyl acetate and larixol. If this were to be true, the 
results could aid in visually selecting high yielding sources of active compounds. The 
samples were therefore sorted by their visual appearance for comparison (Appendix A4.3). 
The samples were sorted into groups (light, dark and mixed) by their overall composition: 
light samples (n = 11) were classified by a predominantly light to golden yellow colour, 
dark samples (n = 16) by a predominantly dark red to brown colour and mixed samples (n 
= 23) by varying light and dark colours. 
 
 
Figure 4.7: Glen Creston cross-beater mill jammed with a Larix sample. 
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The findings based on these groups are displayed in Table 4.10. Dark samples tended to 
have a lower concentration of larixyl acetate and larixol than light and mixed samples, 
yielding a median of 0.011% w/w larixyl acetate, 0.001% w/w larixol and 0.005% 
epimanool. Light samples had the highest larixyl acetate (median 0.021% w/w) and larixol 
(median 0.004% w/w) concentrations compared to the next highest group, but mix samples 
had the highest epimanool concentration (median 0.018% w/w) compared to light (median 
0.007% w/w) and dark samples. It is thought that (light coloured) sawdust, particularly 
from heartwood, contains a high amount of larixyl acetate and this is supported by the 
findings of Pferschy-Wenzig et al.69 The concentration of larixyl acetate and larixol found 
in mix samples (0.018% w/w and 0.003% w/w respectively) was between the 
concentrations found in light and dark samples. The significance of these observations is 
discussed in section 4.3.3.3. 
 
4.3.2 Total content analysis of larixyl acetate, larixol and epimanool in Larix 
The bench extraction method (Section 4.2.2) used in this study was limited by time, 
resources and regulations. The solvents selected for this study (EtOH and PE) were chosen 
due to their environmentally friendly properties and ability to extract the highest quantity 
of active compounds under these constraints (as discussed in Chapter 3). A more suitable 
extraction solvent, such as dichloromethane, may have extracted a higher amount of active 
compounds than the solvents selected (EtOH, PE). Furthermore, Soxhlet extraction, an 
alternative extraction method, is well-known for having a higher recovery of extractable 
compounds from natural products than other extraction methods due to the constant 
Table 4.10: Median and range of larixyl acetate, larixol and epimanool concentrations in 
Larix samples grouped by colour. 
Colour 
category n Compound 
Concentration  
(% w/w of Larix) Number above LODa Median Range 
Light 11 
Larixyl acetate 0.021 0.014 – 4.544 8 
Larixol 0.004 0.002 – 0.578 8 
Epimanool 0.007 0.001 – 0.753 11 
Dark 16 
Larixyl acetate 0.011 0.001 – 0.025 15 
Larixol 0.001 0.002 – 0.011 7 
Epimanool 0.005 0.000 – 0.029 15 
Mix 23 
Larixyl acetate 0.018 0.002 – 0.076 19 
Larixol 0.003 0.001 – 0.134 18 
Epimanool 0.018 0.001 – 0.040 23 
a LOD = limit of detection. n = number of samples. 
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recycling of solvent and application of heat. It is thought that the results from Soxhlet 
extraction would indicate the total recovery of larixyl acetate and larixol from the plant 
material. Therefore, total content analysis of a select group of Larix samples was 
undertaken to determine the absolute highest possible yield of larixyl acetate and larixol 
available. 
 
The five plant samples with the highest total larixol and larixyl acetate content in the PE 
extract from the previous bench-scale extraction study (Larix_27, 30, 42, 46 and 48) were 
chosen for total content analysis. Approximately the same amount of plant material, where 
available, was extracted using a Soxhlet apparatus for comparison. The Soxhlet extraction 
method is described in section 4.2.3 and resulting data are presented in Table 4.11. 
 
Table 4.11: Soxhlet extraction data of the top fivea Larix samples: total extract yields and 
concentrations of larixyl acetate, larixol and epimanool in extracts. The total 
concentration of larixyl acetate and larixol combined in the plant material is 
shown for direct comparison with bench extraction in Table 4.12. 
Larix 
sample 
Mass 
plant 
material 
(g) 
Mass 
extract 
(g) 
Total 
extract 
yield 
from 
Larix 
sample  
(% w/w) 
Concentration in extract (% w/w of extract) 
Larixol Larixyl acetate Epimanool 
Total 
Larixyl 
acetate + 
Larixol 
in extract  
30 60.8 16.4 26.9 2.2 36 6.7 38 
27 71.9 4.7 6.6 14.1 24 3.4 38 
48 65.9 3.7 5.6 9.7 14 9.9 24 
42 67.9 1.9 2.8 2.8 27 5.1 30 
46 70.8 0.6 0.8 4.3 14 4.8 18 
REF 42.3 1.4 3.2 0.9 3 2.0 4 
a The five Larix samples with the highest total larixol and larixyl acetate content in the 
petroleum ether extract resulting from bench extraction (section 4.3.1.1).  
 
A comparison between Soxhlet and bench extraction indicates the difference in 
recoverability of the three compounds using each method, as shown in Figure 4.8 and 
Table 4.12. Soxhlet extraction generally yields a higher quantity of larixol and larixyl 
acetate than bench extraction. The reference sample yield increased by 3.3% using Soxhlet 
extraction. Larix_30 contained the highest quantity of combined larixyl acetate and larixol 
from Soxhlet extraction at 10.15% w/w, which was almost twice the yield of using the 
bench scale extraction method (5.12% w/w). The yield of combined larixyl acetate and 
larixol from Larix_27 using Soxhlet extraction was approximately 4.6 times higher than 
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using bench scale extraction methods. The yields of Larix_42 and Larix_48 were also 
improved by using Soxhlet extraction (12.1 fold and 6.9 fold, respectively). The yield of 
Larix_46, however, remained similar for both bench (0.17% w/w) and Soxhlet (0.15% 
w/w) extraction, which indicates that bench extraction was sufficient to extract all of the 
available larixyl acetate and larixol in Larix_46.  
 
As the sample size was below 10, parametric statistical tests were performed on the data. 
Normality tests on small sample sizes have little power to reject the null hypothesis that 
the data come from a normal distribution, hence small samples always pass normality 
tests118 and so parametric tests are undertaken. It was predicted that Soxhlet extraction 
would result in a higher concentration of larixyl acetate and larixol. Despite the apparent 
large difference in combined larixyl acetate and larixol content of Larix_30 and Larix_27 
between the two methods of extraction, the total percentage larixyl acetate and larixol 
content of the Larix samples was not statistically significantly affected by the extraction 
method used for these 6 samples (Two-way ANOVA, F (1, 5) = 3.794, p = 0.109, n.s.). 
This result however, may be due to the limitation of small sample size, comparison 
between Soxhlet and bench extraction of all 50 Larix samples could provide more 
powerful statistical conclusions of the extraction methods. The pairing of the test was 
effective according to the parametric Pearson correlation coefficient (r = 0.988, p < 
0.0001), which concludes that the two extraction methods are significantly correlated and 
hence both experimental values are expected to vary together; if the extraction percentage 
is high for a particular Larix sample using Soxhlet extraction, the same will be true for that 
sample with bench extraction.  
 
Chapter 4: High yield sources of larixyl acetate and larixol from Larix 
 
 
100 
 
Figure 4.8: Comparison of Soxhlet and bench-scale extraction of the top five Larix 
samples in terms of the total combined larixyl acetate and larixol content. 
 
Table 4.12: Comparison of the Soxhlet and bench-scale extraction of the top fivea Larix 
samples in terms of the yield of combined larixyl acetate and larixol 
extracted. 
Larix sample 
Yield of combined larixyl acetate and larixol from sample  
(% w/w of Larix) 
Soxhlet extraction (48 hour) Bench extraction 
30 10.15 5.12 
27 2.50 0.54 
48 1.31 0.19 
42 0.85 0.07 
46 0.15 0.17 
REF 0.13 0.04 
a The five Larix samples with the highest total larixol and larixyl acetate content in the 
petroleum ether extract resulting from bench extraction (section 4.3.1.1). 
 
The bench-scale extraction was undertaken to determine the highest yielding Larix 
samples sourced from countries in Europe, based on the environmentally friendly 
extraction method using EtOH and PE extraction solvents (determined in Chapter 3) that 
was suitable for industrial use. The extraction method may not have the highest recovery 
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of target compounds (larixyl acetate, larixol or epimanool) as implied by the results in this 
section, but it is a reflection of the quantity of compounds that can be isolated from these 
Larix sources using an environmentally friendly method. 
4.3.3 Statistical evaluations of the Larix samples 
Kolmogorov-Smirnov normality test (see section 6.3.5) evaluation of the distributions of 
all Larix data sets obtained concluded that most of the data sets are not normally 
distributed. Therefore, the data was analysed using non-parametric statistical tests. 
Samples that have concentrations below the limit of detection were assigned a 
concentration value of half that of the limit of detection (LOD/2) to allow for statistical  
comparison with other samples, as suggested by Hornung and Reed.114 Statistical analysis 
was performed using IBM SPSS Statistics software119 version 23.0. These data do not 
follow a Gaussian distribution; therefore, Spearman rank (rs) correlation (see section 6.3.7) 
was used to analyse the linear correlation between two sets of data. Kruskal-Wallis 
statistical tests (see section 6.3.9) were undertaken to assess if there were any significant 
differences between the larixyl acetate, larixol and epimanool medians of three or more 
sample populations. Mann-Whitney U-tests (see section 6.3.8) were performed on each 
pairing of two populations within the same category to identify which groups significantly 
differ in median values and the direction of the difference.  
 
The following sections will evaluate: the relationship between larixyl acetate, larixol and 
epimanool in Larix samples (section 4.3.3.1); the relationship between geographical origin 
of Larix samples and the concentration of larixyl acetate, larixol and epimanool (section 
4.3.3.2); and the relationship between physical characteristics of Larix samples and the 
concentration of larixyl acetate, larixol and epimanool (section 4.3.3.3). 
4.3.3.1 Relationship between larixyl acetate, larixol and epimanool 
There was a strong, positive Spearman’s rank correlation between larixyl acetate and 
larixol concentration (rs = 0.892, P < 0.005), see Table 4.13. There was also a significant 
positive correlation between larixyl acetate and epimanool concentration (rs = 0.577, 
P < 0.005) and larixol and epimanool concentration (rs = 0.613, P < 0.005). As all three 
compounds have a similar structure (only differing by one functional group) and are 
derived from the same biosynthetic pathway,120 it would be expected for them to similarly 
vary in concentration as these results suggest. Larixol is the precursor of larixyl acetate121 
and so it was predicted that these two compounds in particular would have a close 
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relationship. These results mean that the presence of any one of these compounds in a 
Larix sample could be an indicator for the presence of all three compounds.  
 
Table 4.13: Spearman rank correlation coefficients (rS) for the relationship between the 
percentage mass of larixyl acetate, larixol and epimanool in the Larix 
samples. P = probability; significance for correlation at least P < 0.05 using a 
two-tailed test, n = 50. 
Compound  rS Correlation Significance 
Larixyl acetate vs. Larixol 0.892 yes P < 0.005 
Larixyl acetate vs. Epimanool 0.577 yes P < 0.005 
Larixol vs. Epimanool 0.613 yes P < 0.005 
 
4.3.3.2 Relationship between larixol acetate, larixol, epimanool and 
geographical distribution 
Spearman’s rank correlation indicated a significant positive correlation (rs = 0.363, P < 
0.01) in the relationship between larixyl acetate percentage mass in the Larix samples and 
the elevation the samples originated from (Table 4.14). The concentration of larixol and 
epimanool showed no significant correlation with elevation. The Spearman’s correlation 
between the concentration of compounds and the latitude and longitude of their Larix 
source was then assessed. The concentration of larixyl acetate decreases with both 
increasing latitude (rs =-0.446, P < 0.05) and longitude (rs =-0.515, P < 0.005), as does the 
concentration of larixol (latitude: rs =-0.379, P < 0.01 and longitude: rs =-0.391, P < 0.01). 
Latitude and longitude is related to country of origin and so further statistical tests were 
assessed based on country, to determine if this also has a relationship with concentration of 
larixyl acetate or larixol. There was no significant correlation between epimanool 
concentration and latitude or longitude.  
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The median concentration of larixyl acetate in samples sourced at differing elevations was 
found to be significantly different (Kruskal-Wallis, P < 0.01, Table 4.15). There was no 
significant difference found between different elevation groups and larixol or epimanool 
concentrations. 
 
 
Table 4.14: Spearman rank correlation coefficients (rS) for the relationship between 
compound percentage mass in the Larix samples and the latitude, longitude 
and elevation the samples originated from. P = probability; significance for 
correlation at least P < 0.05 using a two-tailed test, n = 50. 
Compound  Geographical variable rS Correlation Significance 
Larixyl acetate 
Latitude -0.446 yes P < 0.05 
Longitude -0.515 yes P < 0.005 
Elevation 0.363 yes P < 0.01 
Larixol 
Latitude -0.379 yes P < 0.01 
Longitude -0.391 yes P < 0.01 
Elevation 0.247 No significant correlation 
Epimanool 
Latitude -0.069 No significant correlation 
Longitude 0.008 No significant correlation 
Elevation -0.017 No significant correlation 
Table 4.15: Median larixyl acetate, larixol and epimanool levels in the Larix samples for 
each elevation group and the Kruskal-Wallis statistical test for the significant 
difference. 
Compound 
Compound median 
(% w/w of Larix sample) 
X2calc Significant? Low 
(0 – 300 m) 
Medium 
(301 – 700 m) 
High 
(701 – 1175 m) 
n 25 20 5 
Larixyl 
acetate 0.003 0.023 0.029 9.341 yes 
P = 0.009 
P < 0.01 
Larixol 0.001 0.005 0.007 4.456 no, P = 0.108 
Epimanool 0.009 0.009 0.012 0.126 no, P = 0.939 
Two-tailed test. Degrees of freedom (d.f) = 2; P = 0.05: X2crit = 5.99; P = 0.01: X2crit = 9.21.  
n = number of samples. 
Table 4.16: Mann-Whitney U test (one tailed) for Elevation. 
Elevation Compound n1 n2 Ucalc Ucrit 0.05 
Ucrit 
0.01 Significant? 
M vs. H Larixyl acetate 20 5 49 25 16 no, P = 0.487 
L = low (0-300m), M = medium (301-700m), H = high (701-1175m). Standardised Mann-
Whitney U-test used when n>20.  n = number of samples. 
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There was no significant difference in the concentration of larixyl acetate found between 
medium and high elevations according to the Mann-Whitney U statistical test (Table 4.16). 
However, it was found that at low elevations the concentration of larixyl acetate was 
significantly lower than medium elevations (P < 0.01, Standardised Mann-Whitney U, 
Table 4.17). Further to this, larixyl acetate showed a significantly higher concentration at 
high elevations compared to low elevations (P < 0.05). These results suggest that larixyl 
acetate concentration increases at higher elevations. The distribution of natural herbivores 
that feed or rely on Larix for breeding could be greater at higher elevations, leading to 
production of more larixyl acetate as a defence. It is thought that damage of trees caused 
by wind, such as wind-felling and root damage caused by swaying, can attract bark beetles 
to breed and so promote the decomposition of those trees.57 Other climatic differences at 
high elevations, such as the prevalence of harsh frost or snow, could also lead to tree 
damage and attract destructive herbivores. Production of larixyl acetate in the oleoresin of 
Larix could therefore play a key defence role against bark beetles at higher elevations, to 
withstand the effects of harsh climatic differences.   
 
The Kruskal-Wallis statistical test for the significant difference (Table 4.18) between 
different country groups shows that the median larixyl acetate and larixol concentrations in 
Larix samples from different countries of origin are significantly different (larixyl acetate: 
P < 0.001 and larixol: P < 0.05). There was however, no significant difference found 
between the country groups and their median epimanool concentration.  
 
Austrian sourced Larix samples were found to have a higher median concentration of 
larixyl acetate (Mann-Whitney U, P < 0.001) and larixol (P < 0.01) than Finnish samples 
(Table 4.19). The median concentrations of larixyl acetate and larixol found in Austrian 
and German samples were not found to be statistically different (Mann-Whitney U). The 
Table 4.17: Standardised Mann-Whitney U test (one tailed) for Elevation 
Elevation Compound n1 n2 Ucalc Zcalc Zcrit 0.05 
Zcrit  
0.01 Significant? 
L vs. M Larixyl acetate 25 20 125 2.856 1.64 2.33 
yes, L < M P = 0.002 P < 0.01 
L vs. H Larixyl acetate 25 5 30 1.81 yes, L < H 
P = 0.037 
P < 0.05 
L = low (0-300m), M = medium (301-700m), H = high (701-1175m). n = number of 
samples. 
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median concentrations of larixyl acetate and larixol were higher in German samples than 
Finnish (Mann-Whitney U, P < 0.01), Larix is not native to Finland.   
 
These data indicate that Finnish samples tend to have a lower concentration of larixol 
acetate and larixol when compared to samples derived from the native Larix countries 
Austria and Germany. These results could indicate the difference between diterpenoid 
concentration of trees grown in native and non-native climates. The natural habitat of 
Larix decidua has geographically different ecotypes in Europe, which show different 
growth rates and other tree characteristics.63 Historic data from Jansen and Geburek’s 
literature survey to determine the cultivation and transfers of European larch suggests that 
native Alpine larch was transferred to Finland through seed trade via Scotland.116 Trees 
Table 4.18: Median larixyl acetate, larixol and epimanool levels in the Larix samples for 
each country group and the Kruskal-Wallis statistical test for the significant 
difference. 
Compound 
Compound median   
(% w/w of Larix) X2calc Significant? Austria Finland Germany 
n 11 20 15 
Larixyl acetate 0.020 0.002 0.025 16.518 yes P = 0.0003 P < 0.001 
Larixol 0.003 0.001 0.004 6.892 yes P = 0.032  P < 0.05 
Epimanool 0.008 0.010 0.010 0.386 no, P = 0.825 
Two-tailed test. Degrees of freedom (d.f) = 2; P = 0.05: X2crit = 5.99; P = 0.01: X2crit = 9.21. 
Italy (n = 1) and Sweden (n = 1) have been omitted from statistical testing due to low n 
values.  n = number of samples. 
Table 4.19: Mann-Whitney U test (one tailed) for Country. 
Country  Compound n1 n2 Ucalc Ucrit 0.05 
Ucrit 
0.01 Significant? 
A vs. F 
Larixyl acetate 
11 20 
33 
69 53 
yes, A > F P = 0.0005 P < 0.001 
Larixol 50 yes, A > F P = 0.006 P < 0.01 
A vs. G 
Larixyl acetate 
11 15 
74 
50 37 
no, P = 0.342 
Larixol 73 no, P = 0.318 
F vs. G 
Larixyl acetate 
20 15 
44 
100 80 
yes, F < G P = 0.0001 P < 0.001 
Larixol 95 yes, F < G P = 0.033 P < 0.05 
A = Austria, F = Finland, G = Germany. n = number of samples. 
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grown in native climates are exposed to common natural predators and hence have adapted 
natural defences to combat these. The suitability of soil, climate and other conditions may 
therefore not be optimised for Larix growth and defence in other areas. 
4.3.3.3 Relationship between larixol acetate, larixol, epimanool and physical 
characteristics  
There was no correlation found between larixyl acetate or epimanool concentration in 
Larix samples and the UHEL categorised tree part the sample was sourced from. There 
was however, a significant difference in larixol concentration between different tree parts 
(Kruskal-Wallis, P < 0.05; Table 4.20). 
 
There was no significant difference found between the concentrations of larixol in bark 
and wood (Table 4.21) and wood and twigs (Table 4.22). Bark was, however, found to 
have a significantly lower concentration of larixol than twigs (Table 4.22, P < 0.01) 
according to the standardised Mann-Whitney U statistical test.  
 
These results suggest that the most efficient source of larixol from Larix would not be 
from bark and that wood and twig sources could provide higher yields of active 
compounds. Diterpenoid compounds and oleoresin are produced in the heartwood of the 
tree and are stored in heartwood resin ducts, in preparation to leach out into the bark to 
provide plant resistance against external pests when required.122 These results indicate that 
the presence of oleoresin-containing compounds in bark is perhaps only a result of 
previous injury to the tree, where oleoresin has been secreted from the heartwood. 
Table 4.20: Median larixyl acetate, larixol and epimanool levels in the Larix samples for 
each tree part and the Kruskal-Wallis statistical test for the significant 
difference.  
Compound 
Compound median 
(% w/w of Larix) X2calc Significant? Bark Twigs Wood 
n 17 22 11 
Larixyl acetate 0.011 0.041 0.018 3.985 no, P = 0.136 
Larixol 0.001 0.007 0.003 6.925 yes P = 0.031 P < 0.05 
Epimanool 0.006 0.014 0.007 3.371 no, P = 0.185 
Two-tailed test. Degrees of freedom (d.f) = 2; P = 0.05: X2crit = 5.99; P = 0.01: X2crit = 9.21. 
n = number of samples. 
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Therefore, increased external environmental pressure could increase the bark content of 
the active compounds.  
Table 4.22: Standardised Mann-Whitney U test (one tailed) for tree part. 
 Tree part Compound n1 n2 Ucalc Zcalc Zcrit  0.05 
Zcrit  
0.01 Significant? 
B vs. T Larixol 17 22 92.5 2.68 1.64 2.33 yes, B < T 
P = 0.003 
P < 0.01 
W vs. T 11 22 106 0.57 No, P = 0.289 
B = bark, T = twigs, W = wood. n = number of samples. 
 
The concentration of larixyl acetate and larixol in Larix samples had no significant 
correlation with colour (light, dark, mix) according to the Kruskal-Wallis statistical test 
(Table 4.23). There was however, a significant difference between the concentration of 
epimanool and colour (P < 0.01). 
Table 4.23: Median larixyl acetate, larixol and epimanool levels in the Larix samples for 
each colour and the Kruskal-Wallis statistical test for the significant 
difference.  
Compound 
Compound median  
(% w/w of Larix) X2calc Significant? Light Dark Mix 
n 11 16 23 
Larixyl acetate 0.021 0.011 0.018 3.747 No, P = 0.154 
Larixol 0.004 0.001 0.003 5.565 No, P = 0.062 
Epimanool 0.007 0.005 0.018 9.936 yes P = 0.007 P < 0.01 
Two-tailed test. Degrees of freedom (d.f) = 2; P = 0.05: X2crit = 5.99; P = 0.01: X2crit = 9.21. 
n = number of samples. 
 
The Mann-Whitney-U statistical test for colour showed that there was no statistical 
indication that light samples have a significantly higher concentration of epimanool than 
dark samples (Table 4.24). There was also no significant difference between the 
concentration of epimanool in light and mixed samples (Table 4.25). However, mixed 
Table 4.21: Mann-Whitney U test (one tailed) for tree part. 
Tree part Compound n1 n2 Ucalc Ucrit  0.05 
Ucrit  
0.01 Significant? 
B vs. W Larixol 17 11 64 57 44 no, P = 0.085 
B = bark, T = twigs, W = wood. Standardised Mann-Whitney U-test used when n > 20. n = 
number of samples. 
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samples had a significantly higher concentration of epimanool (P < 0.001) than dark 
samples.  
 
 
These results suggest that if a source contains a mix of light and dark colour, or green 
needles, then the concentration of epimanool will be high. Larix needles (leaves) were not 
isolated for comparison in this study, however it would be interesting to analyse them in 
future work to identify if they contain a high concentration of epimanool. Tanaka et al. 
extracted 68 mg of larixol from 4.6 kg of Larix kaempferi leaves (0.002% yield) using 
CH2Cl2 as the primary extraction solvent, followed by column chromatography with 
chloroform, ethyl acetate and hexane.70 It is hence possible to extract larixol from leaves of 
Larix species, which indicates the strong possibility of epimanool leaf-extraction. 
  
Table 4.24: Mann-Whitney U test (one tailed) for colour. 
  Compound n1 n2 Ucalc Ucrit  0.05 
Ucrit  
0.01 Significant? 
L vs. D Epimanool 11 16 58 54 41 No, P = 0.072 
L = light, D = dark. n = number of samples. 
Table 4.25: Standardised Mann-Whitney U test (one tailed) for colour. 
  Compound n1 n2 Ucalc Zcalc Zcrit  0.05 
Zcrit  
0.01 Significant? 
L vs. M 
Epimanool 
11 23 105.5 -0.773 
1.64 2.33 
No, P = 0.225 
D vs. M 16 23 69.5 -3.27 yes, D < M P = 0.0004 P <0.001 
L = light, M = mix, D = dark. n = number of samples. 
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4.4 Conclusions 
The primary objectives of this study (objectives 4 and 5 of this thesis) were to quantify 
experimentally the larixyl acetate, larixol and epimanool content in 50 samples of Larix 
raw material from different sources in central and northern Europe, to identify sources of 
Larix with high yields of larixyl acetate and larixol. To achieve these objectives, fifty 
samples of plant material, collected and provided by the University of Helsinki, were 
extracted and analysed qualitatively and quantitatively for the presence of larixol, larixyl 
acetate and epimanool using 1H NMR spectroscopy and GC-FID techniques. 
 
Primary extraction of the Larix samples with ethanol resulted in an average median 
extraction yield of 3.67% (range: 0.54 – 16.75%). Secondary extraction with petroleum 
ether lead to a total extraction yield of median 0.44% (range: 0.07 – 13.65%). In general, 
Larix samples were found to contain a high content of larixyl acetate (median 0.017% 
w/w, range 0.000 – 4.544% w/w), followed by epimanool (median 0.009% w/w, range 
0.000 – 0.752% w/w) and larixol (median 0.003% w/w, range 0.000 – 0.578% w/w). These 
results indicate that there is great variability in the concentration of larixyl acetate, larixol 
and epimanool in Larix and offers compelling evidence that larixyl acetate is found in 
higher quantities than epimanool and larixol in Larix.  
 
One sample, Larix_30, clearly contained the highest concentration (as a percentage of total 
plant material) of larixyl acetate (4.544% w/w), larixol (0.578% w/w) and epimanool 
(0.752% w/w). These high concentrations of larixyl acetate and larixol, combined with a 
high total extraction yield of 13.65%, indicate that Larix_30 is an ideal candidate for 
commercial high-yield extraction. 
 
A secondary objective of this study (objective 6) was to evaluate statistically whether the 
species, geographical location (country of growth, elevation) or physical (tree part, colour) 
properties of the Larix samples affect their larixyl acetate, larixol or epimanool 
concentration.  This was achieved using a variety of statistical tests, including Spearman 
rank correlation, Kruskal-Wallis and Mann-Whitney U tests. Overall, it was found that 
assessing the geographical sources of Larix had a greater impact on identifying 
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correlations with larixyl acetate and larixol concentration than assessing physical 
characteristics. 
 
Finnish samples tend to have a lower median concentration of larixyl acetate and larixol 
when compared to samples derived from the native Larix countries, Austria and Germany. 
A significant positive correlation (Spearman rank, rs = 0.363, P < 0.01) was found between 
larixyl acetate content in the Larix samples and the elevation the samples originated from.  
These results suggest that Larix from native countries and high elevations would contain 
higher amounts of larixyl acetate and larixol. 
 
There was no correlation found between larixyl acetate or epimanool concentration in 
Larix samples and the UHEL categorised tree part, however bark was found to have a 
significantly lower concentration of larixol than twigs (standardised Mann-Whitney U, 
P < 0.01). Mixed samples had a significantly higher median concentration of epimanool 
than dark samples (standardised Mann-Whitney U, P < 0.001), however the concentration 
of larixyl acetate or larixol in Larix samples had no significant correlation with colour 
(light, dark, mix). These results suggest that dark samples tend to have a lower 
concentration of the primary impurity (epimanool) than lighter or mixed samples. 
 
A final question this chapter answered was to determine the absolute total larixol and 
larixyl acetate content of the top five bench-extracted Larix samples. Five of the high-yield 
sources (Larix_27, 30, 42, 46 and 48) were therefore also extracted using Soxhlet 
extraction. Larix_30 contained the highest quantity of combined larixyl acetate and larixol 
from (both bench) and Soxhlet extraction, at 10.15% w/w yield. Additionally, four of the 
five Larix samples extracted, plus the reference sample, increased in active compound 
yield using Soxhlet extraction compared to bench extraction. Statistical tests were 
performed on the data to see if there was any significant difference between the yields of 
the two extraction methods. It was found that the total percentage larixyl acetate and 
larixol content of the Larix samples were not statistically significantly affected by the 
extraction method used for these 6 samples (Two-way ANOVA, F (1, 5) = 3.794, p = 
0.109, n.s.) and that the yields from the two extraction methods were significantly 
correlated (Pearson correlation coefficient, r = 0.988, p < 0.0001). This statistical analysis 
suggests that bench extraction was a good indication of total larixyl acetate and larixol 
content for Larix samples.  
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These findings are of benefit to industrial parties involved in commercialisation of 
Larixyne® as a plant protection product. The results are of direct practical relevance as 
they identify at least two suitable sources for high yield extraction (Larix _30 and Larix 
_48) and suggest the key properties (country and elevation) that should be considered 
when selecting potential Larix raw material sources. The results of this research can also 
be used to calculate the cost-benefit of transporting the Larix sources discussed to an 
extraction facility.  
 
As a result of this study, further research might well be conducted in order to ascertain 
other Larix variables that could be an indication of high larixyl acetate and larixol content, 
such as tree age (Sato et al. suggests that biosynthesis of labdane-type diterpene increases 
with maturity41), height of trunk (diterpenoids were found to be especially abundant in the 
younger tissues at the top of Larix trees by Zule et al.65) or native chorology. This study 
can be used as a foundation to explore other Larix samples of commercial interest, by 
offering a comparative basis for further samples and an indication of the properties that 
have high larixyl acetate and larixol content. 
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Chapter 5: Activity of larixyl acetate and larixol against 
Plasmopara viticola 
5.1 Introduction 
The main aim of the work described in this chapter was to ascertain the activity of larixyl 
acetate, larixol and formulated products of Larix oleoresin extracts (containing larixyl 
acetate and larixol) against the oomycete pathogen, Plasmopara viticola (Berk. & M.A. 
Curtis) Berl. & De Toni (P. viticola). This chapter therefore discusses the results from 
objective 7 of this thesis, which was to determine both the in vitro and in planta activity of 
larixyl acetate, larixol and epimanool against P. viticola and if active, to investigate their 
mode of action. The results of this work are partially presented in publication: Thürig et al 
(Appendix A1.2).123 
 
These results underpin the work undertaken in previous chapters of this thesis because 
without activity, a plant protection product has no purpose. Minimum inhibitory 
concentrations and effective concentration values, calculated from dose response curves, 
can be used to determine the potential of an active compound and compare it to other 
products. Establishing the efficacy of products applied at different time points before 
inoculation was undertaken to understand the persistence of different formulations on 
plants; formulation composition and spray frequency can therefore be adapted to achieve 
the best efficacy when applied in the field.  
 
Preliminary observations on the mode of action of active compounds against P. viticola 
zoospores provided initial knowledge of how formulations could be adjusted to increase 
their rain fastness. All of these components contributed knowledge that was essential to 
improve the commercial formulation of Larixyne® and provide information that was 
required for regulatory purposes and its registration as a plant protection product. 
 
Chapter 1 provides the background literature review of topics discussed in this chapter. 
Chapter 3 describes the most efficient and environmentally-safe methods for the extraction 
of larixyl acetate, larixol and epimanool from Larix by-products (including bark and 
oleoresin). These methods were used to extract pure compounds (larixyl acetate, larixol 
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and epimanool) from Larix plant material, which were then tested for activity. Larix 
oleoresin extracts from Chapter 3 were also formulated into LAR-016 and LAR-042 
formulations; their activity is also discussed in this chapter. 
 
Vitis vinifera var. Chasselas plant seedlings were firstly grown, according to the 
conditions described in section 5.2.1. Stock solutions and P. viticola pathogen inoculum 
were prepared for testing as required (section 5.2.2). The in vitro activity of larixol, larixyl 
acetate, epimanool and Larix oleoresin formulations (methodology in section 5.2.3) was 
assessed by determining the concentrations needed to completely inhibit germination 
and/or activity of zoospores (MIC100) of P. viticola (section 5.3). Further activity tests 
were undertaken in planta (methodologies in section 5.2.4), to determine the dose response 
for larixyl acetate, larixol and a mixture of both in the ratio found naturally in Larix 
oleoresin (section 5.3.2.1) and to determine the effect of formulated product application 
time before disease onset on efficacy (section 5.3.2.2). Preliminary experiments to explore 
the mode of action of larixyl acetate, larixol and epimanool on P. viticola was finally 
explored in section 5.3.3. The results from this chapter are summarised in section 5.4.  
5.2 Experimental  
FiBL (Frick, Switzerland) was the ProLarix project partner organisation responsible for 
activity testing of Larixyne®. All experimental work and analysis presented in this chapter 
was undertaken by the author at FiBL, under the supervision of Dr. Barbara Thürig.  
5.2.1 Plant material 
Potted seedlings of Vitis vinifera var. Chasselas were used in experiments conducted under 
controlled conditions. Individual seedlings were potted into 10 cm pots with approximately 
275 mL peat-rich, pre-fertilised (3 g/L mineral fertilizer, Tardit 3M, Hauert Günther 
Düngerwerke GmbH, Nürnberg, Germany) standard soil (‘Einheitserde Typ 0’, Gebr. 
Patzer GmbH & Co. KG, Sinntal, Germany). Growth conditions were semi-controlled in 
greenhouses; plants were grown at a temperature of 18 – 32 ºC under natural light. 
Additional light was provided where needed with mercury lamps, to allow for a light 
period of 16 hours throughout the year. 
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Figure 5.1: Vitis vinifera var. Chasselas plants ready for experiments. 
 
Seedlings were treated approximately 5 days after potting. All experiments were 
conducted with six replicate plants per product, arranged in a random block design. Six 
plants were selected per product set. Plants were selected as homogenously as possible, as 
pictured in Figure 5.1; the ideal plant had two or three large leaves (2 – 3 days after 
transplanting seedlings into pots), with a third new leaf just growing (most also had two 
cotyledons in the basal cluster).  
5.2.2 Preparation of stock solutions and inoculum 
Stock solutions of each product treatment of larixyl acetate, larixol and epimanool were 
prepared to a concentration of 100 mg/mL in ethanol (EtOH, Sigma-Aldrich, St. Louis, 
Missouri, United States) by dissolving 50 mg in 0.5 mL EtOH in a 50 mL centrifuge tube. 
A 6:1 ratio of the two compounds was also prepared by dissolving 43 mg of larixyl acetate 
and 7 mg of larixol in 0.5 mL EtOH. Material was dissolved into solution using sonication 
and shaking where necessary. 
 
The pathogen tested was Plasmopara viticola PLASVI, an oomycete causing grapevine 
downy mildew. The inoculum was prepared from collected P. viticola sporangia from 
previously infected plants. P. viticola was maintained on grapevine seedlings by weekly 
re-inoculation. This was achieved by washing grapevine leaves, which had visible 
sporangia, in cold distilled water (4 °C, kept cold by placing a beaker in an ice bath). The 
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suspension was stirred on a magnetic stirrer plate at all times to maintain a consistent 
concentration throughout application by keeping the spores in suspension. The sporangia 
were counted with a haemocytometer (0.1 mm depth, 0.0025 mm2, Thoma Celeromics, 
Cambridge, UK). The concentration of the sporangia in the inoculum suspension for in 
vitro testing was 1 x 106 sporangia/mL. The concentration for indoor bioassay screening 
was adjusted using distilled water to 5 x 105 sporangia/mL. These concentrations were 
found to cause reproducible severe disease symptoms in non-treated control plants under 
the same conditions. 
5.2.3 In vitro bioassays 
Larixol, larixyl acetate, a 6:1 ratio of the two compounds and a 1:1:1.6 ratio of larixyl 
acetate, larixol and epimanool were prepared to a concentration of 10 mg/mL in 99.8% 
EtOH from the appropriate stock solution. Two formulations of Larix extracts, LAR-016 
and LAR-042 (Chapter 3, section 3.3.6), were diluted to 10 concentrations serially (1:1) in 
distilled water, to 40 μL/mL and 20 μL/mL respectively. Blank formulations of LAR-016 
and LAR-042 (not containing the active compounds) were used as controls. They were 
serially diluted in distilled water to concentrations of 30 μL/mL and 10 μL/mL 
respectively. 
 
A dilution series was prepared from the solutions of the pure compounds into a 96-well 
dilution plate using a micropipette; 100 μL of solution was diluted with 100 μL distilled 
water in each step to yield test analyte concentrations of: 10,000.00, 5,000.00, 2,500.00, 
1,250.00, 625.00, 312.50, 156.25, 78.13, 39.06 and 10.53 μg/mL. For the EtOH treatment, 
100 μL of 99.8% EtOH was diluted in the same way. 
 
To each well of the test-plate was added 94 μL Evian® water (Évian-les-Bains, France), 6 
μL of each dilution from the series and 20 μL of sporangia solution (inoculum). The total 
volume of each well was 120 μL. This resulted in product concentrations of 500, 250, 125, 
63, 31, 16, 8, 4, 2 and 1 μg/mL. 
 
Plates were left at room temperature and assessed for activity of zoospores under a 
microscope (magnification of 50 – 100) after 1.5 hours. Wells were assigned rankings on 
the spectrum from 0 to 2 according to zoospore activity according to the following criteria: 
0 - no activity (similar to water control); 0.5 - very few zoospores slowly 
Chapter 5: Activity of larixyl acetate and larixol against Plasmopara viticola 
  
 
117 
swimming/floating; 1 - partial activity (about half zoospores swimming); 2 - full activity 
(all zoospores swimming fully). A further activity assessment was undertaken after 3 hours 
from initial preparation. 
Data were log2-transformed to calculate the MIC100 mean and confidence interval values. 
95% confidence intervals (CI) were calculated from transformed data according to 
Equation 5.1. A 95% confidence interval means that you can be 95% certain that the true 
mean of the population is contained within the range of values.124 Data were transformed 
back to the linear scale for presentation and discussion. 
5.2.4 Indoor in planta bioassays 
Plant-pathogen bioassays to determine effective concentrations (EC50 values) of pure 
compounds and experiments to assess the persistence of Larixyne® formulations on plants 
were carried out according to the methods described in this section. Copper based products 
are the standard for treating Plasmopara viticola on grapevine (Chapter 1); therefore, 
products were compared to Cu2+ products to assess their activity. 
 
The highest concentration product solution of larixyl acetate, larixol and a 6:1 combination 
of both was prepared by transferring 0.32 mL of the corresponding stock solution (100 
mg/mL in EtOH) into a 50 mL centrifuge tube and diluting it with 32 mL of distilled 
water. This provided a concentration of 1 mg/mL (0.10% active compound/s). Solutions 
were shaken by hand to allow for dispersion. Subsequent test solutions were then prepared 
through serial dilution of this stock solution (taking 16 mL of previous solution and 
diluting to 32 mL with distilled water) to yield test solutions of compound concentrations: 
0.10%, 0.05%, 0.025%, 0.0125%, 0.00625% and 0.00313% (0.03 – 1 mg/mL). 
 
LAR-016 and LAR-042 are formulations from Larix oleoresin extracts (section 3.3.6.). For 
persistence testing, LAR-016 was prepared to 0.4 and 0.2% formulation concentrations 
(0.10 and 0.05% plant extract) using distilled water. LAR-042 was prepared to 0.2 and 
0.1% formulation concentrations (0.1 and 0.05% plant extract) also using distilled water.  
95% Confidence Interval = 𝑥 ± (1.96 ×  𝑠 × 𝑛−0.5) Equation 5.1: 
95% Confidence interval 
Where 𝑥 = mean MIC100 of the sample, 𝑠 = MIC100 standard deviation, 𝑛 = number of 
experiments. 
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A non-treated, non-inoculated H2O control set (6 plants) was also prepared and analysed 
(only sprayed with distilled water during treatment) to determine if any greenhouse 
infection had occurred. Two inoculated control sets (sprayed with distilled water during 
treatment, followed by inoculation) were also prepared to assess disease severity. Two 
reference sets of Kocide Opti (copper hydroxide, Kocide® OptiTM, DuPont de Nemours, 
Wilmington, DE, USA), one at a high (0.10%) and the other at a low (0.01%) formulation 
concentration (active concentration 0.03 and 0.003% respectively) were also prepared. 
Two sets of dimethylsulphoxide (DMSO) or EtOH treated plants were also tested at 
concentrations of 1.0% and 0.5%. 
5.2.4.1 Application of product and inoculum to plants  
Plants were sprayed with product preparations using an automatic spray cabinet (Larix 
extracts) or an air-assisted hand sprayer (DeVilbiss® Compact MINI HVLP Touch-Up 
Spray Gun) equipped with a spray gun working at 400 kPa of pressure at the nozzle (pure 
compounds). These methods are illustrated in Figure 5.2. Hand-spray was administered at 
arm’s length by holding plant at a 90-degree angle to spray (Figure 5.2). Three bursts of 
spray were used per plant to form a dense layer of small droplets on adaxial and abaxial 
leaf surface. Extra sprays were administered if the leaf coverage was not suitable or the 
spray aim was inaccurate. Plants were left to dry at room temperature for approximately 
two hours before being inoculated. 
 
Figure 5.2: Application of products and inoculum using an air-assisted hand sprayer (left) 
and automatic spray cabinet (right). 
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Inoculum was applied to each plant after the product had dried, between 1 – 4 hours after 
product application for standard in planta bioassays. During persistence testing, inoculum 
was applied 0.5, 2 or 4 days after treatment. Inoculum was prepared immediately before 
application and hand-sprayed on the abaxial surface of each fully developed leaf. Plants 
were inoculated in a random sequence.  
5.2.4.2 Incubation of inoculated plants 
Inoculated plants were subsequently incubated at 20 – 21 ºC in 80 – 99% relative humidity 
(RH) in light for 24 hours. Plants were then sustained at 20 ºC, 60 – 80% RH and a 
16/8 hour day/night light regime until sporulation was promoted (5 – 6 days from 
inoculation) by incubation overnight in the dark at 20 ºC and 80 – 99% RH. Cross-
contamination was not expected to occur in the incubator due to sporulation taking about a 
week to onset after transfer and any secondary or further assessments took place before the 
onset of infection. Plants were then disease assessed. 
5.2.4.3 Disease assessment of plants  
Leaves were disease assessed according to the European and Mediterranean Plant 
Protection Organisation (EPPO) standard continuous percentage scale.125 Disease 
incidence (percentage of leaves with disease symptoms – such as oil spots and/or visible 
sporulation) and disease severity (percentage of leaf area covered by sporulating legions) 
were assessed 6 – 7 days after inoculation. 
 
The cotyledons were not assessed. Additionally, newer leaves (that are waxy and spikier in 
appearance) were also not assessed because they would not have been subjected to product 
or inoculum spraying. Leaves that suffered necrosis were automatically determined to be 
100% infected. Batches were assessed by the same person (either the author or a 
technician) to avoid fluctuations in human error that would cause a difference in 
qualitative results.  
Efficacy = (1 −
DIS𝑖𝑛𝑑
DIS𝑚𝑒𝑎𝑛
)  ×  100 Equation 5.2: 
Efficacy 
Where DISind = disease level of individual plant, DISmean = mean disease level of non-
treated control plants. 
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EC50 = A𝑐𝑜𝑛𝑐 − (
(A𝑟𝑒𝑠𝑝 − 50% max𝑟𝑒𝑠𝑝)  × (A𝑐𝑜𝑛𝑐 − B𝑐𝑜𝑛𝑐)
A𝑟𝑒𝑠𝑝 − B𝑟𝑒𝑠𝑝
) Equation 5.3: 
EC50 
Where 50% max𝑟𝑒𝑠𝑝= 50% of the maximal (100%) response, 
 A𝑟𝑒𝑠𝑝and B𝑟𝑒𝑠𝑝 = closest recorded responses to 50% max𝑟𝑒𝑠𝑝 (A𝑟𝑒𝑠𝑝 > 50%, 
B𝑟𝑒𝑠𝑝 < 50%),  
 A𝑐𝑜𝑛𝑐 and B𝑐𝑜𝑛𝑐= the concentrations at A𝑟𝑒𝑠𝑝and B𝑟𝑒𝑠𝑝. 
Efficacies of products were calculated according to Abbott,126 as per Equation 5.2. 
Efficacies are presented as ‘0%’ in tables where a negative efficacy (disease level lower in 
control) was calculated. The half maximal effective concentration (EC50) response values 
of larixyl acetate, larixol, and 6:1 ratio of larixyl acetate and larixol were calculated 
according to Alexander et al.,127 as per Equation 5.3.  
All data were arcsin-transformed (Equation 5.4) before statistical analysis by one-way 
ANOVA followed by a post-hoc test. Post-hoc Dunnett multiple comparisons tests were 
performed to determine significant differences to the inoculated positive H2O control 
group. Post-hoc Tukey HSD (honestly significant difference) tests were conducted on all 
other possible pairwise datasets. 
5.2.5 In vitro activity testing 
Activity of P. viticola zoospores were examined under microscope after treatment with 
larixyl acetate, larixol and epimanool. The inoculum was prepared approximately one hour 
before experiments were undertaken. The sporangia suspension (19 μL) was pipetted onto 
a microscope slide. An untreated control sample of inoculum (19 μL) was also pipetted 
onto a different area of the same microscope slide to monitor zoospore activity. A dilution 
of pure larixyl acetate or larixol from the dilution series described in section 5.2.3 was then 
pipetted (1 μL) onto the zoospore suspension and mixed using the pipette tip. The resulting 
concentration of active compound in the solution was 63 μg/mL. Zoospore activity was 
then recorded (magnification of 50 – 100) using Jenoptik PROGRES GRYPHAX® 
arcsin-transformation = 𝑎𝑟𝑐𝑠𝑖𝑛√(
DIS
100
)  Equation 5.4: 
Arcsin-transformation 
Where DIS = Disease level in% 
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microscope camera software. A further activity assessment was made 2 hours 15 minutes 
after treatment application. 
5.3 Results and discussion 
5.3.1 In vitro activity of larixol, larixyl acetate and Larix oleoresin formulations 
against Plasmopara viticola 
Minimum inhibitory concentrations (MIC100) of different treatments needed to completely 
inhibit P. viticola zoospore germination and/or activity were calculated in order to 
compare their activity to other plant protection products. Five independent 96-well test 
plate experiments (method in section 5.2.3) were carried out. The raw data for the MIC100 
experiments can be found in Appendix A5.1. 
 
It was suspected that the first set of MIC100 tests were performed on impure material, 
which was isolated during the ForestSpeCs project (Figure 5.3). The impure material had 
different physical characteristics to the >95% pure compounds isolated during this thesis 
work. The impure larixyl acetate was yellow in colour, where pure isolated larixyl acetate 
was crystalline white. The impure larixol was a brown hard paste and pure isolated larixol, 
a white solid. 
 
Figure 5.3: Impure larixyl acetate (left) and larixol (right) isolated during ForestSpeCs and 
used by FiBL for activity testing. 
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However, the results from the MIC100 experiments indicated no large difference between 
the values resulting from pure and impure compounds (Appendix A5.1). In one 
experimental plate (Appendix A5.1 Test plate two), the MIC100 values of both pure and 
impure larixyl acetate and larixol were 4 and 8 μg/mL respectively. Therefore it was likely 
that the impurities that caused discolouration of the impure compounds were only a very 
minor component and so the MIC100 results of pure and impure compounds were combined 
and are displayed in Table 5.1. 
Table 5.1: Minimal inhibitory concentrations (MIC100) of a series of different treatments 
against Plasmopara viticola in in vitro experiments. The MIC100 values of 
LAR-016† and LAR-042† indicate the plant extract concentrations contained in 
the formulations. 
Treatment 
Minimum inhibitory 
concentration (MIC100) (μg/mL) n 
Mean Confidence Interval Lower 95% Upper 95% 
Larixyl acetate 7 4 12 7 
Larixol 16 11 24 7 
Larixyl acetate : Larixol (6 : 1) 10 5 21 5 
Larixyl acetate : Larixol : Epimanool (6 : 1 : 1.6) 8 2 31 2 
Epimanool 13 5 30 3 
LAR-016 † 31 31 31 2 
LAR-042 † 45 6 335 2 
LAR-016 (Blank) 354 179 697 2 
LAR-042 (Blank) 88 11 681 2 
EtOH 210 150 295 4 
† LAR-016 and LAR-042 are formulations from Larix oleoresin extracts (section 3.3.6.) 
 Table 5.1 displays the results of the minimum inhibitory concentrations (MIC100) of 
different products needed to completely inhibit P. viticola zoospore germination and/or 
activity. 95% Confidence intervals (CI) are also presented. EtOH was used to make up the 
stock solutions of the products and so it was also tested for any P. viticola inhibition. 
Unusually, EtOH demonstrated some inhibition of P. viticola in vitro, with a MIC100 of 
210 μg/mL (CI 150:295 μg/mL, n = 4). It is well known that EtOH can disrupt the 
structure and function of fungal cell membranes128 and therefore could contribute to 
inhibition of fungal-related cells such as oomycetes at high concentrations. However, the 
MIC100 of EtOH was higher than most of the products and so thought not to interfere with 
the results from those products. 
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The mean MIC100 of larixyl acetate was 7 μg/mL (CI 4:12 μg/mL, n = 7) and of larixol was 
16 μg/mL (CI 11:24 μg/mL, n = 7). Both of these compounds indicate high in vitro activity 
against P. viticola, with small confidence intervals. 
 
These results show that epimanool had a mean MIC100 of 13 μg/mL (CI 5:30 μg/mL, 
n = 3). This was a positive outcome to observe, as epimanool was easily extracted 
alongside larixyl acetate and larixol from Larix bark and oleoresin (Chapter 3). 
Furthermore, epimanool was difficult to separate from larixol during purification and so if 
it also shows activity against P. viticola then this step might not be required, which could 
potentially save time and money. However, after further activity tests, epimanool did not 
indicate any inhibition of P. viticola at a concentration comparable to estimated amounts in 
LAR-016 formulation (Thürig, personal communication, e-mail, June 30, 2015). 
 
Two different combinations of active compounds in the ratios naturally found in Larix 
oleoresin were also tested to see if any additional synergistic activity resulted. A 
combination of larixyl acetate and larixol (in 6:1 ratio) had a mean MIC100 of 10 μg/mL 
(CI 5:21 μg/mL, n = 5) against P. viticola. Adding epimanool to the mixture (larixyl 
acetate, larixol and epimanool in 6:1:1.6 ratio) resulted in a slightly lower mean MIC100 of 
8 μg/mL (CI 2:31 μg/mL, n = 2). The MIC100 of larixyl acetate was slightly lower than the 
MIC100 of both mixtures, indicating that no synergistic effect occurred by combining 
larixyl acetate with larixol or epimanool. 
 
LAR-042 had a mean MIC100 of 45 μg/mL (CI 6:335 μg/mL, n = 2), containing a 
30 μg/mL equivalent of combined larixyl acetate and larixol, whereas LAR-016 had a 
slightly lower mean MIC100 of 31 μg/mL (CI 31:31 μg/mL, n = 2), containing a 21 μg/mL 
equivalent of the combined active compounds. These two results suggest that lower 
concentrations of LAR-016 could be used in Larixyne® compared to LAR-042.  
 
The ‘blank’ formulation matrix of both LAR-016 and LAR-042 formulations additionally 
showed some signs of inhibition at 354 μg/mL (CI 179:697 μg/mL, n = 2) and 88 μg/mL 
(CI 11:681 μg/mL, n = 2), respectively. This result was unexpected as the blank 
formulations should not have contained any active constituents. It could be that the low 
power of the experimental values (n = 2) contributed to anomalous mean results. 
Conversely, the blank formulation matrices of LAR-016 and particularly LAR-042 could 
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have some activity against P. viticola in vitro. Limited activity of formulation additives in 
vitro is not considered problematic, especially if they are not active in planta. 
Unfortunately, the exact formulation constituents were unknown to the author of this thesis 
and so no direct speculation on specific additive contribution to activity could be made. 
As P. viticola is an obligate parasite, natural zoospore death was expected after at least 
three hours of non-host contact. Experimental test-plate one (Appendix A5.1) was also 
assessed after three hours to see if any further inhibition had occurred. Many more of the 
spores had become inactive; particularly those treated with larixyl acetate, LAR-016 or 
LAR-042. No further inhibition was seen to P. viticola treated with EtOH or a blank LAR-
016 formulation. 
5.3.2 Indoor in planta activity of larixol, larixyl acetate and Larix oleoresin 
formulations against Plasmopara viticola 
Indoor in planta experiments were undertaken to determine the activity of larixol, larixyl 
acetate and Larix oleoresin formulations against P. viticola on grapevine seedlings. 
Confidence intervals were calculated according to Equation 5.1 (section 5.2.3), efficacies 
of products were calculated according to Equation 5.2 (section 5.2.4.3) and half maximal 
effective concentration (EC50) values were calculated according to Equation 5.3 (section 
5.2.4.3). 
5.3.2.1 Dose response 
Pure compounds isolated from Larix turpentine were used to assess the dose response of 
larixyl acetate and larixol on Vitis vinifera var. Chasselas seedlings against Plasmopara 
viticola. A combination of larixyl acetate and larixol was also assessed to see if there was 
any enhanced activity resulting from interaction between the two compounds. These pure 
compounds were artificially mixed in the ratio that they are typically found in Larix 
oleoresin: 6:1. A copper reference (Cu2+) was also tested in each experiment for 
comparison. Full result data sets, including mean severity, incidence, efficacy, standard 
deviations and EC50 calculations can be found in Appendix A5.2 – A5.8.  
 
Two independent experiments (A, B) were undertaken. Non-treated controls were found to 
have mean disease severities of 94 ± 6% (A) and 82 ± 10% (B). Natural variation in 
disease pressure occurred as the experiments were conducted at different times and so 
under slightly different experimental conditions. This resulted in variation between the 
calculated efficacies and EC50 values for each experiment.  
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The efficacy of larixyl acetate reached 98% (A) and 74% (B) at the highest concentration 
tested (1 mg/mL). Further repeat tests were undertaken by FiBL to determine the efficacy 
of larixyl acetate to be ≥ 89% at concentrations of at least 0.5 mg/mL.123 Larixol efficacy 
reached 90% at 1 mg/mL (A) and 78% at the highest concentration tested in experiment B 
(1 mg/mL). Mixtures of larixyl acetate and larixol (6:1) reached very high efficacies of 
86% and 100% (0.5 and 1.0 mg/mL) in experiment A and 82% and 99% (0.5 and 
1.0 mg/mL) in experiment B. Efficacies of Cu2+ (0.03 and 0.003%) were ≥ 80% (A) and ≥ 
90% (B). EtOH was also tested at two concentrations (0.5 and 1%) for efficacy as it was 
used to prepare the stock solutions for products: no efficacy was observed (0 – 8%; not 
significantly different (ns) from the control according to the Dunnett test). 
 
Dose response curves of the data are illustrated in Figure 5.4. The dose response curves of 
a mixture of larixyl acetate and larixol in proportions found in Larix oleoresin (6:1) were 
comparable to the dose response curves of pure larixyl acetate and larixol in individual 
experiments. The half-maximal effective concentration (EC50) response value of larixyl 
acetate was found to be 0.22 mg/mL (A) and 0.69 mg/mL (B). Larixol had EC50 values of 
0.20 (A) and 0.59 (B) mg/mL. The EC50 of the 6:1 mixture of larixyl acetate and larixol 
was 0.21 (A) and 0.30 (B) mg/mL. The EC50 values of larixyl acetate and larixol were 
comparable within individual experiments and the EC50 values of the 6:1 mixture were 
similar to the lowest EC50 values found for larixyl acetate and larixol.  
 
The solubility of pure compounds was very limited in water, due to their unpolar nature. 
However, the availability of pure compounds at the time of testing was too limited to 
develop into a formulation for testing. Therefore, it would be expected that the EC50 values 
reported here are higher than the true EC50 values and that the efficacies stated correspond 
to a lower product concentration than reported. To determine the true EC50 values of pure 
larixyl acetate and larixol in planta, further activity testing of the pure compounds, 
prepared in a formulation that fully dissolves the compounds, is therefore required. 
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Figure 5.4: Dose-response curves of larixyl acetate (LA), larixol (L) and a 6:1 
combination of larixyl acetate and larixol (LA:L) on Vitis vinifera var. 
Chasselas seedlings against Plasmopara viticola. Means and standard 
deviations (n = 6) are represented. Two independent experiments (A, B) 
were carried out and a copper reference (Cu2+) was tested in each 
experiment. Non-treated controls were found to have mean disease 
severities of 94 ± 6% (A) and 82 ± 10% (B). 
(A) 
(B) 
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Further work, reported in Thürig et al., states that the efficacy of Larix oleoresin extract, in 
LAR-016 formulation, reached ≥ 99% at concentrations between 0.5 and 1 mg/mL plant 
extract at very high disease pressures.123 This formulated Larix oleoresin extract efficacy is 
higher than the efficacies reported in this section for pure larixyl acetate and larixol. 
Furthermore, the EC50 of LAR-016 was 0.20 mg/mL, which contained the equivalent of 
0.14 mg/mL combined larixyl acetate and larixol.123 This concentration was lower than the 
EC50 values for the pure larixyl acetate and larixol discussed previously in this section. 
However, the efficacies and EC50 values of the pure compounds (discussed in this section) 
had not been formulated. These results suggest that testing an effective formulation of pure 
larixyl acetate and larixol is needed to determine their in planta activity and EC50 values, 
before comparison with other formulated products. 
5.3.2.2 Persistence testing 
How long a product is active in planta is an important parameter to assess the effectiveness 
of a product. The activity of extracts compared to the length of time between product 
application and pathogen infection would give an indication of the longevity of product 
activity in planta. Two formulations of larch oleoresin extracts (LAR-016 and LAR-042) 
at high (0.10%) and low (0.05%) concentrations were therefore tested for their activity 
against P. viticola on grapevine seedlings when applied at different time points (0.5, 2 and 
4 days) before pathogen inoculation. 
 
Data were arcsin-transformed to normalise variance before analysis129 by one-way analysis 
of variance (ANOVA, section 6.3.10) followed by a post-hoc tests. Post-hoc Dunnett 
multiple comparisons tests were performed to determine significant differences to the 
inoculated H2O control group (α = 0.05). Post-hoc Tukey HSD tests were conducted on all 
other possible pairwise datasets.  
 
All Cu2+ positive reference products, except for one, had significantly higher mean 
efficacies (56 – 99%) than the inoculated H2O control group (Figure 5.5 and Figure 5.6) 
according to the Dunnett multiple comparison test, with probability values ranging from 
P < 0.01 to P < 0.0001. One low concentration (0.003%) Cu2+ product applied two days 
before inoculation had 0 ± 27% efficacy and therefore was not significantly different to the 
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control (Dunnett test, ns). This low efficacy was unexpected as the Cu2+ efficacy of 
products applied much earlier than inoculation (4 days) had high efficacies (56 – 92%).  
 
Figure 5.5: Efficacy of formulated Larix oleoresin extract LAR-016 and Cu2+ reference on 
grapevine seedlings against Plasmopara viticola. Mean disease severity of 
the non-treated control was 61% ± 17%. Mean and standard deviations (n = 
6) are presented. Lowercase letters are shared between data that are not 
significantly different; different lowercase letters indicate significance 
differences between products (P < 0.05). A post-hoc Dunnett test determined 
significant difference from control (* = P < 0.05, ** = P < 0.01, 
*** = P < 0.001, **** = P < 0.0001).  
 
The mean efficacies of LAR-016 applied at different times before inoculation with 
P. viticola are presented in Figure 5.5. LAR-016 applied half a day before inoculation at a 
concentration of 0.1% had the highest overall mean efficacy against P. viticola (97 ± 3%) 
compared to all other LAR-016 products of different concentrations and times before 
inoculation: half a day (0.05%: 70 ± 10% efficacy), two days (0.10% = 46 ± 37%, 0.05% = 
17 ± 2% efficacy) or four days (0.10% = 31 ± 32%, 0.05% = 0 ± 24% efficacy). The mean 
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efficacy of LAR-016 0.1% applied half a day before inoculation was furthermore found to 
be statistically higher than all other times of application according to a Tukey HSD test: 
two days (0.1% P < 0.0001, 0.05% P < 0.0001) or four days (0.1% P < 0.0001, 0.05% P < 
0.0001) before inoculation.  
 
The mean efficacy of high and low concentrations of LAR-016, applied half a day before 
inoculation, were found to be significantly different, according to a post-hoc Tukey HSD 
test (P = 0.0038). The two formulations both had high efficacies, but these results show 
that crop protection from P. viticola using LAR-016 formulation was most effective when 
applied half a day before inoculation (disease onset) at a high active concentration 
(0.10%). 
 
Application of LAR-016 at a lower concentration of 0.05%, also half a day before 
inoculation, yielded the second highest overall mean efficacy of LAR-016 against 
P. viticola. This mean efficacy was not found to be statistically different to the mean 
efficacy of 0.10% LAR-016 applied two days before inoculation (Tukey HSD, ns.) but was 
significantly higher than LAR-016 applied at a lower concentration of 0.05% two days 
before inoculation (Tukey HSD, P = 0.0029) and at two concentrations applied four days 
before inoculation (0.10% P = 0.0387, 0.05% P < 0.0001).  
 
These results suggest that if cost is a priority, a lower concentration of actives (0.05%) in 
LAR-016 formulation can be used to prevent P. viticola if applied half a day before 
disease onset. However, the efficacy of using a lower concentration LAR-016 is lost if 
applied any earlier (two or four days) before disease onset. The more time between 
application of an effective product and disease onset means that less overall repeated 
applications would be needed.  
 
In conclusion, LAR-016 offered significant protection against P. viticola half a day before 
inoculation at both high and low concentrations. However, this efficacy decreased when 
the product was applied any earlier (2 or 4 days) before inoculation. Therefore, LAR-016 
should be applied in the field shortly before infection periods, in order to guarantee 
efficacy of the product. Knowing when to apply the product can be achieved by using 
decision support systems.5,130  
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The Cu2+ control did not show a similar decrease in efficacy when applied at earlier time 
points before inoculation. Therefore, these results show that application of LAR-016 
would need to be repeated more frequently than Cu2+ products. Further research is 
recommended to evaluate if higher concentrations of LAR-016 or LAR-042 can prevent 
the decrease in efficacy when applied at earlier time points before inoculation. 
 
The mean efficacies of LAR-042 applied at different times on grapevine seedlings before 
inoculation with P. viticola are presented in Figure 5.6. Application of high (0.10%) and 
 
Figure 5.6: Efficacy of formulated Larix oleoresin extract LAR-042 and Cu2+ reference on 
grapevine seedlings against Plasmopara viticola. Mean disease severity of 
the non-treated control was 61% ± 17%. Mean and standard deviations 
(n = 6) are presented. Lowercase letters are shared between data that are not 
significantly different; different lowercase letters indicate significance 
differences between products (P < 0.05). A post-hoc Dunnett test determined 
significant difference from control (* = P < 0.05, ** = P < 0.01, 
*** = P < 0.001, **** = P < 0.0001).  
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low (0.05%) concentrations of LAR-042 half a day before inoculation clearly resulted in 
the highest mean efficacies: 79 ± 30% and 71 ± 19%, respectively. The next highest mean 
efficacy was seen in 0.10% LAR-042 applied four days before inoculation (49 ± 24% 
efficacy). No significant difference was found between the mean efficacies of these three 
products according to the three appropriate Tukey HSD tests (ns, ns, ns), however all three 
products were found to be significantly different to the control product according to the 
Dunnett multiple comparisons test (applied half a day before inoculation: 0.10% P < 
0.0001, 0.05% P <0.001 and applied four days before inoculation: 0.10% P < 0.05).  
 
These results indicate that the moderately high efficacy of LAR-042 applied at 0.10% 
concentration four days before disease onset against P. viticola was comparable to LAR-
042 applied at 0.05% and 0.10% concentration half a day before disease onset. Although 
the efficacy of LAR-042 was not very high, the results indicate that an improved 
formulation might contribute to prolonged activity in the field. This could have positive 
implications for customers using the plant protection product because if the activity against 
P. viticola was high four days after application, then Larixyne® would need to be applied 
less frequently. Less frequent applications are beneficial to the customer because it saves 
time, money and energy.  
 
LAR-042 applied half a day before inoculation at 0.10% active concentration was found to 
have a significantly higher mean efficacy than LAR-042 applied at the same concentration 
two days before inoculation (0.10% = 28 ± 27% efficacy; Tukey HSD, P = 0.0045). This 
was surprising, as the same product applied four days before inoculation did show 
comparable efficacy; it would be expected that a product applied two days before 
inoculation would have greater or comparable efficacy to the same product applied four 
days before inoculation. This suggests an anomalous result. However, disease incidence of 
products at this concentration applied two and four days before disease inoculation were 
comparable; plants were arranged in a random order throughout the experiment so that no 
cross-contamination or disease promotion ‘hotspots’ should have affected datasets. The 
Cu2+ control also showed effective disease control when applied two days before 
inoculation at a high concentration (93 ± 9% efficacy). Therefore, the reason for this 
finding is unknown and repeat testing would need to be undertaken during future 
formulation development to determine the underlying factors. 
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LAR-042 at 0.05% concentration, applied half a day before inoculation was also found to 
have a significantly higher mean efficacy than the same concentration applied two days 
before inoculation (Tukey HSD, P = 0.0130). The 0.05% LAR-042 product applied two 
days before inoculation had the lowest efficacy for the LAR-042 formulation; however, the 
low concentration copper control also indicated very low mean efficacy (0%) at this 
application time.  
 
No significant difference was found between Cu2+ 0.03% efficacy and the efficacy of 
0.10% LAR-016 or 0.10% LAR-042 products applied half a day before inoculation. The 
two Larixyne® formulations (0.10% concentration) also did not significantly differ in 
mean efficacy (Tukey HSD, ns) when applied half a day before inoculation. These results 
indicate that LAR-016 and LAR-042 formulations have similar efficacies when applied 
half a day before inoculation.  
 
These findings further strengthen the argument that high concentrations (0.10%) of Larix 
oleoresin extract formulations of LAR-016 and LAR-042 can be as efficient as high 
concentrations of currently used copper plant protection strategies when all are applied 
half a day before disease onset under controlled conditions. However, the efficacy of 
Larixyne® is currently decreased if applied sooner than half a day before inoculation. 
 
LAR-042 was the only formulation to have a significantly different efficacy from the 
control when applied four days before inoculation (Dunnett test, P < 0.05). This finding 
suggests that the LAR-042 formulation has a longer period of efficacy against P. viticola 
than LAR-016, potentially due to more effective leaf adhesion and coverage (increased 
rainfastness). The MIC100 of LAR-016 was slightly lower than LAR-042 (section 5.3), so 
this finding suggests that the LAR-016 formulation could be further improved to increase 
the longevity of its efficacy. 
5.3.3 In vitro activity of larixyl acetate, larixol and epimanool 
Activity of antifungal plant protection products can be classified broadly into two 
mechanisms: direct antifungal activity or indirect antifungal control (such as exclusion of 
pathogen from the host, or induction of host defence response).131,132 If active compounds 
can inhibit P. viticola zoospore activity in vitro, without the presence of a Vitus vinifera 
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host, then it can be inferred that the mode of action of those compounds involves the 
zoospores directly. This would hence mean that they are direct antifungal agents.  
 
Activity of zoospores after treatment with larixyl acetate, larixol and epimanool 
(experimental details in section 5.2.5) were monitored under a microscope and results 
recorded. Video recordings (Appendix A5.9) were started immediately after product was 
applied to the zoospore suspension; hence the video time indicates the time taken from 
product application to zoospore immobility. 
 
Nearly all zoospores treated in vitro with larixyl acetate became immobile after 2.53 min. 
In the video (Appendix A5.9 Larixyl acetate), the slide was repositioned at 2.53 min to 
show the control solution, which had full activity of zoospores swimming. It was thought 
that larixyl acetate could cause disruption to the cell wall of the zoospore. Most of the 
spores moved in straight lines across the suspension before becoming immobile. However, 
some spores appeared to move in small circles before dying; one example of this is 
demonstrated in Video A from 0.01–1.05 min, where a single zoospore moves in a circular 
motion until it becomes immobile and appears to spin in the suspension (clarified in Figure 
5.7). This behaviour would suggest that something from the zoospore propelled it in one 
direction. Release of cell contents, caused by damage to the cell wall, could be the reason 
for this erratic movement. 
 
Figure 5.7: Inhibition of P. viticola zoospores using larixyl acetate (63 μg/mL), as seen in 
the video of larixyl acetate activity (Appendix A5.9 Larixyl acetate). A single zoospore 
(circled in green) can be seen to demonstrate circular movement from 0.01 min, before 
stopping at 1.05 min, where it appears to spin in place. 
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Around 2.13 min after treatment with larixol, zoospores were visibly slower and some had 
stopped moving (Appendix A5.9 Larixol). At 3.33 min, nearly all zoospores were 
immobile. The slide was repositioned at 5.03 min to show the control solution, which had 
full activity of zoospores (all zoospores swimming fully).  
After 4.47 min from initial treatment with epimanool, very few zoospores were still 
swimming (Appendix A5.9 Epimanool). The slide was repositioned at 10.02 min to show 
the control solution, which had full activity of zoospores. One clear inhibition of zoospore 
movement can be seen from 3.09 – 3.50 min (clarified in Figure 5.8), where the zoospore 
enters the frame from the centre-bottom and swims upwards until it becomes immobile. 
 
Larixyl acetate, larixol and epimanool have demonstrated inhibition of P. viticola oospores 
in vitro, without a host present. These results therefore indicate that larixyl acetate, larixol 
and epimanool are direct antifungal agents against the P. viticola pathogen.  
5.4 Conclusions 
This chapter determined the in vitro and in planta activity against Plasmopara viticola of 
larixyl acetate, larixol, epimanool and formulated products of Larix extracts (objective 7 of 
this thesis). Economically viable plant protection products based on plant extracts require 
high activity of the active compound at low concentrations. Satisfactory results 
demonstrating this for larixyl acetate and larixol were obtained through the research 
presented in this chapter. 
 
 
Figure 5.8: Inhibition of P. viticola zoospores using epimanool (63 μg/mL), as seen in the 
video of epimanool activity (Appendix A5.9 Epimanool). A single zoospore (circled in 
green) can be seen to enter the frame at 3.09 min from center-bottom (left) and then move 
upwards, finally stopping at 3.50 min (right). 
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In vitro activity was established by assessing MIC100 values. The mean minimal 
concentrations of larixyl acetate and larixol needed to completely inhibit zoospore activity 
were low (7 and 16 μg/mL, respectively). In addition, LAR-016 and LAR-042 
formulations of Larix oleoresin extracts also had low mean MIC100 values of 31 and 45 
μg/mL (containing 21 and 30 μg/mL larixyl acetate and larixol combined, respectively). 
Combining larixyl acetate with larixol or epimanool did not result in a lower MIC100 than 
larixyl acetate alone, indicating that no proof of synergistic effect on activity could be 
identified between these compounds.  
 
The dose responses of larixyl acetate, larixol and a mixture of both compounds in the ratio 
naturally found in Larix oleoresin (6:1) were identified in planta. Larixyl acetate and 
larixol showed high in planta (Vitis vinifera var. Chasselas) efficacies against P. viticola 
under semi-controlled conditions, at low concentrations (EC50 0.2 – 0.7 mg/mL).  
 
Formulated products of Larix oleoresin extracts, LAR-016 and LAR-042, were assessed 
for their efficacy at different application times in planta before inoculation. Crop 
protection of grapevine seedlings from P. viticola was most effective when using LAR-016 
and LAR-042 formulations applied at high concentration (0.10%), half a day before 
disease onset (97 ± 3% and 79 ± 30% mean efficacy, respectively). The high efficacies of 
these organic products were comparable to each other and to Cu2+ efficacy at the highest 
concentration (0.03%), which demonstrates their potential as a plant protection product to 
reduce Cu2+ use.  
 
Furthermore, the efficacy of LAR-016 generally declined as the time between application 
and inoculation increased. In contrast, LAR-042 was the only formulation that had a 
significantly different efficacy from the control when applied four days before disease 
onset. This finding suggests that LAR-042 has a longer period of efficacy against 
P. viticola than LAR-016, which supports the idea that improving the formulation of 
Larixyne® can increase its persistence on plants and hence activity.  
 
The potential mode of action of larixyl acetate, larixol and epimanool against P. viticola 
activity was determined by exploring the in vitro interaction of compounds with P. viticola 
oospores microscopically. These compounds demonstrated inhibition of zoospores in vitro 
without a host present, and so demonstrated direct antifungal activity. Furthermore, larixyl 
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acetate was the quickest to inhibit zoospore mobility (2.53 min), followed by larixol 
(3.33 min) and epimanool (4.47 min). These results provide further evidence that larixyl 
acetate provides the best activity against P. viticola from compounds extracted from Larix. 
 
The effective concentration of Larix extracts (0.1%) and its active compounds larixyl 
acetate and larixol were comparable to other plant extract concentrations previously 
identified in the literature. Juncus effusus (common rush) extract and its active ingredient 
dehydroeffusol had mean EC50 values of 1.23 and 0.18 mg/mL respectively and mean 
MIC100 values of 24 and 4 μg/mL respectively.28 An extract of Inula viscosa (false 
yellowhead) leaves provided effective protection at 0.125 – 1% concentration on plants,32 
alongside extracts of Abies sibirica (Siberian fir, 0.1 – 1%), Melaleuca alternifolia 
(narrow-leaved tea-tree, essential oil, 0.1 – 1.5%), Quillaja saponaria (soapbark, 0.1 – 1%) 
and Yucca schidigera (Mojave yucca, 0.1 – 1%).12 Most of these other plant extracts were 
found not feasible for commercial production due to their subsequent phytotoxicity, high 
cost or low availability.12 
 
Other plant extracts required much higher concentrations for activity against P. viticola. 
Glycyrrhiza glabra (liquorice) crude extract had an EC50 of 1% on cucumbers30 but 5% on 
grapevine.12 Dagostin et al. also found that extract concentrations of 5% Rheum 
rhabarbarum (rhubarb) and 1 – 2.5% Solidago virgaurea (European goldenrod) were 
required for activity on grapevine.12 Salvia officinalis (sage) extract was also effective at a 
higher concentration of 5%.29 
 
In summary, the research presented in this chapter shows that larixyl acetate, larixol and 
formulations containing these two compounds are valid contenders to reduce and 
potentially replace the use of copper in organic vineyards. The findings from this chapter 
of work were used to protect the intellectual property relating to the innovation of using 
larixyl acetate and larixol to treat P. viticola. They also contributed to the data 
requirements for active substances (Regulation (EC) No 283/2013)133 and plant protection 
products (Regulation (EC) No 284/2013)72 needed to place a plant protection product 
(Larixyne®) on the market (Regulation (EC) No 1107/2009)47. 
 
As a result of this study, further research is already in progress by ProLarix partners to 
improve the formulations of Larix extracts to meet the required product activity. Further 
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investigation into the application time before inoculation and rain fastness of Larixyne® 
on field plants is also underway. It is hoped that this research will also serve as a base for 
future studies into understanding the exact mode of action of active compounds on P. 
viticola, which could lead to improved Larixyne® formulations or open up opportunities to 
develop more effective synthetic derivatives of larixyl acetate or larixol for non-organic 
plant protection purposes. 
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Chapter 6: General experimental techniques 
This chapter describes the general experimental techniques undertaken during the work 
discussed in this thesis. Specific experimental procedures undertaken to produce the results 
described in each chapter are presented within that chapter. 
6.1 Separation techniques 
Separation of crude extracts was undertaken using both gravity and flash column 
chromatography. 
6.1.1 Thin layer chromatography 
Thin layer chromatography was used to identify the success of extractions and separations. 
Fractions and compounds of interest were spotted onto aluminium backed 0.2 mm silica-
gel plates (Merck Art. 5554) and separated using an eluent of appropriate polarity, 
achieved by using a ratio of solvents (including MeOH, CH2Cl2 and diethyl ether). 
Developed plates were visualised using p-anisaldehyde spray reagent (1.5% p-
anisaldehyde, 2.5% conc. H2SO4, 96% cold MeOH) under heat. UV-active compound 
spots were visualised under UV light. 
6.1.2 Column chromatography 
Large (ᴓ 6 cm) gravity columns were prepared using Merck Art. 9385 silica gel (Sigma 
Aldrich, St. Louis, Missouri, United States) to separate crude extracts of Larix bark. Two 
different solvent systems were used: CH2Cl2 and hexane. The CH2Cl2 column solvent 
system started at 20% CH2Cl2 to hexane, with the concentration of CH2Cl2 gradually 
increased to 100% over 4 L of eluent. MeOH was then used to flush the system of any 
remaining compounds. The hexane column had an initial solvent system of 1% ethyl 
acetate to hexane and the concentration of ethyl acetate was gradually increased to 100% 
over 6.5 L of eluent. Fractions between 50 – 150 mL were collected and analysed using 
thin layer chromatography (previous section). 
 
Further separation of fractions containing larixyl acetate, larixol and epimanool were 
undertaken to isolate pure compounds. This was achieved using a series of smaller gravity 
columns (ᴓ 1 cm) packed with Sephadex® LH-20 (Sigma Aldrich, St. Louis, Missouri, 
United States) with 100% CH2Cl2. Small fractions (1 – 2 mL) were collected and analysed 
using thin layer chromatography and 1H NMR techniques. 
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6.1.3 Flash chromatography 
A Reveleris® X2 Flash Chromatography System (W.R Grace & Co., Columbia, United 
States) was used for separation of crude and purified extracts. The flash system offers 
benefits of speed and autonomy over gravity chromatography. The Reveleris® system 
used both evaporative light scattering (ELS) and UV detectors (211, 254 nm) to identify 
the different compounds. These were automatically collected into 23 mL fractions. 
Samples were either dry packed directly onto the silica column (120 g column), or 
introduced to the column by liquid injection (20 g cartridge). The solvent system used to 
separate crude extracts is presented in Table 6.1. 
 
Table 6.1: The solvent system used to separate crude extracts using a Reveleris® X2 Flash 
Chromatography System 
Time (min) Solvent system Solvent composition over time 
0 – 3 Hexane 100% 
4 – 6 Hexane: CH2Cl2 Gradient elution to 80:20 
7 – 9 Hexane: CH2Cl2 80:20 
10 – 13 Hexane: CH2Cl2 Gradient elution to 50:50 
14 – 17 Hexane: CH2Cl2 50:50 
18 – 27 Hexane: CH2Cl2 Gradient elution to 100% CH2Cl2 
28 – 37 CH2Cl2 100% 
38 – 47 CH2Cl2:ethyl acetate Gradient elution to 98:2 
48 – 52 CH2Cl2:ethyl acetate 98:2 
53 – 57 CH2Cl2:ethyl acetate Gradient elution to 80:20 
58 – 72 CH2Cl2:ethyl acetate 80:20 
Pure standards of larixol and larixyl acetate were further collected by using the following 
solvent conditions: 0-10 min gradual change of 100% CH2Cl2 to 80:20% ethyl acetate, 
then 20 minutes at CH2Cl2:ethyl acetate 80:20%. The fractions were further purified using 
gravity column chromatography, as described above. 
6.2 Identification techniques 
6.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR analysis was carried out on a 500 MHz Bruker AVANCE NMR spectrophotometer 
(Bruker Corporation, Billerica, United States) at the University of Surrey. Chemical shifts 
were reported in ppm (G) and coupling constants (J) were measured in Hz. Samples were 
submitted in either deuterated chloroform (CDCl3) or MeOH (CD3OD). Resulting spectra 
were referenced to the according solvent peaks: δH 7.26, δC 77.23 for CDCl3 and δH 4.87, 
δC 49.15 for CD3OD in respect to the internal standard tetramethylsilane (0 ppm). 1D 
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analysis was undertaken for all isolated compounds of interest for identification purposes. 
2D analysis was undertaken to verify the purity of epimanool, larixol and larixyl acetate 
standards. Full 1H and 13C spectra and resonances for larixol, larixyl acetate and epimanool 
can be found in Appendix A6.1 – A6.7. 
6.2.2 Gas-Chromatography Mass-Spectroscopy (GC-MS) 
Gas-chromatography mass-spectrometry (GC-MS) techniques were used to identify key 
components of extracts and pure compounds. Samples were prepared in either MeOH 
(HPLC grade, Sigma Aldrich, St. Louis, Missouri, United States) or CH2Cl2 (Sigma 
Aldrich). Larixyl acetate, larixol and epimanool in samples were identified by the NIST 
library.103 Peak retention times were also cross-referenced to reference samples of the 
compounds (external standards). 
6.2.2.1 GC-MS method for the analysis of CH2Cl2 and MeOH Larix bark 
Soxhlet extracts 
GC-MS analysis was performed on an Agilent Technologies 7890A GC-system equipped 
with a Zebron ZB5MS, 30 m x 0.25 (i.d.) mm, column and Agilent Technologies 5975C 
inert XL EI/CI MSD with triple axis detector. Helium was used as the carrier gas, 
(1 mL/min), with an inlet temperature of 280 °C. Split injection was used (split ratio of 
15:1 with a split flow of 15 mL/min, septum purge flow of 3 mL/min and total flow 
19 mL/min) with an injection volume of 2 µL (10 µL syringe). The oven temperature was 
programmed as follows: 50 °C held for 3 min, 50 to 250 °C at 10 °C/min and held at 
250 °C for 2 min to give a total run time of 25 min. There was a solvent delay of 4 min. 
The retention times using this method were 24.44 min for larixyl acetate, 23.64 min for 
larixol, and 21.52 min for epimanool. 
6.2.2.2 GC-MS method for the analysis of Larix oleoresin and other samples 
GC-MS analysis was performed on an Agilent Technologies 7890A GC-system equipped 
with a Zebron ZB5MS, 30 m x 0.25 (i.d.) mm, column and Agilent Technologies 5975C 
inert XL EI/CI MSD with triple axis detector. Helium was used as the carrier gas, 
(1 mL/min), with an inlet temperature of 280 °C. Split injection was used (split ratio of 
50:1 with a split flow of 50 mL/min, septum purge flow of 3 mL/min and total flow 
54 mL/min) with an injection volume of 2 µL (10 µL syringe). The oven temperature was 
programmed as follows: 50 °C held for 3 min, 50 to 250 °C at 10 °C/min and held at 
250 °C for 12 min to give a total run time of 35 min. There was a solvent delay of 3 min. 
The retention times using this method were 23.90 min for larixyl acetate, 23.07 min for 
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larixol, and 21.13 min for epimanool. GC-MS spectra for pure (> 95%) reference standards 
of larixyl acetate, larixol and epimanool and their MS peaks can be found in Appendix 
A6.8 – A6.11. 
6.2.3 Ultraviolet-visible (UV-Vis) spectroscopy 
Ultraviolet-visible (UV-Vis) spectroscopy was undertaken to determine the appropriate 
wavelength to detect the compounds of interest, using a Biochrom Libra S60 
spectrophotometer, version 5504 V1.0.3 (Biochrom Ltd., Cambridge, UK). Samples were 
scanned for absorbance from 190.0 nm to 500.0 nm in 1.0 nm steps using a quartz cell with 
1 cm path-length. 
6.3 Statistical analyses of analytical results 
The following statistical analyses were used to evaluate the data in this thesis. All 
statistical analysis was undertaken using either IBM SPSS Statistics software119 for 
Windows version 23.0 (IBM Corp., Armonk, USA) or GraphPad Prism version 7.0c for 
Mac OS X (GraphPad Software, La Jolla, United States). The critical level for rejection of 
the null hypothesis was taken to be a P value of 0.05, with values below this considered to 
be statistically significant.  
6.3.1 Mean  
The arithmetic mean is a measure of the average value of a sample size. It is calculated 
from the sum of all measurements, divided by the number of measurements (Equation 
6.1).134 
𝑥 =  
∑ 𝑥𝑖
𝑛
 Equation 6.1: 
Mean 
Where 𝑥 = arithmetic mean of the sample, 𝑛 = number of samples. 
6.3.2 Median 
Median values are often used in non-parametric statistics, instead of the arithmetic mean. 
To calculate the median for a number of observations (𝑛), they are first arranged in 
ascending order. If 𝑛 is odd, then the median is the value of the 1
2
(𝑛 + 1)th observation. If 
𝑛 is even, then the median is the average of the 1
2
𝑛th and the 1
2
(𝑛 + 1)th observations.134 
 
Chapter 6: General experimental techniques 
 
  
 
143 
6.3.3 Standard deviation 
The spread of values was measured using standard deviation, s, which takes into account 
all values. The standard deviation of a population, 𝜎 (Equation 6.2), is estimated without 
bias by the standard deviation of a measured sample, 𝑠 (Equation 6.3).134 
𝜎 = √∑(𝑥𝑖 − 𝜇)
2/𝑛
𝑖
 Equation 6.2: 
Standard deviation of a population 
𝑠 = √∑(𝑥𝑖 − ?̅?)
2/(𝑛 − 1)
𝑖
 Equation 6.3: 
Standard deviation of a sample 
Where s = standard deviation, 𝜎 = population, 𝜇 = measured mean of a population, 
𝑛 = number of samples.  
The measured mean of a population, 𝜇, is the true value if there are no systematic errors.  
6.3.4 Relative standard deviation 
The relative standard deviation (RSD) is also known as the coefficient of variation (CV) 
and is a calculation of the relative error (Equation 6.4), which can be used to compare the 
precision of results with different units or magnitudes.134 
𝑅𝑆𝐷 = 100 𝑠/?̅? Equation 6.4: Relative standard deviation 
Where 𝑥 = arithmetic mean of the sample and s = standard deviation 
6.3.5 Kolmogorov-Smirnov goodness-of-fit test 
The Kolmogorov-Smirnov goodness-of-fit method can be used to test for normality of 
continuous distributions. The original data is first transformed into the standard normal 
variable (𝑧) using Equation 6.5, before applying the Kolmogorov-Smirnov method.134 
𝑧 =
𝑥 − 𝜇
𝜎
 Equation 6.5: 
Kolmogorov-Smirnov goodness-of-fit 
Where 𝜇 = measured mean of a population, 𝜎 = standard deviation of 𝑥. 
The sample cumulative distribution function is then compared with the cumulative 
distribution function of a hypothesized Gaussian distribution and the test statistic is based 
on the largest vertical difference between the functions.134 The null hypothesis that the data 
follow a specified (normal) distribution is rejected if the test statistic is greater than the 
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critical value (derived from critical value tables) at the chosen significance level (two-
tailed test at P = 0.05).135  
6.3.6 Pearson correlation coefficient 
Pearson correlation evaluates the liner correlation between two variables (Equation 6.6) 
and assumes that both coordinate values are sampled from populations that have Gaussian 
distributions.136  
The correlation coefficient, rp, represents the direction and degree of the correlation and is 
assigned on a scale of -1 to 1. An rp value of 1 indicates a perfect correlation; the two 
variables increase or decrease together. An rp value of -1 indicates a perfect inverse 
correlation; as one variable increases, the other decreases. An rp value of 0 indicates that 
there is no linear correlation between the variables. Other positive values on the scale 
indicate the tendency for the variables to increase or decrease together, and negative values 
indicate the tendency for one variable to increase as the other decreases.  
6.3.7 Spearman rank correlation coefficient 
Spearman correlation is similar to Pearson correlation, but it does not assume the 
distribution of the sampled population.136 Spearman rank correlation is a nonparametric 
correlation coefficient that measures the strength and direction of monotonic association 
between two variables. The variables are first converted from absolute values to ranks 
(from lowest to highest), where tied ranks are averaged. The differences, di, between ranks 
are then calculated for each data point. The correlation coefficient, rs, is calculated 
according to Equation 6.7 for datasets with no tied ranks and Equation 6.8 for tied-rank 
datasets.  
𝑟𝑝 =
∑ [(𝑥𝑖 − ?̅?)(𝑦𝑖 − ?̅?)]𝑖
√[∑ (𝑥𝑖 − ?̅?)2𝑖 ][∑ (𝑦𝑖 − ?̅?)2𝑖 ]
 Equation 6.6: 
Pearson correlation coefficient 
𝑟𝑠 = 1 −
6 ∑ 𝑑𝑖
2
𝑛(𝑛2 − 1)
 Equation 6.7:  
Spearman correlation coefficient (no tied-ranks) 
𝑟𝑠 =
∑ (𝑥𝑖𝑖 − ?̅?)(𝑦𝑖 − ?̅?)
√∑ (𝑥𝑖𝑖 − ?̅?)2 ∑ (𝑦𝑖𝑖 − ?̅?)2
 Equation 6.8: 
Spearman correlation coefficient (tied-rank)  
Where di = the difference in paired ranks, n = number of cases, i = paired score. 
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Similar to Pearson correlation coefficient values, the Spearman correlation coefficient, rs, 
is assigned on a scale of -1 to 1. However, Spearman correlation values represent the 
direction and degree of monotonic correlation. 
6.3.8 Mann-Whitney U-test 
The Mann-Whitney U-test is a non-parametric test used to compare medians of two 
unpaired groups. It is used to test the null hypothesis that two groups come from the same 
population (have the same median) or if observations in one group tend to be larger than 
observations in the other. Values are firstly ranked from lowest to highest, independent of 
which sample group they are in. If ties occur (same value) then each tie is assigned an 
average rank value.134 Ucalc is then calculated according to Equation 6.9. The null 
hypothesis is rejected if the Ucalc value is less than or equal to the critical value (Ucrit) at a 
specified significance level (from critical values tables) and so the two groups are 
concluded to come from different populations and have significantly different medians. 
The Mann-Whitney U-test critical values table only extends to n = 20. When groups have 
sample sizes greater than 20, U is considered to be normally distributed and must be 
converted to a standardised value (Z) using Equation 6.10.137 Conversely to the 
comparison of Ucalc/Ucrit values, if Zcalc is greater than the critical value of Z (Zcrit) then the 
null hypothesis is rejected and the two groups are concluded to have significantly different 
medians. 
𝑍 =
𝑈 − 𝑚𝑈
𝜎𝑈
 
Equation 6.10: 
Standardised Mann-Whitney U-test 
 
 
 
Where 𝑚𝑈= mean and 𝜎𝑈= standard deviation: 
𝑚𝑈 =  
𝑛1𝑛2
2
       𝜎𝑈 = √
𝑛1𝑛2(𝑛1 + 𝑛2 + 1)
12
 
𝑈𝑐𝑎𝑙𝑐 = 𝑛1𝑛2 +
𝑛2(𝑛2 + 1)
2
− 𝑅2 Equation 6.9: Mann-Whitney U-test 
Where group one has the smaller sum of ranks (R), 𝑛1 = sample size for group one, 𝑛2 = 
sample size for group two, 𝑅2 = group two sum of ranks. 
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6.3.9 Kruskal-Wallis test 
The Kruskal-Wallis test is a non-parametric test used to compare medians of three or more 
groups. Values are firstly ranked from lowest to highest, independent of which sample 
group they are in. If ties occur (same value) then each tie is assigned an average rank 
value. The chi-squared statistic (𝑋2) is then determined according to Equation 6.11. 
This calculated value is then compared to critical 𝑋2 values at a particular significance 
level, where the degrees of freedom are k – 1. The null hypothesis, that the medians of the 
groups are not significantly different, is rejected if 𝑋2calc is greater than 𝑋2crit.134 
6.3.10 One-way ANOVA, Tukey HSD and Dunnett tests 
Analysis of variance (ANOVA) tests whether the difference between the means of three or 
more groups is too great to be explained by random error. One-way ANOVA tests the 
hypothesis that all population means are equal. If the hypothesis is rejected, then it can be 
concluded that a controlled factor leads to a significant difference between the mean values 
obtained between groups.134 
 
If the null hypothesis was rejected in an analysis of variance (ANOVA) test then post-hoc 
multi comparisons tests, such as the Tukey honestly significant difference (HSD) and 
Dunnett tests, are conducted to compare individual pairs of groups. The Tukey HSD test138 
compares every mean value with every other mean value, whereas the Dunnett test139 
compares every mean to a control mean. When multiple comparisons are made, there is a 
greater chance of obtaining a statistically significant result when the ‘true’ result is not 
significant (Type-I error). Strict thresholds for declaring statistical significance are 
therefore set by these post-hoc tests to control Type-I errors.140 However, correcting for 
multiple comparisons also gives less power to detect true differences.141 
𝑋2 =
12
𝑁2 + 𝑁
(∑
𝑅𝑖
2
𝑛𝑖
𝑘
𝑖=1
) − 3(𝑁 + 1) Equation 6.11: 
Kruskal-Wallis test 
Where  N = sum of the number of samples in all groups, Ri = sum of the rank values for 
a particular group, k = number of groups. 
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Chapter 7: Conclusions  
The overall aim of this work was to provide the tools needed to commercialise an organic 
botanical plant protection product from Larix by-products, which could be used to treat 
Plasmopara viticola. This thesis makes a significant contribution to developing and 
meeting the requirements for registering a new plant protection product, Larixyne®, for 
the organic agricultural market. The results of this work are partially presented in 
publication: Thürig et al. (Appendix A1.2).123 
 
The work conducted in this thesis fills significant gaps in research knowledge, in regards 
to: developing analytical HPLC and GC-FID protocols for quantitative analysis of larixyl 
acetate, larixol and epimanool in Larix extracts; establishing industrially suitable and 
scalable Larix extraction procedures; identifying European Larix sources with the highest 
recovery yield of larixyl acetate and larixol using an extraction method suitable for organic 
farming; and determining the in vitro and in planta activity of larixyl acetate, larixol and 
formulated products of Larix oleoresin extracts (containing larixyl acetate and larixol) 
against the oomycete pathogen, Plasmopara viticola, on Vitis vinifera. 
 
Seven research objectives were accomplished to achieve the overall research aim. 
Objective 1 (discussed in Chapter 2) was met by producing a validated method of 
quantification for larixyl acetate, larixol and epimanool in Larix extracts using high-
performance liquid-chromatography (HPLC) and gas chromatography (GC). 
 
Objective 2 (discussed in Chapter 3) was met by developing a scalable method to extract 
high-yields of larixyl acetate and larixol from Larix bark that was suitable for organic 
farming. EtOH and PE were identified as the best solvent candidates for the industrial 
extraction of larixyl acetate and larixol from Larix bark.  
 
Objective 3 (discussed in Chapter 3) was met by purifying Larix decidua oleoresin and 
evaluating its recovery-yield compared to L. decidua bark. Larix oleoresin provided 
superior extraction yields of larixyl acetate (58.77% composition) and larixol (7.67% 
composition) in comparison to Larix bark (30.53% composition larixyl acetate and 8.45% 
composition larixol). Purification of Larix oleoresin using AMP was used to produce 
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approximately 2.0 kg (2014) and 6.0 kg (2015) of extract that was formulated (LAR-016, 
LAR-042) and used to determine Larixyne® activity in field experiments. 
 
Objective 4 (discussed in Chapter 4) was met by extracting 50 samples of Larix raw 
material from different sources in central and northern Europe and analysing their larixyl 
acetate, larixol and epimanool content using qualitative 1H NMR spectroscopy and 
quantitative GC-FID techniques.  
 
Objective 5 (discussed in Chapter 4) was met by comparing the concentrations of larixyl 
acetate and larixol in Larix samples and identifying the highest-yielding sources. One 
sample was determined the best candidate for commercial high-yield extraction, due to its 
high extraction yield of 13.65% and concentration (percentage of total plant material) of 
larixyl acetate (4.544% w/w), larixol (0.578% w/w) and epimanool (0.752% w/w).  
 
Objective 6 (discussed in Chapter 4) was met by evaluating statistically whether the 
species, geographical location (country of growth, elevation) or physical (tree part, colour) 
properties of the Larix samples affected their larixyl acetate, larixol or epimanool 
concentration. Overall, it was found that assessing the geographical sources of Larix had a 
greater impact on identifying correlations with larixyl acetate and larixol concentration 
than assessing physical characteristics. 
 
Objective 7 (discussed in Chapter 5) was met by determining the in vitro and in vivo 
activity of larixyl acetate, larixol and epimanool against Plasmopara viticola and 
investigating their mode of action. Larixyl acetate and larixol exhibited excellent efficacies 
in vitro (mean MIC100 of 7 and 16 μg/mL) and in planta (EC50 0.2 – 0.7 mg/mL). These 
compounds demonstrated direct antifungal activity by inhibiting zoospores in vitro without 
a plant host present. 
 
Due to the work conducted in this thesis, Larixyne® now presents a potential replacement 
to the use of copper-containing agrochemicals for the prevention and treatment of P. 
viticola in organic viticulture. Use of Larixyne® as an alternative to copper will benefit 
both human health and the environment by reducing the presence of copper in agricultural 
ecosystems. Additionally, by maximising the potential of a cheap, renewable by-product 
(Larix bark), Larixyne® can provide extra value to the forestry industry. 
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A2.1 HPLC chromatograms of larixyl acetate, larixol and epimanool run using a 
preliminary HPLC method (conditions as reported in section 2.3.1). 
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A2.2 HPLC chromatogram of the standard stock solution of larixyl acetate, 
larixol and epimanool 
 
A2.3 GC-FID chromatogram of the standard stock solution of larixyl acetate, 
larixol and epimanool 
 
 A27 
 
 
 
 
 
 
 
 
 
 
 
  Appendix 3
 
Extraction of larixyl acetate and larixol from Larix
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A3.1 Purification of Larix oleoresin hexane extract using sodium hydroxide 
 
   
   
     
1a: 1st NaOH wash; 1b: 1st NaOH wash – ready to decant;  
2a: 2nd NaOH wash after shaking; 2b: 2nd NaOH wash – ready to decant;  
3a: 3rd NaOH wash after shaking; 3b: 3rd NaOH wash – during separation; 
3c: 3rd NaOH wash – ready to decant. 
1a 1b 
2a 2b 
3a 3b 3c 
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A3.2 1H NMR spectrum of EtOH (10 mm) extract (blue) overlaid with larixyl acetate (purple), larixol (green) and epimanool 
(red) 
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A3.3 1H NMR spectrum of Larix oleoresin 
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A3.4 1H NMR spectrum of the EtOH Larix bark extract before (blue) and after (red) purification with PE 
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A3.5 Overlaid 1H NMR spectra of purified Larix oleoresin extract obtained using sodium hydroxide and either PE (blue) or 
hexane (red) 
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A3.6 1H NMR spectrum of purified Larix decidua oleoresin extract obtained using sodium hydroxide and hexane (blue), 
overlaid with the resin-acid salt precipitate from the reaction (red). 
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A3.7 Overlaid 1H NMR spectra of crude (red) and purified with 2-amino-2-methyl-1-propanol (blue) Larix oleoresin. 
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A3.8 Overlaid 1H NMR spectra of crude (red) and purified with 2-amino-2-methyl-1-propanol (blue) Larix oleoresin 
(expanded). 
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A3.9 Comparison between the H2O:EtOH Larix bark extract before (blue) and after (red) purification with 2-amino-2-
methyl-1-propanol 
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A4.1 Larix sample code names 
Larix samples were assigned several code names for use in this thesis and ProLarix project 
reports. They are decoded below. SURR = University of Surrey assigned ProLarix name, 
UHEL = University of Helsinki assigned ProLarix name. 
 
Thesis code SURR code UHEL Code  Thesis code SURR code UHEL Code 
01 SURR_bark_08 15345  26 SURR_bark_10 21546 
02 SURR_bark_11 26927  27 SURR_bark_15 33848 
03 SURR_bark_35 27083  28 SURR_bark_02 47058 
04 SURR_bark_18 30976  29 SURR_bark_14 60631 
05 SURR_bark_42 37231  30 SURR_bark_34 62880 
06 SURR_bark_19 71113  31 SURR_bark_09 63700 
07 SURR_bark_07 75577  32 SURR_bark_24 72655 
08 SURR_bark_04 75779  33 SURR_bark_01 82859 
09 SURR_bark_20 76305  34 SURR_bark_06 83846 
10 SURR_bark_39 77455  35 SURR_bark_28 63700 
11 SURR_bark_12 90279  36 SURR_bark_45 90368 
12 SURR_bark_13 10620  37 SURR_bark_29 53249 
13 SURR_bark_17 11551  38 SURR_bark_38 90600 
14 SURR_bark_43 13119  39 SURR_bark_46 21505 
15 SURR_bark_47 13491  40 SURR_bark_31 32049 
16 SURR_bark_23 18106  41 SURR_bark_49 22278 
17 SURR_bark_30 34770  42 SURR_bark_48 48167 
18 SURR_bark_44 41067  43 SURR_bark_50 97365 
19 SURR_bark_37 44104  44 SURR_bark_26 77379 
20 SURR_bark_41 49037  45 SURR_bark_36 88629 
21 SURR_bark_40 59337  46 SURR_bark_27 83463 
22 SURR_bark_05 80182  47 SURR_bark_33 49177 
23 SURR_bark_16 85436  48 SURR_bark_25 47286 
24 SURR_bark_21 94771  49 SURR_bark_32 33451 
25 SURR_bark_03 13163  50 SURR_bark_22 60933 
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A4.2 Larix sample information 
Larix sample information, including: a photograph, country, latitude, longitude, elevation above sea level (a.s.l), tree part, colour, secondary 
level colour and species. Photographs of the samples taken in a 10 cm diameter petri dish. 
Larix 
sample Image Country 
Latitude 
(deg.) 
Longitude 
(deg.) 
Elevation 
a.s.l (m) Tree part Colour 
Secondary level 
descriptor Species 
01 
 
Finland 60.18 24.9 15 Twigs Dark Large chips Larix gmelinii 
02 
 
Germany 48.08 12.2 445 Twigs Mix Medium chips Larix decidua 
03 
 
 
 
 Germany 49.72 12.16 419 Bark Dark Large chips Larix decidua 
04 
 
Austria 47.56 13.99 485 Bark Dark Large chips Larix decidua 
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05 
 
Germany 48.35 12.45 470 Wood Light Large chips Larix decidua 
06 
 
Austria 47.73 13.04 450 Bark Dark Large chips Larix decidua 
07 
 
Finland 61.8 29.31 81 Bark Dark Fine chips Larix sibirica 
08 
 
Austria 47.12 13.76 1030 Wood Light Fine chips Larix decidua 
09 
 
Austria 47.56 13.99 485 Wood Light Fine chips Larix decidua 
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10 
 
Finland 61.8 29.31 81 Bark Dark Fine chips Larix decidua 
11 
 
Austria 47.12 13.76 1030 Bark Dark Large chips Larix decidua 
12 
 
Italy 46.25 11.18 1175 Bark Dark Fine chips Larix decidua 
13 
 
Austria 47.56 13.99 485 Bark Dark Fine chips Larix decidua 
14 
 
Germany 48.08 12.2 445 Bark Dark Large chips Larix decidua 
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15 
 
Finland 60.68 23.79 120 Twigs Mix Medium chips Larix decidua 
16 
 
Finland 60.68 23.79 120 Wood Light Large chips Larix decidua 
17 
 
Austria 47.25 15.7 400 Bark Dark Large chips Larix decidua 
18 
 
Germany 48.35 12.13 466 Twigs Mix Medium chips Larix decidua 
19 
 
Finland 60.68 23.79 120 Twigs Mix Medium chips Larix decidua 
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20 
 
Germany 49.72 12.16 419 Bark Dark Large chips Larix decidua 
21  Finland 60.68 23.79 120 Wood Dark Fine chips Larix decidua 
22 
 
Finland 60.68 23.79 120 Bark Dark Fine chips Larix decidua 
23 
 
Germany 51.3 9.4 232 Bark Dark Fine chips Larix decidua 
24 
 
Finland 60.68 23.79 120 Wood Light Large chips Larix decidua 
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25 
 
Finland 60.68 23.79 120 Wood Light Large chips Larix decidua 
26 
 
Finland 60.18 24.9 15 Twigs Mix Green needles Larix gmelinii 
27 
 
Finland 60.18 24.9 15 Twigs Mix Green needles Larix gmelinii 
28 
 
Sweden 59.9 17.6 15 Twigs Mix Green needles Larix decidua 
29 
 
Estonia 58.3 26.5 80 Twigs Mix Large chips Larix decidua 
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30 
 
Germany 48.35 12.45 470 Wood Light Fine chips Larix decidua 
31 
 
Finland 60.68 23.79 120 Bark Mix Medium chips Larix decidua 
32 
 
Germany 48.35 12.45 470 Bark Dark Large chips Larix decidua 
33 
 
Germany 48.38 12.21 394 Twigs Mix Green needles Larix decidua 
34 
 
Finland 60.15 21.59 10 Twigs Mix Green needles Larix decidua 
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35 
 
Finland 60.68 23.79 120 Bark Mix Large chips Larix decidua 
36 
 
Estonia 58.3 26.5 80 Twigs Mix Large chips Larix decidua 
37 
 
Finland 60.18 24.9 15 Twigs Mix Green needles Larix kaempferi 
38 
 
Finland 60.06 24.07 15 Twigs Mix Green needles Larix decidua 
39 
 
Germany 48.08 12.2 445 Twigs Mix Large chips Larix decidua 
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40 
 
Austria 47.35 13.4 920 Twigs Mix Large chips Larix decidua 
41 
 
Finland 60.1 23.95 20 Twigs Mix Green needles Larix decidua 
42 
 
Austria 47.56 13.99 485 Wood Light Large chips Larix decidua 
43 
 
Germany 48.35 12.45 470 Wood Light Large chips Larix decidua 
44 
 
Germany 51.3 9.4 232 Twigs Mix Large chips Larix decidua 
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45 
 
Germany 48.17 12.38 406 Twigs Mix Large chips Larix decidua 
46 
 
Germany 48.35 12.45 470 Wood Light Fine chips Larix decidua 
47 
 
Austria 47.4 13.25 697 Twigs Mix Large chips Larix decidua 
48 
 
Austria 47.12 13.76 1030 Twigs Light Fine chips Larix decidua 
49 
 
Finland 60.06 24.07 15 Twigs Mix Green needles Larix decidua 
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50 
 
Finland 60.06 24.07 15 Bark Mix Medium chips Larix decidua 
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A4.3 Larix samples categorised by their visual appearance into colour groups 
(light, dark, mixed). 
 
Light Dark Mix 
(Light to golden 
yellow) (Dark red to brown) 
(Mix of light and dark and green 
needles) 
25 09 04 23 19 44 41 
16 08 11 12 15 40 27 
24 30 03 21 18 39 38 
42 48 17 22 31 45 33 
43 46 01 07 50 47 34 
05  20 13 02 36 26 
  06 10  29 28 
  14   35 49 
  32    37 
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 Colour Category 
Larix samples 
Light (n = 11) Dark (n = 16) Mixed (n = 23) 
Larix_05 Larix_01 Larix_02 
Larix_08 Larix_03 Larix_15 
Larix_09 Larix_04 Larix_18 
Larix_16 Larix_06 Larix_19 
Larix_24 Larix_07 Larix_31 
Larix_25 Larix_10 Larix_50 
Larix_30 Larix_11 Larix_29 
Larix_42 Larix_14 Larix_35 
Larix_43 Larix_17 Larix_36 
Larix_46 Larix_20 Larix_39 
Larix_48 Larix_32 Larix_40 
 Larix_01 Larix_44 
 Larix_03 Larix_45 
 Larix_04 Larix_47 
 Larix_06 Larix_26 
 Larix_07 Larix_27 
  Larix_28 
  Larix_33 
  Larix_34 
  Larix_37 
  Larix_38 
  Larix_41 
  Larix_49 
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A4.4 The concentrations and qualitative 1H NMR spectroscopy resonance 
peaks of larixyl acetate, larixol and epimanool in Larix samples. 
 
Larix 
sample 
Total concentrationa in Larix sample  
(% w/w of Larix) 
Qualitative 1H NMR Spectroscopy 
Resonance peaksb 
Larixyl  
acetate Larixol Epimanool Larixyne
c Larixol acetate Larixol 2.06 (s) ppm 5.07* ppm 3.86 (dt) ppm 
01 0.002 - - 0.002 P P T 
02 0.051 0.006 0.015 0.058 P P T 
03 0.004 - 0.001 0.004 P P T 
04 0.014 0.003 0.008 0.017 P P T 
05 0.018 0.003 0.004 0.020 P P T 
06 0.011 - 0.002 0.011 P P T 
07 - - 0.001 - T T T 
08 0.014 0.002 0.005 0.016 P P T 
09 0.030 0.007 0.011 0.037 P P T 
10 0.019 0.011 0.009 0.030 P P P 
11 0.004 - 0.001 0.004 P P T 
12 0.022 0.004 0.008 0.026 P P P 
13 0.011 0.002 0.006 0.013 P P T 
14 0.001 - 0.000 0.001 T T T 
15 - - 0.001 - T T T 
16 - - 0.005 - T T T 
17 0.020 0.003 0.005 0.023 P P T 
18 0.065 0.014 0.032 0.078 P P T 
19 0.002 - 0.003 0.002 T T T 
20 0.005 - 0.001 0.005 T T T 
21 0.013 0.002 0.021 0.015 T T T 
22 0.003 - 0.029 0.003 T T T 
23 0.012 - 0.005 0.012 P P T 
24 - - 0.007 - T T T 
25 - - 0.001 - T T T 
26 0.042 0.034 0.016 0.076 T T T 
27 0.039 0.134 0.038 0.172 T T P 
28 0.068 0.007 0.050 0.075 P P T 
29 0.032 0.009 0.008 0.041 P P T 
30 4.544 0.578 0.753 5.122 P P P 
Table continued on next page... 
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31 0.003 - 0.026 0.003 T T T 
32 0.025 0.006 0.011 0.030 P T T 
33 0.076 0.005 0.005 0.081 P P T 
34 - - 0.003 - T T T 
35 0.005 0.001 0.039 0.006 T T T 
36 0.059 0.009 0.013 0.069 P P T 
37 0.017 0.012 0.019 0.030 T T T 
38 0.002 0.001 0.007 0.003 T T T 
39 0.017 0.002 0.011 0.019 P P T 
40 0.043 0.012 0.020 0.055 P P T 
41 - - 0.034 - T T T 
42 0.173 0.016 0.040 0.188 P P P 
43 0.021 0.004 0.005 0.025 P P P 
44 0.061 0.003 0.010 0.064 P P T 
45 0.058 0.008 0.022 0.065 P P T 
46 0.055 0.017 0.015 0.072 P P P 
47 0.051 0.016 0.026 0.067 P P T 
48 0.310 0.227 0.203 0.537 P P P 
49 - 0.003 0.011 0.003 T T T 
50 0.018 0.002 0.028 0.020 T T T 
aConcentrations below the limit of detection are displayed in the results tables as ‘–‘. 
bResonance peaks typical of larixyl acetate and larixol presence. (s) = singlet, * = overlapped 
resonances (double-doublet for H-17A and double-triplet for H-6), (dt) = double triplet. T = 
peak trace and P = peak. cLarixyne = combined total concentrations of larixyl acetate and 
larixol; denoted as ‘–‘ if both larixyl acetate and larixol concentrations are below the limit of 
detection.  
 
Larix 
sample 
Total concentrationa in Larix sample  
(% w/w of Larix) 
Qualitative 1H NMR 
Spectroscopy Resonance peaksb 
Larixyl 
acetate Larixol Epimanool Larixyne
a 
Larixol acetate Larixol 
2.06 (s) 
ppm 
5.07* 
ppm 
3.86 (dt) 
ppm 
REF1 0.029 0.005 0.016 0.033 P P P 
REF2 0.031 0.004 0.015 0.036 P P P 
REF3 0.045 0.007 0.023 0.052 P P P 
Median 0.031 0.005 0.016 0.036 
 
Mean 0.035 0.005 0.018 0.040 
Std. 
Deviation 0.009 0.001 0.004 0.010 
aConcentrations below the limit of detection are displayed in the results tables as ‘–‘. 
bResonance peaks typical of larixyl acetate and larixol presence. (s) = singlet, * = overlapped 
resonances (double-doublet for H-17A and double-triplet for H-6), (dt) = double triplet. T = 
peak trace and P = peak.  
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A4.5 The extract yields (EtOH and PE) of Larix samples and the 
concentrations of larixyl acetate, larixol and epimanool in the PE 
extracts. 
Larix 
sample 
Extract yield  
(% w/w of Larix) 
Yield of 
PE 
extract 
from 
ethanol 
extract  
(% w/w of 
EtOH 
extract) 
Concentrationa in secondary PEb extract  
(% w/w of PE extract) 
Primary 
EtOH 
Secondary 
PE 
Larixyl 
acetate Larixol Epimanool Larixyne
c 
01 6.46 0.12 1.9 1.4 - - 1.4 
02 7.43 0.79 10.7 6.5 0.78 1.86 7.3 
03 3.45 0.11 3.2 3.2 - 0.69 3.2 
04 3.95 0.29 7.5 4.9 1.15 2.87 6.0 
05 0.61 0.17 27.5 10.6 1.59 2.49 12.2 
06 4.51 0.16 3.7 6.8 - 0.95 6.8 
07 7.58 0.09 1.2 - - 1.07 - 
08 0.72 0.19 29.5 7.4 1.19 2.41 8.6 
09 1.09 0.64 58.0 4.7 1.04 1.79 5.8 
10 2.29 0.28 12.3 6.9 3.84 3.29 10.7 
11 6.11 0.18 3.0 2.2 - 0.54 2.2 
12 5.12 0.22 4.5 9.9 1.63 3.63 11.6 
13 3.47 0.23 7.0 4.6 0.88 2.45 5.5 
14 3.38 0.07 2.0 1.9 - 0.42 1.9 
15 2.48 0.31 12.4 - - 0.49 - 
16 0.95 0.17 18.1 - - 2.77 - 
17 4.62 0.29 6.4 6.8 1.01 1.85 7.8 
18 4.58 0.57 12.5 11.3 2.37 5.66 13.7 
19 3.15 0.45 14.3 0.5 - 0.74 0.5 
20 3.69 0.17 4.6 3.0 - 0.62 3.0 
21 7.19 0.69 9.6 1.9 0.28 3.12 2.2 
22 6.65 0.46 7.1 0.6 - 6.25 0.6 
23 7.00 0.27 4.0 4.4 - 1.73 4.4 
24 0.91 0.17 18.5 - - 4.07 - 
25 0.69 0.11 17.5 - - 0.68 - 
26 5.43 1.12 21.5 3.8 3.03 1.46 6.8 
27 4.65 0.81 18.0 4.8 16.57 4.73 21.4 
28 3.00 0.89 30.6 7.7 0.81 5.69 8.5 
29 2.06 0.46 23.6 6.9 1.90 1.71 8.8 
30 16.75 13.65 81.5 33.3 4.23 5.51 37.5 
Table continued on next page... 
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31 5.77 0.43 7.6 0.6 - 6.18 0.6 
32 3.76 0.32 8.4 7.8 1.81 3.32 9.6 
33 3.66 0.68 19.1 11.2 0.72 0.72 11.9 
34 2.63 0.36 14.4 - - 0.80 - 
35 7.76 0.60 7.7 0.8 0.13 6.61 0.9 
36 3.36 0.60 17.8 9.9 1.55 2.10 11.5 
37 5.35 0.80 15.0 2.2 1.50 2.34 3.7 
38 5.88 1.55 26.3 0.2 0.05 0.45 0.2 
39 3.42 0.39 11.5 4.3 0.51 2.68 4.8 
40 2.30 0.54 23.4 8.1 2.24 3.64 10.3 
41 3.09 1.10 35.6 - - 3.12 - 
42 1.89 0.70 36.8 24.8 2.25 5.75 27.1 
43 0.54 0.22 40.9 9.2 1.94 2.32 11.2 
44 1.81 0.45 24.8 13.6 0.73 2.13 14.3 
45 3.26 0.66 20.3 8.7 1.14 3.35 9.9 
46 0.67 0.31 45.8 17.8 5.57 4.77 23.4 
47 4.04 0.77 19.1 6.6 2.01 3.42 8.6 
48 4.22 1.87 44.4 16.5 12.12 10.83 28.6 
49 5.77 2.01 34.8 - 0.13 0.55 0.1 
50 6.93 1.19 17.2 1.5 0.20 2.37 1.7 
aConcentrations below the limit of detection are displayed in the results tables as ‘–‘. bPE = 
petroleum ether.  cLarixyne = Combined total concentrations of larixyl acetate and larixol; 
denoted as ‘–‘ if both larixyl acetate and larixol concentrations are below the limit of 
detection.  
 
Larix 
sample 
Extract yield  
(% w/w of Larix) 
Yield of PE 
extract 
from 
ethanol 
extract  
(% w/w of 
ethanol 
extract) 
Concentration in secondary PEa 
extract  
(% w/w of PE extract) 
Primary 
ethanol 
Secondary 
PE 
Larixyl 
acetate Larixol Epimanool Larixyne
b 
REF1 3.58 0.39 11.2 7.5 1.17 4.16 8.7 
REF2 3.61 0.36 10.0 8.7 1.18 4.04 9.9 
REF3 4.04 0.77 19.1 5.9 0.85 2.96 6.7 
Median 3.61 0.39 11.2 7.5 1.17 4.04 8.7 
Mean 3.74 0.51 13.4 7.4 1.07 3.72 8.4 
Std. Dev. 0.26 0.23 4.9 1.4 0.19 0.66 1.6 
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A4.6 Qualitative 1H NMR spectra of Larix samples 
Figure A4.6.REF: Qualitative 1H NMR spectrum of Larix_REF. 
 
 
Figure A4.6.REFb: GC-FID chromatogram of Larix_REF. 
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Figure A4.6.1: Qualitative 1H NMR spectrum of Larix_01. 
 
 
Figure A4.6.1b: GC-FID chromatogram of Larix_01. 
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Figure A4.6.2: Qualitative 1H NMR spectrum of Larix_02. 
 
 
Figure A4.6.2b: GC-FID chromatogram of Larix_02. 
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Figure A4.6.3: Qualitative 1H NMR spectrum of Larix_03. 
 
 
Figure A4.6.3b: GC-FID chromatogram of Larix_03. 
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Figure A4.6.4: Qualitative 1H NMR spectrum of Larix_04. 
 
 
Figure A4.6.4b: GC-FID chromatogram of Larix_04. 
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Figure A4.6.5: Qualitative 1H NMR spectrum of Larix_05. 
 
 
Figure A4.6.5b: GC-FID chromatogram of Larix_05. 
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Figure A4.6.6: Qualitative 1H NMR spectrum of Larix_06. 
 
 
Figure A4.6.6b: GC-FID chromatogram of Larix_06. 
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Figure A4.6.7: Qualitative 1H NMR spectrum of Larix_07. 
 
 
 
Figure A4.6.7b: GC-FID chromatogram of Larix_07. 
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Figure A4.6.8: Qualitative 1H NMR spectrum of Larix_08. 
 
 
 
Figure A4.6.8b: GC-FID chromatogram of Larix_08. 
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Figure A4.6.9: Qualitative 1H NMR spectrum of Larix_09. 
 
 
Figure A4.6.9b: GC-FID chromatogram of Larix_09. 
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Figure A4.6.10: Qualitative 1H NMR spectrum of Larix_10. 
 
 
Figure A4.6.10b: GC-FID chromatogram of Larix_10. 
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Figure A4.6.11: Qualitative 1H NMR spectrum of Larix_11. 
 
 
Figure A4.6.11b: GC-FID chromatogram of Larix_11. 
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Figure A4.6.12: Qualitative 1H NMR spectrum of Larix_12. 
 
 
Figure A4.6.12b: GC-FID chromatogram of Larix_12. 
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Figure A4.6.13: Qualitative 1H NMR spectrum of Larix_13. 
 
 
Figure A4.6.13b: GC-FID chromatogram of Larix_13. 
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Figure A4.6.14: Qualitative 1H NMR spectrum of Larix_14. 
 
 
Figure A4.6.14b: GC-FID chromatogram of Larix_14. 
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Figure A4.6.15: Qualitative 1H NMR spectrum of Larix_15. 
 
 
Figure A4.6.15b: GC-FID chromatogram of Larix_15. 
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Figure A4.6.16: Qualitative 1H NMR spectrum of Larix_16. 
 
 
Figure A4.6.16b: GC-FID chromatogram of Larix_16. 
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Figure A4.6.17: Qualitative 1H NMR spectrum of Larix_17. 
 
 
Figure A4.6.17b: GC-FID chromatogram of Larix_17. 
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Figure A4.6.18: Qualitative 1H NMR spectrum of Larix_18. 
 
 
Figure A4.6.18b: GC-FID chromatogram of Larix_18. 
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Figure A4.6.19: Qualitative 1H NMR spectrum of Larix_19. 
 
 
Figure A4.6.19b: GC-FID chromatogram of Larix_19. 
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Figure A4.6.20: Qualitative 1H NMR spectrum of Larix_20. 
 
 
Figure A4.6.20b: GC-FID chromatogram of Larix_20. 
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Figure A4.6.21: Qualitative 1H NMR spectrum of Larix_21. 
 
 
Figure A4.6.21b: GC-FID chromatogram of Larix_21. 
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Figure A4.6.22: Qualitative 1H NMR spectrum of Larix_22. 
 
 
Figure A4.6.22b: GC-FID chromatogram of Larix_22. 
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Figure A4.6.23: Qualitative 1H NMR spectrum of Larix_23. 
 
Figure A4.6.23b: GC-FID chromatogram of Larix_23. 
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Figure A4.6.24: Qualitative 1H NMR spectrum of Larix_24. 
 
Figure A4.6.24b: GC-FID chromatogram of Larix_24. 
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Figure A4.6.25: Qualitative 1H NMR spectrum of Larix_25. 
 
Figure A4.6.25b: GC-FID chromatogram of Larix_25. 
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Figure A4.6.26: Qualitative 1H NMR spectrum of Larix_26. 
 
Figure A4.6.26b: GC-FID chromatogram of Larix_26. 
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Figure A4.6.27: Qualitative 1H NMR spectrum of Larix_27. 
 
Figure A4.6.27b: GC-FID chromatogram of Larix_27. 
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Figure A4.6.28: Qualitative 1H NMR spectrum of Larix_28. 
 
Figure A4.6.28b: GC-FID chromatogram of Larix_28. 
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Figure A4.6.29: Qualitative 1H NMR spectrum of Larix_29. 
 
Figure A4.6.29b: GC-FID chromatogram of Larix_29. 
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Figure A4.6.30: Qualitative 1H NMR spectrum of Larix_30. 
 
Figure A4.6.30b: GC-FID chromatogram of Larix_30. 
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Figure A4.6.31: Qualitative 1H NMR spectrum of Larix_31. 
 
Figure A4.6.31b: GC-FID chromatogram of Larix_31. 
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Figure A4.6.32: Qualitative 1H NMR spectrum of Larix_32. 
 
Figure A4.6.32b: GC-FID chromatogram of Larix_32. 
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Figure A4.6.33: Qualitative 1H NMR spectrum of Larix_33. 
 
Figure A4.6.33b: GC-FID chromatogram of Larix_33. 
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Figure A4.6.34: Qualitative 1H NMR spectrum of Larix_34. 
 
Figure A4.6.34b: GC-FID chromatogram of Larix_34. 
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Figure A4.6.35: Qualitative 1H NMR spectrum of Larix_35. 
 
Figure A4.6.35b: GC-FID chromatogram of Larix_35. 
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Figure A4.6.36: Qualitative 1H NMR spectrum of Larix_36. 
 
Figure A4.6.36b: GC-FID chromatogram of Larix_36. 
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Figure A4.6.37: Qualitative 1H NMR spectrum of Larix_37. 
 
Figure A4.6.37b: GC-FID chromatogram of Larix_37. 
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Figure A4.6.38: Qualitative 1H NMR spectrum of Larix_38. 
 
Figure A4.6.38b: GC-FID chromatogram of Larix_38. 
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Figure A4.6.39: Qualitative 1H NMR spectrum of Larix_39. 
 
Figure A4.6.39b: GC-FID chromatogram of Larix_39. 
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Figure A4.6.40: Qualitative 1H NMR spectrum of Larix_40. 
 
Figure A4.6.40b: GC-FID chromatogram of Larix_40. 
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Figure A4.6.41: Qualitative 1H NMR spectrum of Larix_41. 
 
Figure A4.6.41b: GC-FID chromatogram of Larix_41. 
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Figure A4.6.42: Qualitative 1H NMR spectrum of Larix_42. 
 
Figure A4.6.42b: GC-FID chromatogram of Larix_42. 
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Figure A4.6.43: Qualitative 1H NMR spectrum of Larix_43. 
 
Figure A4.6.43b: GC-FID chromatogram of Larix_43. 
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Figure A4.6.44: Qualitative 1H NMR spectrum of Larix_44. 
 
Figure A4.6.44b: GC-FID chromatogram of Larix_44. 
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Figure A4.6.45: Qualitative 1H NMR spectrum of Larix_45. 
 
Figure A4.6.45b: GC-FID chromatogram of Larix_45. 
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Figure A4.6.46: Qualitative 1H NMR spectrum of Larix_46. 
 
Figure A4.6.46b: GC-FID chromatogram of Larix_46. 
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Figure A4.6.47: Qualitative 1H NMR spectrum of Larix_47. 
 
Figure A4.6.47b: GC-FID chromatogram of Larix_47. 
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Figure A4.6.48: Qualitative 1H NMR spectrum of Larix_48. 
 
Figure A4.6.48b: GC-FID chromatogram of Larix_48. 
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Figure A4.6.49: Qualitative 1H NMR spectrum of Larix_49. 
 
Figure A4.6.49b: GC-FID chromatogram of Larix_49. 
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Figure A4.6.50: Qualitative 1H NMR spectrum of Larix_50. 
 
Figure A4.6.50b: GC-FID chromatogram of Larix_50. 
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  Appendix 5
 
Efficacy of larixyl acetate and larixol against Plasmopara 
viticola 
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A5.1 In vitro bioassays 
These tables represent the 96-well plates of the in vitro testing discussed in section 5.3.1. Zoospore activity was assigned rankings on a scale 
from 0 – 2 according to the following criteria: 0 - no activity (similar to water control); 0.5 - very few zoospores slowly swimming/floating; 1 - 
partial activity (about half zoospores swimming); 2 - full activity (all zoospores swimming fully). Plates were assessed after 1.5 - 2 hours after 
treatment 
 
Test plate one: Minimal inhibitory concentrations (MIC100) of a series of different products against Plasmopara viticola, in vitro 
Activity in Test plate Dilution (μg/mL) 
Minimum inhibitory 
concentration (MIC) 
(μg/mL) 
control 500 250 125 63 31 16 8 4 2 1 control 1.5 – 2 
hours after 
treatment 
3 hours 
after 
treatment Well plate position 1 2 3 4 5 6 7 8 9 10 11 12 
LA (impure) A 2 0 0 0 0 0 0.5 1 1 2 2 2 31 8 
L (impure) B 2 0 0 0 0 0 1 2 2 2 2 2 31 31 
LA:L 6:1 (impure) C 2 0 0 0 0 0 1 1.5 2 2 2 2 31 8 
LAR-016 D 2 0 0 0 0 0 0.5 1 2 2 2 2 31 16 
LAR-042 E 2 0 0 0 1 1 2 2 2 2 2 2 125 63 
LAR-016 (Blank) F 2 2 2 2 2 2 2 2 2 2 2 2 >500 >500 
LAR-042 (Blank) G 2 0 0 1.5 2 2 2 2 2 2 2 2 250 125 
EtOH H 2 0 0 0.5 2 2 2 2 2 2 2 2 250 500 
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Test plate two: Minimal inhibitory concentrations (MIC100) of a series of different products against Plasmopara viticola, in vitro 
Activity in Test plate Dilution (μg/mL) Minimum inhibitory 
concentration 
(MIC) (μg/mL) 
control 500 250 125 63 31 16 8 4 2 1 control 
Well plate position 1 2 3 4 5 6 7 8 9 10 11 12 
LA (impure) A 2 0 0 0 0 0 0 0 0 0.5 1 2 4 
L (impure) B 2 0 0 0 0 0 0 0 0.5 1 2 2 8 
LA (pure) C 2 0 0 0 0 0 0 0 0 0.5 1 2 4 
L (pure) D 2 0 0 0 0 0 0 0 0.5 1 2 2 8 
LA:L 6:1 (pure) E 2 0 0 0 0 0 0 0 0 0.25 1 2 4 
Epimanool F 2 0 0 0 0 0 0 0 0.5 1 2 2 8 
EtOH G 2 0 0 0 0.25 0.5 1 1 2 2 2 2 125 
               Test plate three: Minimal inhibitory concentrations (MIC100) of a series of different products against Plasmopara viticola, in vitro 
Activity in Test plate Dilution (μg/mL) Minimum inhibitory 
concentration 
(MIC) (μg/mL) 
control 500 250 125 63 31 16 8 4 2 1 control 
Well plate position 1 2 3 4 5 6 7 8 9 10 11 12 
LA (impure) A 2 0 0 0 0 0 0 0 0.25 2 2 2 8 
L (impure) B 2 0 0 0 0 0 0 0.25 2 2 2 2 16 
LA (pure) C 2 0 0 0 0 0 0 0 0 1 2 2 4 
L (pure) D 2 0 0 0 0 0 0 0.5 2 2 2 2 16 
LA:L 6:1 (pure) E 2 0 0 0 0 0 0 0.25 0.25 1 2 2 16 
Epimanool F 2 0 0 0 0 0 0.25 0.25 1 2 2 2 31 
EtOH G 2 0 0 0.5 1 2 2 2 2 2 2 2 250 
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Test plate four: Minimal inhibitory concentrations (MIC100) of a series of different products against Plasmopara viticola, in vitro 
Activity in Test plate Dilution (μg/mL) Minimum inhibitory 
concentration 
(MIC) (μg/mL) 
control 500 250 125 63 31 16 8 4 2 1 control 
Well plate position 1 2 3 4 5 6 7 8 9 10 11 12 
LA (impure) A 2 0 0 0 0 0 0 0 1 2 2 2 8 
L (impure) B 2 0 0 0 0 0 0.5 2 2 2 2 2 31 
LA:L 6:1 (impure) C 2 0 0 0 0 0 0 0 2 2 2 2 8 
LA:L:EM 6:1:1.6 (impure) D 2 0 0 0 0 0 0 0.25 1 2 2 2 16 
LA (pure) E 2 0 0 0 0 0 0 0 1 2 2 2 8 
L (pure) F 2 0 0 0 2 0.25 0 2 2 2 2 2 16 
LA:L 6:1 (pure) G 2 0 0 0 0 0 0 0 1 2 2 2 8 
LA:L:EM 6:1:1.6 (pure) H 2 0 0 0 0 0 0 0 0 1 2 2 4 
               Test plate five: Minimal inhibitory concentrations (MIC100) of a series of different products against Plasmopara viticola, in vitro 
Activity in Test plate Dilution (μg/mL) Minimum inhibitory 
concentration 
(MIC) (μg/mL) 
control 500 250 125 63 31 16 8 4 2 1 control 
Well plate position 1 2 3 4 5 6 7 8 9 10 11 12 
LAR-016 A 2 0 0 0 0 0 0.25 0.25 0.5 2 2 2 31 
LAR-042 B 2 0 0 0 0 0 0 0.25 0 2 2 2 16 
LAR-016 (Blank) C 2 0 0 2 2 2 2 2 2 2 2 2 250 
LAR-042 (Blank) D 2 0 0 0 0 0 2 2 2 2 2 2 31 
EtOH E 2 0 0 2 2 2 2 2 2 2 2 2 250 
Epimanool F 2 0 0 0 0 0 0 0 1 2 2 2 8 
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A5.2 Indoor in planta bioassay calculation of half-maximal effective 
concentration (EC50) response values for larixyl acetate, larixol and 
epimanool. 
 Parameter Larixyl acetate Larixol Epimanool 
𝟓𝟎% 𝐦𝐚𝐱𝒓𝒆𝒔𝒑 50.00 % 50.00 % 50.00 % 
Aresp 74.30 % 78.00 % 82.20 % 
Bresp 35.20 % 43.70 % 42.00 % 
Log Aconc 0.00 0.00 -0.30 
Log Bconc -0.30 -0.30 -0.60 
Log [EC50] -0.19 -0.25 -0.54 
EC50 0.65 mg/mL 0.57 mg/mL 0.29 mg/mL 
 
Where 50% max𝑟𝑒𝑠𝑝= 50 % of the maximal (100 %) response, A𝑟𝑒𝑠𝑝and B𝑟𝑒𝑠𝑝 = closest 
recorded responses to 50% max𝑟𝑒𝑠𝑝 (A𝑟𝑒𝑠𝑝 > 50 %, B𝑟𝑒𝑠𝑝 < 50 %), and  A𝑐𝑜𝑛𝑐 and B𝑐𝑜𝑛𝑐= 
the concentrations at A𝑟𝑒𝑠𝑝and B𝑟𝑒𝑠𝑝. EC50 was calculated according to Equation 5.3. 
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A5.3 Independent experiment A data (severity and incidence) used to prepare 
dose-response curves of larixyl acetate, larixol and a 6:1 combination of 
larixyl acetate and larixol (LA:L) on Vitis vinifera var. Chasselas seedlings 
against Plasmopara viticola. 
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A5.4 Independent experiment A data (severity and incidence) used to prepare dose-response curves of larixyl acetate, larixol 
and a 6:1 combination of larixyl acetate and larixol (LA:L) on Vitis vinifera var. Chasselas seedlings against Plasmopara 
viticola. 
Product Concentration Inoculation n Mean severity (%) SD 
Efficacy 
severity (%) SD Sig. 
Mean 
incidence (%) SD 
Efficacy 
incidence (%) SD Sig. 
H2O non-inoc. 0 no 6 0 0 - - - 0 0 - - - 
Control (H2O) 0 yes/spray 6 94 6 - - - 100 0 - - - 
Cu2+ (Ref) 0.03% yes/spray 6 6 4 94 5 **** 39 17 61 17 **** 
Cu2+ (Ref) 0.003% yes/spray 6 19 15 80 16 **** 74 15 26 15 ns 
Larixyl acetate 0.1% yes/spray 6 2 3 98 3 **** 17 20 83 20 **** 
Larixyl acetate 0.05% yes/spray 6 20 22 79 24 **** 70 27 30 27 * 
Larixyl acetate 0.025% yes/spray 6 40 18 57 19 **** 83 20 17 20 ns 
Larixyl acetate 0.0125% yes/spray 6 78 14 16 15 ns 100 0 0 0 ns 
Larixyl acetate 0.00625% yes/spray 6 84 8 10 8 ns 100 0 0 0 ns 
Larixyl acetate 0.00313% yes/spray 6 75 11 20 12 ns 97 8 3 8 ns 
Larixol 0.1% yes/spray 6 9 10 90 11 **** 35 32 65 32 **** 
Larixol 0.05% yes/spray 6 22 15 77 17 **** 75 23 25 23 ns 
Larixol 0.025% yes/spray 6 29 22 69 23 **** 71 29 29 29 * 
Larixol 0.0125% yes/spray 6 71 21 24 22 * 100 0 0 0 ns 
Larixol 0.00625% yes/spray 6 90 6 3 6 ns 100 0 0 0 ns 
Larixol 0.00313% yes/spray 6 84 13 10 14 ns 100 0 0 0 ns 
LA:L (6:1) 0.1% yes/spray 6 0 1 100 1 **** 8 13 92 13 **** 
LA:L (6:1) 0.05% yes/spray 6 13 8 86 9 **** 46 25 54 25 **** 
LA:L (6:1) 0.025% yes/spray 6 40 12 57 13 **** 83 13 17 13 ns 
LA:L (6:1) 0.0125% yes/spray 6 61 22 35 23 *** 97 8 3 8 ns 
LA:L (6:1) 0.00625% yes/spray 6 82 8 12 9 ns 100 0 0 0 ns 
LA:L (6:1) 0.00313% yes/spray 7 80 6 14 7 ns 100 0 0 0 ns 
EtOH 1% yes/spray 6 86 7 8 8 ns 100 0 0 0 ns 
EtOH 0.5% yes/spray 6 92 7 2 7 ns 100 0 0 0 ns 
n = number of samples. SD = standard deviation. Sig. = Significance compared to H2O inoculated control (Dunnett's test – ns = P > 0.05, * = P ≤ 0.05, ** = P 
≤ 0.01, *** = P ≤ 0.001 , **** = P ≤ 0.0001) 
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A5.5 Independent experiment B data (severity and incidence) used to prepare 
dose-response curves of larixyl acetate, larixol and a 6:1 combination of 
larixyl acetate and larixol (LA:L) on Vitis vinifera var. Chasselas seedlings 
against Plasmopara viticola. 
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A5.6 Independent experiment B data (severity and incidence) used to prepare dose-response curves of larixyl acetate, larixol 
and a 6:1 combination of larixyl acetate and larixol (LA:L) on Vitis vinifera var. Chasselas seedlings against Plasmopara 
viticola.
Product Concentration Inoculation n 
Mean 
severity 
(%) 
SD Efficacy severity (%) SD Sig. 
Mean 
incidence 
(%) 
SD Efficacy incidence (%) SD Sig. 
H2O non-inoc. 0 no 6 0 0 - - - 0 0 - - - 
Control (H2O) 0 Yes/Spray 6 82 11 - - - 100 0 - - - 
Cu2+ (Ref) 0.03% Yes/Spray 6 0 1 99 1 **** 14 22 86 22 **** 
Cu2+ (Ref) 0.003% Yes/Spray 6 8 11 90 13 **** 50 41 50 41 *** 
Larixyl acetate 0.1% Yes/Spray 6 21 20 74 24 **** 81 22 19 22 ns 
Larixyl acetate 0.05% Yes/Spray 6 53 25 35 31 ns 89 17 11 17 ns 
Larixyl acetate 0.025% Yes/Spray 6 65 28 20 34 ns 89 17 11 17 ns 
Larixyl acetate 0.0125% Yes/Spray 6 84 12 -3 14 ns 100 0 0 0 ns 
Larixyl acetate 0.00625% Yes/Spray 6 77 17 6 21 ns 94 14 6 14 ns 
Larixyl acetate 0.00313% Yes/Spray 6 87 10 -6 12 ns 100 0 0 0 ns 
Larixol 0.1% Yes/Spray 6 18 23 78 28 **** 64 31 36 31 * 
Larixol 0.05% Yes/Spray 6 46 24 44 30 ns 83 18 17 18 ns 
Larixol 0.025% Yes/Spray 6 78 16 5 19 ns 100 0 0 0 ns 
Larixol 0.0125% Yes/Spray 6 74 10 9 13 ns 94 14 6 14 ns 
Larixol 0.00625% Yes/Spray 6 76 24 7 29 ns 100 0 0 0 ns 
Larixol 0.00313% Yes/Spray 6 82 11 0 14 ns 100 0 0 0 ns 
LA:L (6:1) 0.1% Yes/Spray 6 1 1 99 1 **** 28 33 72 33 **** 
LA:L (6:1) 0.05% Yes/Spray 6 15 15 82 18 **** 61 18 39 18 ** 
LA:L (6:1) 0.025% Yes/Spray 6 47 19 42 23 ns 82 21 18 21 ns 
LA:L (6:1) 0.0125% Yes/Spray 6 58 27 28 33 ns 89 27 11 27 ns 
LA:L (6:1) 0.00625% Yes/Spray 6 83 14 -2 18 ns 94 14 6 14 ns 
LA:L (6:1) 0.00313% Yes/Spray 6 94 10 -15 13 ns 100 0 0 0 ns 
EtOH 1% Yes/Spray 6 87 12 -6 14 ns 100 0 0 0 ns 
EtOH 0.5% Yes/Spray 6 85 15 -4 19 ns 94 14 6 14 ns 
n = number of samples. SD = standard deviation. Sig. = Significance compared to H2O inoculated control (Dunnett's test – ns = P > 0.05, * = P ≤ 0.05, ** = P 
≤ 0.01, *** = P ≤ 0.001 , **** = P ≤ 0.0001) 
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A5.7 Severity and incidence of formulated Larix oleoresin extracts (LAR-016, 
LAR-042) on grapevine seedlings against Plasmopara viticola, applied at 
different time-points before inoculation. 
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A5.8 Severity, incidence and efficacy of formulated Larix oleoresin extracts (LAR-016, LAR-042) on grapevine seedlings 
against Plasmopara viticola, applied at different time-points before inoculation. 
Product Concentration 
Application 
(days before 
inoculation) 
Inoculation n 
Mean 
severity 
(%) 
SD 
Efficacy 
severity 
(%) 
SD Significance 
Mean 
incidence 
(%) 
SD 
Efficacy 
incidence 
(%) 
Significance 
H2O non-inoc. 0 - no 6 0 0 - - - 0 0 - - 
Control (H2O) 0 - Yes/Spray 6 61 17 - - - 100 0 - - 
Cu2+ (Ref) 0.03% 0.5 Yes/Spray 6 0 0 99 1 **** 13 14 88 **** 
Cu2+ (Ref) 0.003% 0.5 Yes/Spray 6 24 18 60 30 ** 78 11 22 ns 
LAR-016 0.1% 0.5 Yes/Spray 6 2 2 97 3 **** 32 37 68 **** 
LAR-016 0.05% 0.5 Yes/Spray 6 18 6 70 10 *** 71 29 29 ns 
LAR-042 0.1% 0.5 Yes/Spray 6 13 18 79 30 **** 38 31 63 **** 
LAR-042 0.05% 0.5 Yes/Spray 6 18 11 71 19 *** 68 32 32 ns 
Cu2+ (Ref) 0.03% 2 Yes/Spray 6 5 6 93 9 **** 26 23 74 **** 
Cu2+ (Ref) 0.003% 2 Yes/Spray 6 69 16 0 27 ns 100 0 0 ns 
LAR-016 0.1% 2 Yes/Spray 6 33 17 46 28 ns 88 14 13 ns 
LAR-016 0.05% 2 Yes/Spray 6 50 15 17 25 ns 96 10 4 ns 
LAR-042 0.1% 2 Yes/Spray 6 44 16 28 27 ns 87 15 13 ns 
LAR-042 0.05% 2 Yes/Spray 6 51 15 16 25 ns 79 19 21 ns 
Cu2+ (Ref) 0.03% 4 Yes/Spray 6 5 3 92 4 **** 44 16 56 *** 
Cu2+ (Ref) 0.003% 4 Yes/Spray 6 26 13 56 21 ** 79 25 21 ns 
LAR-016 0.1% 4 Yes/Spray 6 42 12 31 20 ns 92 13 8 ns 
LAR-016 0.05% 4 Yes/Spray 6 62 18 0 30 ns 97 7 3 ns 
LAR-042 0.1% 4 Yes/Spray 6 31 14 49 24 * 71 6 29 * 
LAR-042 0.05% 4 Yes/Spray 6 37 13 39 21 ns 75 22 25 ns 
n = number of samples. SD = standard deviation. Significance compared to an inoculated H2O control in a Dunnett's test (ns = P > 0.05, 
* = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001 , **** = P ≤ 0.0001) Efficacies are presented as ‘0’ where a negative efficacy (disease level lower 
in control) was calculated. 
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A5.9 Activity of P. viticola zoospores after treatment with larixyl acetate, 
larixol and epimanool 
 
Compound Hyperlink to video 
Larixyl acetate https://youtu.be/e_FAP13jBwg 
Larixol https://youtu.be/-P7DUeAgo3Q 
Epimanool https://youtu.be/edyddd3ftBE 
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A6.1 1H NMR spectra for larixyl acetate 
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A6.2 13C NMR spectra for larixyl acetate 
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A6.3 1H NMR spectra for larixol 
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A6.4 13C NMR spectra for larixol 
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A6.5 1H NMR spectra for epimanool 
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A6.6 13C NMR spectra for epimanool 
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A6.7 1H and 13C resonances for larixyl acetate, larixol and epimanool 
Larixyl acetate: 
1H NMR data (500 MHz): GH 5.90 (dd, J = 10.7, 17.4 Hz, H-14), 5.19 (dd, J = 1.2, 17.4 
Hz, H-15A), 5.05 (dd, J = 1.1, 10.7 Hz, H-15B), 5.03 (dt, J = 5.5, 11.3 Hz, H-6), 4.92 (d, 
J = 1.2 Hz, H-17A), 4.64 (d, J = 1.2 Hz, H-17B), 2.65 (dd, J = 5.2, 12.1 Hz, H-7β), 2.03 (s, 
6-Ac-CH3), 2.01 (m, H-7α), 1.74 (m, H-12β),  1.74 (m, H-1β), 1.60 (m, H-9), 1.57 (m, H-
11β), 1.55 (m, H-2β), 1.47 (m, H-2α), 1.35 (m, H-3α), 1.34 (m, H-11α), 1.27 (s, H-16), 
1.27 (m, H-12α), 1.25 (m, H-3β), 1.40 (d, J = 10.7 Hz, H-5), 1.05 (m, H-1α), 1.01 (s, H-
19), 0.87 (s, H-18) and 0.74 (s, H-20).  
 
13C NMR data (125 MHz): GC 170.2 (6-Ac), 145.1 (C-14), 144.3 (C-8), 111.7 (C-15), 
109.5 (C-17), 73.5 (C-13), 73.3 (C-6), 57.6 (C-5), 56.4 (C-9), 44.2 (C-7), 43.5 (C-3), 41.3 
(C-12), 39.9 (C-10), 39.1 (C-1), 36.2 (C-19), 33.5 (C-4), 27.7 (C-16), 22.5 (C-18), 22.5 (6-
Ac-CH3), 19.0 (C-2), 18.0 (C-11) and 16.0 (C-20).  
 
Larixol:  
1H NMR data (500 MHz): GH 5.89 (dd, J = 10.8, 17.4 Hz, H-14), 5.18 (dd, J = 1.0, 17.3 
Hz, H-15A), 5.03 (dd J = 1.0, 10.8 Hz, H-15B), 4.86 (s, H-17A), 4.58 (s, H-17B), 3.80 (dt,  
J = 4.8, 10.7 Hz, H-6), 2.65 (dd, J = 5.1, 12.3 Hz, H-7β), 2.03 (dd, J = 12.3, 12.3 Hz, H-
7α), 1.75 (m, H-12β) 1.57 (m, H-9),  1.72 (m, H-1β), 1.55 (m, H-2β), 1.53 (m, H-11β), 
1.47 (m, H-2α), 1.47 (m, H-11α), 1.36 (m, H-3α), 1.27 (s, H-16), 1.26 (m, H-12α), 1.23 
(m, H-3β), 1.16 (s, H-19), 1.11 (d, J = 10.7 Hz, H-5), 1.02 (m, H-1α), 1.00 (s, H-18) and 
0.69 (s, H-20).  
 
13C NMR data (125 MHz): GC 145.6 (C-8), 145.2 (C-14), 111.7 (C-15), 108.4 (C-17), 73.6 
(C-13), 71.7 (C-6), 60.5 (C-5), 56.5 (C-9), 49.2 (C-7), 43.8 (C-3), 41.4 (C-12), 39.6 (C-
10), 39.3 (C-1), 36.7 (C-19), 33.9 (C-4), 27.7 (C-16), 22.4 (C-18), 19.1 (C-2), 18.1 (C-11) 
and 16.1 (C-20).  
 
Epimanool: 
1H NMR data (500 MHz): GH 5.90 (dd, J = 10.7, 17.3 Hz, H-14), 5.19 (dd,  J = 1.0, 17.3 
Hz, H-15A), 5.03 (dd, J = 1.0, 10.8 Hz, H-15B), 4.80 (s, H-17A), 4.49 (s, H-17B), 2.36 
(dd,  J = 4.8, 13.1 Hz, H-7β), 1.96 (m, H-7α), 1.76 (m, H-1β), 1.74 (m, H-12β), 1.72 (m, 
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H-6α), 1.54 (m, H-9), 1.48 (m, H-2α), 1.40 (m, H-2β), 1.40 (m, H-3α), 1.36 (m, H-11α), 
1.34 (m, H-11β), 1.31 (m, H-6β), 1.27 (s, H-16), 1.26 (m, H-12α), 1.17 (m, H-3β), 0.86 (s, 
H-19), 1.07  (d, J = 10.7 Hz, H-5), 1.01 (m, H-1α), 0.79 (s, H-18) and 0.67 (s, H-20).  
 
13C NMR data (125 MHz): GC 148.7 (C-8), 145.2 (C-14), 111.6 (C-15), 106.5 (C-17), 73.7 
(C-13), 57.3 (C-9), 55.6 (C-5), 42.2 (C-3), 41.4 (C-12), 40.4 (C-10), 39.1 (C-1), 38.4 (C-
7), 33.6 (C-4), 33.6 (C-19), 27.6 (C-16), 24.4 (C-6), 21.7 (C-18), 19.4 (C-2), 17.7 (C-11) 
and 14.5 (C-20).  
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A6.8 GC-MS Spectrum for larixyl acetate 
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A6.9 GC-MS Spectrum for larixol 
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A6.10 GC-MS Spectrum for epimanool 
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A6.11 GC-MS peaks present for larixyl acetate, larixol and epimanool 
Larixyl acetate: 
Peaks were present at m/z = 55.1 (31.9 %), 69.1 (55.5 %), 81.1 (41.4 %), 91.1 (30.8 %), 
95.1 (47.4 %), 105.1 (45.9 %), 109.1 (37.1 %), 119.1 (43.6 %), 123.1 (47.9 %), 133.1 
(31.3 %), 147.1 (25.5 %), 153.1 (100.0 %), 173.1 (20.9 %), 185.1 (32.2 %), 200.2 
(19.4 %), 227.2 (12.1 %), 242.2 (17.5 %), 255.2 (60.5 %), 270.2 (15.7 %), 333.2 (0.2 %, 
[M - CH3]+).  
 
Larixol: 
Peaks were present at m/z = 55.1 (50.3 %), 69.1 (100.0 %), 81.1 (60.8 %), 91.1 (33.9 %), 
95.1 (68.9 %), 109.1 (96.5 %), 121.1 (47.0 %), 135.1 (38.7 %), 153.1 (61.2 %), 187.1 
(21.9 %), 219.2 (11.9 %), 255.2 (33.8 %), 273.2 (21.3 %), 288.2 (6.1 %), 306.4 (0.01 %, 
[M]+). 
 
Epimanool: 
Peaks were present at m/z = 55.1 (37.5 %), 69.1 (45.8 %), 81.1 (75.3 %), 91.1 (31.6 %), 
95.1 (79.0 %), 107.1 (46.2 %), 123.1 (43.4 %), 137.1 (100.0 %), 189.2 (25.4 %), 257.2 
(65.6 %), 272.3 (14.6 %), 290.3 (0.3 %, [M]+). 
     
Appendix 6 
A132 
A6.12 The UV-Vis spectrophotometric data for larixyl acetate 
 
(1 mg/mL in MeOH) 
 
 
 
 
 
 
 
 
 
 
 
 
Peak Absorbance 
191 -1.738 
193 -1.836 
196 -1.897 
212 1.808 
312 0.04 
331 0.011 
335 0.009 
341 0.005 
  
Appendix 6 
A133 
A6.13 The UV-Vis spectrophotometric data for larixol 
 
(1 mg/mL in MeOH) 
 
 
 
 
 
 
 
 
 
 
 
Peak Absorbance 
193 -1.65 
197 -1.673 
210 2.005 
230 3.487 
236 3.376 
239 3.316 
242 3.43 
286 0.226 
  
Appendix 6 
A134 
A6.14 The UV-Vis spectrophotometric data for epimanool 
 
(1 mg/mL in MeOH) 
 
 
 
 
 
 
 
 
 
Peak Absorbance 
191 -1.445 
195 -1.531 
212 2.288 
216 2.578 
218 2.659 
220 2.709 
357 0.038 
368 0.025 
  
Appendix 6 
A135 
A6.15 The UV-Vis spectrophotometric data for larixyl acetate, larixol and 
epimanool combined  
 
(Combined in a 1:1:1 ratio, with each component having a concentration of 0.1 mg/mL in 
MeOH) 
 
 
 
 
 
 
 
 
Peak Absorbance 
192 -1.826 
195 -1.941 
210 1.566 
222 0.468 
280 0.107 
326 0.009 
359 -0.004 
363 -0.003 
 
 
 
 
 
 
 
Appendix 6 
A136 
A6.16 The UV-Vis spectrophotometric data for Larix_REF  
 
(2 mg/mL in MeOH) 
 
 
 
 
 
 
 
 
 
 
Peak Absorbance 
192 -1.574 
212 1.926 
214 1.928 
260 0.431 
281 0.577 
308 0.365 
310 0.359 
314 0.351 
 
  
Appendix 6 
A137 
A6.17 The UV-Vis spectrophotometric data for Larix oleoresin 
 
(1 mg/mL in MeOH) 
 
 
 
 
 
 
Peak Absorbance 
215 2.588 
217 2.761 
219 2.995 
221 3.073 
231 3.829 
236 3.679 
253 3.832 
261 3.842 
 
 
